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Summary
The bacterial twin-arginine translocase (Tat) pathway is able to export large folded
proteins across the cytoplasmic membrane. It derives its name from the almost
invariant twin-arginine motif present in the signal peptide of Tat substrates.
Components of the Tat pathway have been identified in many bacteria, and in
Escherichia coli one of these essential proteins, TatA, forms large complexes of
variable size. The research presented in this thesis sought to gain insight into the Tat
pathway in E. coli and the cyanobacterium Synechocystis sp. PCC6803, mainly
focusing on the TatA component of the E. coli Tat pathway and how its various
domains contribute to function and complex formation.
Green fluorescent protein tagged with a Tat signal peptide was used to compare the
Tat pathway in E. coli and Synechocystis, using biochemical and bioimaging
techniques. Substitution of the twin-arginine motif with lysine residues highlighted
differences between the specificity of the two systems.
The transmembrane (TM) domain and amphipathic helix (APH) of E. coli TatA were
analysed using synthetic peptides and the TOXCAT assay. Investigation of the TM
domain demonstrated it is α-helical and spontaneously inserts into membranes. It
interacts relatively weakly and substitution of a glutamine does not affect these
interactions or function of the protein at high expression levels. In contrast, the APH
only forms an α-helical secondary structure in high detergent concentration or in the
presence of negatively charged lipids, and does not insert into lipid bilayers.
Analysis of the unstructured C-terminus of TatA led to the identification of an acidic
motif just after the APH. Removal of this motif has a severe effect on function and
complex formation of TatA. Removal of the C-terminus does not affect the
proofreading abilities of TatA.
The research presented here has led to the proposal of a new model for TatA
complex formation in E. coli – the weak interactions of the TM domains bring the
monomers together, whilst interactions between the acidic motif and other regions
stabilise these complexes.
xvi
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The transport of proteins is an essential process in all living cells. A large number of
proteins are not synthesised where they are required and must be directed to different
cellular compartments, often having to cross one or more lipid bilayer membranes.
These lipid membranes play an important role in the cell, separating subcellular
compartments, maintaining ion gradients and compartment composition. However
they also form a barrier which proteins need to cross in order to reach their final
destination. Cells have developed complex translocation pathways in order to
transport proteins across these barriers. Translocation pathways have been
characterised in many different membrane systems, including those of the
endoplasmic reticulum (ER), peroxisomes, chloroplasts, and the inner and outer
membranes of prokaryotes (Aldridge et al., 2009; Brown & Baker, 2008; Cross et
al., 2009; Driessen & Nouwen, 2008; Milenkovic et al., 2007; Rapoport, 2007).
Despite the wide variety and complexity of transport pathways, there are general
principles which are common to most systems (Schatz & Dobberstein, 1996). The
first of these principles is the signal peptide, also known as the signal-, leader-,
targeting-, transit- or pre-sequence. This is a sequence of amino acids, often located
on the amino- (N-) terminus of the substrate, which targets the protein to the correct
cellular compartment (von Heijne, 1990). Its length and composition varies between
pathways, providing recognition specificity. Upon reaching its destination, the signal
peptide is usually cleaved from the precursor protein (preprotein) and the mature
protein is free to function. Chaperones may bind to the preprotein before
translocation, keeping it in the conformation required for transport and also directing
it to the membrane receptor, which recognises the signal peptide. Interactions
between the membrane receptor and the signal peptide lead to association with a
membrane integrated translocation pore. These transmembrane (TM) protein
channels are typically hetero-oligomeric complexes and contain a hydrophilic pore
through which preproteins pass. Gating of the translocation pore prevents leakage
and maintains the integrity of the membrane. Translocation motors also exist to drive
the transport of the preprotein through the TM protein channel. Originally it was
thought that preproteins must be maintained in a largely unfolded conformation
during translocation. However pathways have been discovered which are able to
export folded proteins across membranes without compromising the integrity of the
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membrane. One of these pathways, the twin-arginine translocase (Tat) pathway, is
the subject of this study.
1.1 Protein translocation in bacteria
The structure of a Gram-negative bacterium, such as Escherichia coli, is relatively
simple, Figure 1.1A. Bacterial cells typically have four compartments; the
cytoplasm, the cytoplasmic (inner) membrane, the periplasm and the outer
membrane. Proteins are synthesised in the cytoplasm, however ~20% of proteins
must be targeted to one of the other three compartments or the extracellular medium
via the cytoplasmic membrane (Pugsley, 1993). The majority of proteins are
translocated across the cytoplasmic membrane by the general secretory (Sec)
pathway. Specialised pathways to export proteins to the outer membrane also exist,
reviewed in (Kostakioti et al., 2005). These can either work in conjunction with
cytoplasmic membrane translocation pathways such as the Sec and Tat pathways,
§1.2 and §1.3, or in isolation, translocating the proteins across both the cytoplasmic
and outer membrane in one step. Here, the translocation across the bacterial
cytoplasmic membrane is reviewed, concentrating on the Sec and Tat pathways.
Homologues of the Sec and Tat pathways also exist in plant chloroplast thylakoid
membranes. It is widely accepted that the Gram-negative, photosynthetic
cyanobacteria are the ancestors of plastids in higher plants. As such they present an
interesting study in protein translocation, providing a possible link between thylakoid
and bacterial systems. As well as the cytoplasmic and outer membranes of a typical
Gram-negative bacterium, cyanobacteria also contain an internal thylakoid
membrane system, Figure 1.1B and C. Homologues of the general cytoplasmic
membrane translocation pathways have been identified in cyanobacteria (Aldridge et
al., 2008; Fulda et al., 2000; Nakai et al., 1993; Nakai et al., 1994; Srivastava et al.,
2005), however they have not been characterised like those present in E. coli and
chloroplast thylakoid membranes.
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Figure 1.1 Schematics of Gram-negative and cyanobacterial cells. A. A typical Gram-negative
bacterial cell consists of four compartments, indicated by arrows. B. As well as the four basic
compartments, cyanobacterial cells also have thylakoid lumen and membranes. C. An electron
micrograph of Synechocystis sp. PCC6803 shows the complexity of the cell interior.
1.2 The Sec pathway
In bacteria, the Sec pathway is responsible for the export of the majority of
extracellular proteins. It is also involved in the insertion of membrane proteins into
the bacterial cytoplasmic membrane, reviewed in (Xie & Dalbey, 2008). It has been
identified in the cytoplasmic membrane of both Gram-negative and Gram-positive
bacteria (Driessen & Nouwen, 2008), the thylakoid membrane of chloroplasts
(Aldridge et al., 2009), the endoplasmic reticulum (ER) (Johnson & van Waes, 1999)
and archaea (Bolhuis, 2004). Components of the Sec pathway have also been
identified in cyanobacteria (Nakai et al., 1993; Nakai et al., 1994). The pathway
functions in a similar way in all systems identified so far, with proteins being
exported in an unfolded conformation. In its simplest form the system consists of
Cytoplasm
Outer
membrane
Periplasm
Thylakoid
membrane
Thylakoid
lumen
B
Cytoplasm
C
Periplasm
Cytoplasm
Cytoplasmic
(inner)
membrane
A
Outer
membrane
Cytoplasmic
(inner)
membrane
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protein targeting components, a motor protein and a membrane integrated
translocation pore. Proteins which are destined to be exported by the Sec pathway are
synthesised with a signal peptide which is recognised by protein targeting
components and then directed for export. The signal peptide is on average 24 amino
acids long (Cristobal et al., 1999) and has a tripartite structure, composed of a
positively charged N-terminal region (N-region), a hydrophobic core (H-region) and
a polar C-terminal region (C-region) which normally contains a signal peptidase
cleavage site. In E. coli the hydrophobicity of the signal peptide affects which protein
targeting factors bind and hence determines if the protein is exported co- or post-
translationally (de Gier et al., 1998; Lee & Bernstein, 2001). Integral membrane
proteins do not typically have a signal peptide and instead the hydrophobic TM
domains act as signal peptides.
1.2.1 The components of the Sec pathway
In E. coli translocation by the Sec pathway can proceed by two different routes,
depending on the interactions between the preprotein and the protein targeting
components, signal recognition particle (SRP) and SecB. The bacterial SRP is much
smaller than its eukaryotic homologue and consists of a 4.5 S RNA and a 48 kDa
GTPase P48 or Ffh (fifty four homologue), reviewed in (Egea et al., 2005). SecB is a
cytosolic chaperone which, as well as being involved in the Sec pathway, has also
been shown to have general chaperone activity (Ullers et al., 2004; Zhou et al.,
2001). Depending on the hydrophobicity of the preprotein signal peptide, either SRP
or SecB bind and translocation proceeds co- or post-translationally, respectively, as
discussed in §1.2.2.
The motor protein, which drives translocation of the unfolded preprotein by ATP
hydrolysis, is the soluble SecA protein. This is a central component of the bacterial
Sec pathway and interacts with nearly all other components. Recent structural studies
of SecA homologues from various bacteria have shown that it crystallises as a dimer
(Papanikolau et al., 2007; Sharma et al., 2003; Vassylyev et al., 2006; Zimmer et al.,
2006). It is found to localise to both the cytosol and the cytosolic membrane (Cabelli
et al., 1991), the latter through interactions with anionic phospholipids (Lill et al.,
1990) and the Sec translocation pore (Hartl et al., 1990).
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The Sec translocation pore in E. coli is composed of three integral membrane
proteins, SecY, SecE and SecG, which form a stable complex denoted SecYEG
(Akimaru et al., 1991; Brundage et al., 1990). Structural studies of SecYEG and its
homologues have revealed information on the possible mechanism of translocation
(Breyton et al., 2002; Mitra et al., 2005; van den Berg et al., 2004). SecY is a 10 TM
domain protein, which has its N- and C-termini located on the cytoplasmic side of
the membrane. The 10 TM helices are organised into two separate domains, which
are connected by a periplasmic loop to form a clamshell-like structure with a central
pore. SecE, a 3 TM domain protein, holds together the two domains of SecY, whilst
SecG, with a single TM domain, localises on the periphery of the complex. The
structure of the SecYEG complex reveals a cavity at the periplasmic face of the
membrane which is ‘plugged’ by a periplasmic loop of SecY. It is thought that this
plug is displaced when translocation is initiated and results in an aqueous channel
across the membrane (Harris & Silhavy, 1999). It is likely that the SecY clamshell-
like structure also expands to allow insertion of the signal peptide and the early
mature region of the preprotein in a hairpin-like structure.
1.2.2 Co- and post-translational export
There are two major routes by which proteins are directed to the Sec translocation
pore in E. coli. In the first, which is used mainly by integral membrane proteins, SRP
interacts with the signal peptide or hydrophobic TM domain of the nascent protein,
directing it to be exported co-translationally, Figure 1.2A. The SRP binds to the
ribosome and protein nascent chain, and then interacts with FtsY; a membrane bound
protein which also interacts with SecYEG (Angelini et al., 2005; Bernstein et al.,
1989). This interaction enables FtsY and the Ffh subunit of SRP to bind GTP. Upon
GTP hydrolysis the ribosome and nascent chain complex are transferred to the
SecYEG complex and the protein continues to be translated with the ribosome
driving export or membrane insertion of the protein via SecYEG.
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Figure 1.2 Protein translocation by the Sec pathway in bacteria. Newly synthesised proteins are
directed to the Sec translocase by different routes. A. Co-translationally, preproteins associate with the
signal recognition particle (SRP) and then associate with the Sec translocase via FtsY, which requires
GTP. B. Post-translationally, a preprotein either associates directly with the Sec translocase or binds
SecB, which keeps it in a largely unfolded state and directs it to the translocase. C. After association
with the translocase the protein is threaded through the channel formed by the SecYEG complex,
driven by ATP hydrolysis by SecA. The proton motive force (PMF) can also drive translocation. Once
translocation is completed, the signal peptide is cleaved and the protein is able to fold. Figure adapted
from (Driessen & Nouwen, 2008).
The second route, which is used by the majority of secretory proteins in E. coli,
exports proteins post-translationally, Figure 1.2B. The signal peptide of the protein is
recognised by SecB, which binds to the newly synthesised protein and keeps it in a
largely unfolded conformation. SecB then binds to SecA, the unfolded preprotein is
transferred to SecA, and SecB disassociates. The signal peptide may also bind
directly to SecA, without the need for SecB. Translocation through the SecYEG pore
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complex is initiated by the binding of ATP to SecA, which enables the hairpin-like
structure of the signal peptide and the early mature preprotein to insert, Figure 1.2C.
Upon ATP hydrolysis, the bound preprotein is released and then rebound by SecA.
This rebinding results in the translocation of ~ 2–2.5 kDa of preprotein through the
pore and further binding of ATP also results in translocation of a similar amount of
protein. Subsequent rounds of binding and hydrolysis of SecA result in a stepwise
‘pushing’ of the preprotein through the SecYEG pore complex, until translocation is
complete and SecA disassociates. The proton motive force (PMF) is also involved at
various points of the translocation process, stimulating insertion of the preprotein
(van Dalen et al., 1999) and driving translocation (Driessen, 1992). Upon completion
of translocation the signal peptide of the preprotein is cleaved off by a signal
peptidase SPase I (Paetzel et al., 2002), and the mature protein folds in the
periplasm.
1.2.3 Membrane protein insertion
As well as translocating proteins across the membrane, the co-translational Sec
pathway is involved in the insertion of proteins into the cytoplasmic membrane. The
TM domain of a preprotein can act as a signal peptide and bind SRP, directing it to
SecYEG. Just how SecYEG recognises that the protein must be inserted into the
membrane is still unknown but it is believed that the hydrophobicity of the TM
domain and charge distributions around its flanking region halt translocation (Duong
& Wickner, 1998; von Heijne, 1986; White & von Heijne, 2008; Xie et al., 2007). At
this point it is likely that the SecYEG channel forms a lateral gate through which TM
domains can partition into the lipid bilayer (van den Berg et al., 2004). YidC, a
structural homologue to Oxa1 in mitochondria and Alb3 in chloroplasts, has been
shown to be involved in the insertion of membrane proteins either independently or
in collaboration with the Sec pathway, reviewed in (Xie & Dalbey, 2008). The Tat
pathway is also involved in the insertion of membrane proteins, though to a lesser
extent, as discussed in §1.3.1.
1.3 The Tat pathway
Before the discovery of the Tat pathway, it was thought that the Sec pathway was
solely responsible for the export of proteins across the bacterial cytoplasmic
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membrane. It had also been shown that a Sec-type system was involved in the
translocation of proteins across the thylakoid inner membrane (Laidler et al., 1995;
Schuenemann et al., 1999; Yuan et al., 1994). Export via the Sec pathway is driven
by ATP and the PMF, however a subset of thylakoid lumenal proteins were
identified which did not require ATP for transport but instead depended on the
difference in pH between the lumen of the thylakoid and the stroma (Cline et al.,
1992; Klosgen et al., 1992; Mould & Robinson, 1991). The identification of these
proteins led to the discovery of a new Sec-independent pathway in chloroplasts
termed the ΔpH pathway. Analysis of the signal sequences of proteins exported via
this pathway revealed the presence and importance of a highly conserved twin-
arginine (RR) motif (Chaddock et al., 1995), which later led to the pathway being
termed the twin-arginine translocase (Tat) pathway. Isolation of an export deficient
mutant and identification of a protein involved in the ΔpH pathway, Hcf106, led to
the identification of homologues in prokaryotes (Settles et al., 1997). Components of
the Tat pathway have since been identified in the cytoplasmic membrane of both
Gram-positive and Gram-negative bacteria, archaea and cyanobacteria, with putative
homologues also identified in plant mitochondria (Yen et al., 2002).
Interest in the Tat pathway has grown since its discovery because of its unique
features which distinguish it from other pathways. Unlike the Sec pathway, where
proteins are exported in an unfolded conformation, the Tat pathway is able to export
folded proteins. This has led to commercial interest with a view to secreting complex
heterologous proteins which are not compatible with the Sec pathway (Brüser, 2007;
Kim et al., 2005). Although there are other pathways which can translocate folded
proteins, namely import pathways in the peroxisome (Glover et al., 1994; Walton et
al., 1995) and transport across the nuclear membrane in eukaryotes (Feldherr &
Akin, 1990), the Tat pathway is thus far the only pathway to be identified which
achieves this across a coupled membrane. Additionally, the absence of any Tat
component homologues in animal and fungal cells, and the importance of Tat
substrates in virulence (De Buck et al., 2008) have highlighted the pathway’s
potential as a novel target for antimicrobial drugs.
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1.3.1 The role of the Tat pathway
The Tat pathway is involved in a number of processes in the cell due to its ability to
export folded proteins without compromising the integrity of the membrane. The first
evidence that it is able to export folded proteins came from the identification of Tat
substrates which contained cytoplasmically inserted cofactors, reviewed in (Berks et
al., 2003). Cofactor containing Tat substrates are involved in a variety of processes
in the cell. A major group of Tat substrates are molybdenum containing enzymes,
which catalyse a diverse range of redox reactions including those essential for the
global carbon, nitrogen and sulphur cycles. The most common Tat substrates are
iron-sulphur (FeS) proteins which are involved in generation of radicals and redox
reactions. Other Tat substrates which contain cofactors include hydrogenases and
copper containing proteins. To enable the cofactors to be inserted into these proteins
by cytoplasmic chaperones or other factors, the protein must be substantially or
completely folded. There is no evidence to suggest these cofactors can be bound in
the periplasm so it is believed the proteins must be fully or largely folded when
exported. In addition, prevention of the binding of cofactors has been shown to block
transport of Tat substrates. When the cofactors of trimethylamine-N-oxide (TMAO)
reductase (TorA) are not inserted, it is no longer exported to the periplasm (Santini et
al., 1998), and substitutions in the [4Fe-4S] centre of the FeS protein NrfC, which
were expected to disrupt cofactor binding and folding, result in a complete block of
export (Matos et al., 2008). These studies also suggest some sort of quality control
and proofreading, which is discussed in §1.3.2.
Further evidence for the export of folded proteins comes from the Tat dependent
translocation of proteins apparently without Tat signal peptides. The E. coli
periplasmic nickel-containing hydrogenase 2 is composed of a small subunit
containing a Tat signal peptide and a large subunit which does not contain a signal
peptide. The two subunits are only exported when they both bind their cofactors and
form a complex, which is then targeted to the Tat pathway by the signal peptide on
the small subunit in a so-called hitchhiker mechanism (Rodrigue et al., 1999).
The export of heterologous proteins provides further evidence of the ability of the
Tat pathway to export folded proteins. Green fluorescent protein (GFP) was
demonstrated to be active in both the cytoplasm and periplasm of E. coli when
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targeted with a Tat signal peptide (Thomas et al., 2001). However, when exported
via the Sec pathway, in an unfolded conformation, GFP was apparently unable to
fold correctly after translocation and was not active in the periplasm (Feilmeier et al.,
2000). It was also demonstrated that PhoA was only transported if its native
disulphide bonds, which stabilise its structure, were able to form (DeLisa et al.,
2003).
The ability to export folded proteins is important, and this is certainly the case for the
archaeon Halobacterium sp. strain NCR-1, which exports the majority of its
secretory proteins via the Tat pathway (Bolhuis, 2002; Rose et al., 2002). The
extensive use of the Tat pathway is most likely due to the need for proteins to fold in
the cytoplasm and avoid aggregation caused by the virtually saturating levels of salt
present in their environment.
In addition to translocation of folded proteins across membranes, the Tat pathway
also demonstrates a novel mechanism for the insertion of proteins into the membrane
(De Buck et al., 2007; Hatzixanthis et al., 2003; Summer et al., 2000). In E. coli five
predicted Tat substrates were indentified that contained a single C-terminal α-helical
TM domain (Hatzixanthis et al., 2003; Sargent et al., 2002). Fusion of these C-
terminal domains to periplasmic soluble proteins led to membrane localisation,
demonstrating the Tat pathway’s involvement in insertion. Bioimaging of the
cyanobacterium Synechocystis sp. PCC6803 has also demonstrated that the predicted
Tat substrate, PetC3, localises to the membrane (Aldridge et al., 2008). The
mechanism by which proteins are inserted is as yet unknown. It is likely that
recruitment of the substrate to the membrane and translocation are two separate
events since in Legionella pneumophila the Rieske FeS protein, PetA, was still
inserted into the membrane in Tat deletion strains but in the incorrect orientation (De
Buck et al., 2007).
The Tat pathway has also been highlighted as playing a role in the virulence of
bacteria. Homologues of components of the Tat pathway have been identified in a
number of human and plant pathogens including E. coli O:157, Pseudomonas
aeruginosa, Mycobacterium tuberculosis and Agrobacterium tumefaciens (Dilks et
al., 2003; Yen et al., 2002). Tat deletion strains of these pathogens demonstrate
multiple phenotypes including effects on infection, iron acquisition, biofilm
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formation and response to stress conditions, reviewed in (De Buck et al., 2008). In
M. tuberculosis difficulty in obtaining tat mutants indicates that the Tat pathway
could be essential under standard laboratory conditions (Saint-Joanis et al., 2006).
However, to date only one protein with a direct role in virulence has been confirmed
as a Tat substrate, the phospholipase C protein (De Buck et al., 2005; McDonough et
al., 2005; Saint-Joanis et al., 2006; Voulhoux et al., 2001). More research must be
undertaken to understand just how the Tat pathway affects virulence and which
proteins are involved. Nonetheless, studies have so far demonstrated that the Tat
pathway is important for virulence and may be a good candidate for the target of
novel antimicrobial drugs.
1.3.2 Proofreading and quality control
The Tat pathway is believed to be dedicated to the transport of folded proteins, often
with cofactors bound, but how does the cell ensure that proteins are correctly folded
and have their cofactor inserted before translocation? The transport of misassembled
proteins could interfere with correctly assembled proteins, slow the translocation
process down and be costly in terms of resources. The proposed solution is the
existence of a proofreading or quality control mechanism, which rejects incorrectly
assembled proteins, reviewed in (Sargent, 2007). The existence of such a mechanism
is supported by studies demonstrating that the E. coli TorA was only exported upon
cofactor insertion (Santini et al., 1998), and PhoD, heterologously expressed with a
Tat signal peptide, could only be exported when correctly folded (DeLisa et al.,
2003).
For a subset of cofactor binding proteins, this quality control is provided by the
existence of cytosolic chaperones. This is the case for the widely studied E. coli
TorA, whose chaperone has been identified as TorD (Ilbert et al., 2003; Jack et al.,
2004). This chaperone binds to the signal peptide of TorA, preventing recognition of
the twin-arginine motif until the cofactor is correctly inserted and TorA is ready for
export. Similar chaperones have been identified for a number of cofactor binding
proteins (Oresnik et al., 2001; Potter & Cole, 1999) but these all appear to be
substrate-specific and no binding affinity to other Tat substrates has been observed
(Hatzixanthis et al., 2005). The existence of a more general quality control
mechanism, which recognises hydrophobic stretches, has been proposed (DeLisa et
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al., 2003). This is supported by research which demonstrated that the export of
globular proteins via the Tat pathway could be blocked by the insertion of exposed
hydrophobic stretches (Richter et al., 2007).
More recently, the role of the components of the Tat pathway in the rejection and
subsequent degradation of unfolded proteins has been demonstrated (Matos et al.,
2008; Matos et al., 2009). Mutated NrfC which could not correctly bind cofactors
was not exported and was instead quickly degraded in wild-type cells. It was also
demonstrated that the E. coli Tat pathway components, TatA, TatE and TatD, play a
role in the rejection and degradation of the misassembled proteins, discussed in
§1.3.4. This indicates that the Tat substrates interact extensively with the components
of the Tat pathway before rejection and subsequent degradation.
Relatively little is still known about the exact mechanism of proofreading and quality
control. Although some components involved in this process have been identified, it
is still not clear how the misassembled proteins are identified. The situation is further
complicated by the ability of the thylakoid Tat system to tolerate incorrectly folded
protein (Hynds et al., 1998), demonstrating there is still much work to be done.
1.3.3 The Tat signal peptide
Apart from a few specialised systems (e.g. type I secretion), proteins destined for
export are synthesised with a signal peptide (as discussed above). Like the Sec signal
peptide the Tat signal peptide has a tripartite structure, with a polar N-region,
hydrophobic H-region, and polar C-region, Figure 1.3. It typically contains an Ala-
Xaa-Ala (A-x-A) cleavage motif, where Xaa is any amino acid, at the end of the C-
region where the signal peptide is cleaved off after translocation. Investigations into
the secondary structure of the Tat signal peptides indicate that they are largely
unstructured in an aqueous environment (Kipping et al., 2003; San Miguel et al.,
2003). However, in a membrane mimicking environment the SufI signal sequence
was shown to be 40% α-helical (San Miguel et al., 2003). This is similar to the Sec
signal peptide whose secondary structure depends on the local environment (Jones et
al., 1990).
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Figure 1.3 The Tat signal peptide. A typical tripartite signal peptide structure applies to Tat signal
peptides; a polar amino domain (N-region), hydrophobic core (H-region), and polar carboxyl domain
(C-region). Tat signal peptides are distinguished by the presence of a twin-arginine containing motif at
the end of the N-region. They are also typically longer and less hydrophobic than Sec signal peptides.
The cleavage motif at the end of the C-region, A-x-A, where the signal peptide is cleaved off to form
the mature protein is also shown.
Tat signal peptides contain distinct properties which enable cells to differentiate them
from Sec signal peptides. Sequence analysis of Tat substrates revealed the existence
of an almost invariant twin-arginine motif in the N-region, which gave rise to the
pathway’s name (Berks, 1996; Chaddock et al., 1995). Further analysis of bacterial
Tat signal peptides revealed a highly conserved seven amino acid motif; T/S-R-R-x-
F-L-K, where x is any amino acid (Berks, 1996; Stanley et al., 2000), and the other
amino acids appear with a frequency of more than 50% in Gram-negative bacteria.
The RR-motif of the signal peptide is almost invariant in all Tat substrates analysed
thus far. Naturally occurring Tat substrates without RR-motifs have, however, been
identified – E. coli penicillin amidase with an RNR motif (Ignatova et al., 2002), and
the TtrB subunit of Salmonella enterica tetrathionate reductase with a KR motif
(Hinsley et al., 2001). The conservative substitution of a single arginine with lysine
does not always block transport of substrates in E. coli (Buchanan et al., 2001;
DeLisa et al., 2002; Stanley et al., 2000), indicating other factors may be involved.
This is supported by evidence that the residues in position -1 and +2, with respect to
RR, are also important for translocation by the E. coli and Bacillus subtilis Tat
systems (Mendel et al., 2008). In contrast, substitution of either of the arginines with
lysine blocks transport in the thylakoid Tat pathway (Chaddock et al., 1995),
demonstrating potential differences between the bacterial and thylakoid Tat
pathways. The consensus Tat signal sequence is also different in thylakoids; R-R-x-
x-Φ, where Φ is leucine, phenylalanine, valine or methionine (Brink et al., 1998).
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As well as the twin-arginine motif, Tat signal peptides also differ from Sec signal
peptides in several other ways. Tat signal peptides are typically longer than their Sec
counterparts, with an average length of 38 amino acids (Cristobal et al., 1999). Sec
signal peptides are also more hydrophobic, and increasing the hydrophobicity of Tat
signal peptides can convert them into Sec signals (Cristobal et al., 1999; Ize et al.,
2002). Additional basic residues in the C-region (Bogsch et al., 1997; Ize et al.,
2002) and a proline in the H-region (Cristobal et al., 1999; Ize et al., 2002) have also
been identified as playing a role in Tat signal peptide recognition.
Despite differences in the importance of the RR-motif in the thylakoid and bacterial
Tat pathways, there is a high level of conservation of the Tat signal peptide between
different species. This has been demonstrated by the ability of Tat signal peptides to
direct transport when expressed heterologously in different organisms. Several
studies have shown export of bacterial proteins in plants (Halbig et al., 1999; Mori &
Cline, 1998; Wexler et al., 1998) and the signal peptide of E. coli TorA efficiently
directs the export of GFP when expressed in the cyanobacterium Synechocystis
(Spence et al., 2003). However, not all Tat substrates are transferable as
demonstrated by the lack of export of B. subtilis PhoD and Zymomonas mobilis
GFOR proteins in E. coli.
Several bioinformatic tools have been developed to aid the identification of Tat
substrates (Bendtsen et al., 2005; Dilks et al., 2003; Rose et al., 2002; Taylor et al.,
2006). These programs have proved quite accurate in identifying Tat substrates,
however the need to confirm predictions experimentally is also important as several
proposed Tat substrates in B. subtilis have since been demonstrated to be Sec
substrates (Jongbloed et al., 2002). Nonetheless, bioinformatics can provide a useful
tool in highlighting potential Tat substrates.
1.3.4 Components of the Tat pathway
The first gene to be identified and characterised in the Tat pathway was the maize
hcf106 gene (Settles et al., 1997; Voelker & Barkan, 1995). Analysis of the E. coli
genome revealed the existence of two homologous genes, tatA and tatB, and led to
the identification of three membrane proteins which are necessary for the function of
the Tat pathway; TatA, TatB and TatC (Bogsch et al., 1998; Sargent et al., 1998;
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Weiner et al., 1998). In E. coli, genes encoding these three proteins form an operon
along with a fourth gene, tatD, Figure 1.4. Although no role in the Tat translocation
process has been identified for TatD (Wexler et al., 2000), recent research has
highlighted its role in the quality control mechanism of the Tat pathway (Matos et
al., 2009). A fifth monocistronic gene, tatE, which is homologous to tatA and tatB
has also been identified. It is believed that TatA and TatE have overlapping function
or similar roles, as only deletion of both genes can stop translocation (Sargent et al.,
1998). TatA is expressed at much higher levels than TatE (Jack et al., 2001), so it is
thought that tatE is a cryptic gene duplication of tatA, and studies have concentrated
on TatA. All of the E. coli tat genes are expressed at constitutive levels in a variety of
growth conditions (Jack et al., 2001), indicating that the Tat pathway is involved in a
number of processes in the cell.
tatA tatB tatC tatD
tatE
E. coli 86.6 min
E. coli 14.2 min
Figure 1.4 Chromosomal organisation of the genes encoding the Tat components in E. coli. tatA,
tatB and tatC, which are all essential for function, are organised in an operon along with a fourth gene,
tatD. A putative hairpin structure is seen between tatC and tatD. tatE is monocistronic and is most
likely a cryptic gene duplication of tatA as the product of the genes are functionally interchangeable.
Figure adapted from (Palmer & Berks, 2003).
The Tat pathway is present in many organisms, and homologues of the E. coli Tat
components have been identified and characterised in a number of different species
(Yen et al., 2002). The number of components involved in the Tat pathway can vary
between species. Thylakoids and Gram-negative bacteria typically have pathways
consisting of two TatA/B/E homologues and one TatC homologue. The majority of
Gram-positive bacteria contain pathways which only consist of one TatA/B/E
homologue and one TatC homologue, with some, such as B. subtilis, containing
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multiple Tat pathways that operate in parallel (Dilks et al., 2003; Jongbloed et al.,
2006; Yen et al., 2002).
1.3.4.1 TatA
Despite being the smallest of the three proteins involved in the E. coli Tat pathway,
TatA is the most abundant, with ~25- and ~50-fold higher expression than TatB and
TatC, respectively (Jack et al., 2001). TatA has been shown to form large homo-
oligomeric complexes and because of this is thought to form the translocation pore of
the Tat pathway (Gohlke et al., 2005; Oates et al., 2005). This 89 amino acid
membrane protein is predicted to have an N-terminal α-helical TM domain, followed
by a short ‘hinge’ region, an α-helical amphipathic helix (APH) and a largely
unstructured C-terminus domain, Figure 1.5 and Figure 1.6. Although predicted to
have an N-out topology, the exact orientation of TatA has not been proved
conclusively. Protease accessibility experiments indicate that it has an N-out
topology (Porcelli et al., 2002), however a recent study probing the accessibility of
single cysteine mutants to thiol-reactive components concluded that it has an N-in
topology (Chan et al., 2007). This study also suggested a dual topology for the C-
terminus of TatA, a hypothesis previously put forward in a study using TEV protease
accessibility and reporter fusion constructs (Gouffi et al., 2004). Both studies
proposed that the APH of TatA could insert into the membrane as part of the
translocation process thus giving the C-terminus a dual topology. Although it has
been demonstrated that TatA expressed without its TM domain can still interact with
liposomes and phospholipid monolayers (Porcelli et al., 2002), no insertion into lipid
bilayers has been demonstrated. Research into the B. subtilis TatA homologue,
TatAd, demonstrated that whilst the predicted TM domain was able to insert into
lipid bilayers, there was no evidence of insertion of the APH (Lange et al., 2007).
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Figure 1.5 Predicted structure and topological arrangement of the E. coli Tat components. TatA
and TatB are predicted to have a similar secondary structure; an N-terminal α-helical TM domain,
followed by a short ‘hinge’ region, an α-helical amphipathic helix and a largely unstructured C-
terminal region. They are both predicted to have an N-out topology. TatC is a six TM domain protein
with both its N and C-termini located in the cytoplasm.
A number of mutagenesis studies have been performed on TatA, highlighting the
importance of several residues (Barrett et al., 2003a; Barrett et al., 2005; Greene et
al., 2007; Hicks et al., 2003; Hicks et al., 2005). In a recent cysteine scanning study,
where single amino acids in the TM domain and APH were substituted by cysteine,
the majority of the substitutions in the APH lead to loss of function, indicating the
sensitivity of the APH to substitution (Greene et al., 2007). Several other loss-of-
function substitutions also localise to the APH (Barrett et al., 2005; Hicks et al.,
2003; Hicks et al., 2005). The single substitution of a phenylalanine (Phe39), and the
triple substitution of three lysines in the APH (Lys37, Lys40, Lys41) both lead to a
block of export, Figure 1.6. The Phe39 substitution is dominant and blocks export
even in the presence of wild-type TatA (Hicks et al., 2003). The cysteine scanning
study also highlighted a glutamine in the TM domain (Gln8), which when substituted
with cysteine or alanine blocked function (Greene et al., 2007). A glutamic acid in a
similar position of the thylakoid Tha4 TM domain (Glu10) is also important for
function (Dabney-Smith et al., 2003).
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101 cgtcgatcaa aggctttaaa aaagcaatga gcgatgatga accaaagcag
A S I K G F K K A M S D D E P K Q
151 gataaaacca gtcaggatgc tgattttact gcgaaaacta tcgccgataa
D K T S Q D A D F T A K T I A D
201 gcaggcggat acgaatcagg aacaggctaa aacagaagac gcgaagcgcc
K Q A D T N Q E Q A K T E D A K R
251 acgataaaga gcaggtgtaa
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Figure 1.6 The TatA sequence and predicted secondary structure. A. Numbered sequence of tatA
(lowercase), with the translated sequence of TatA (bold uppercase). The secondary structure predicted
by PSIPRED v2.5 is shown with the α-helical domains highlighted; TM domain (blue), APH (red), C-
terminal domain (grey). B. Schematic of TatA in the membrane with the predicted topology. The TM
domain and APH are shown in blue and red, respectively. A glutamine in the TM domain which is
discussed in this chapter is shown in orange, an acidic motif identified in Chapter 6 is shown in green,
three lysines in the APH which are important for function, and a GxxxG motif are also labelled.
The TM domain and APH are highly conserved in TatA homologues, however the C-
terminus varies widely in composition, Appendix A. The TM domain of TatA is
essential for translocation and upon its deletion TatA becomes soluble (De Leeuw et
al., 2001; Porcelli et al., 2002). Substitution of the TatA TM domain with the
homologous TM domain from TatB leads to a loss of function, demonstrating that it
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is not just a membrane anchor (Lee et al., 2002). It is thought the TatA TM domain is
involved in interactions which drive the formation of TatA complexes, §1.3.4.5 (De
Leeuw et al., 2001; Greene et al., 2007; Porcelli et al., 2002). In contrast, the C-
terminus of TatA appears to be non-essential for function. Truncations by up to 40
amino acids from the C-terminus of E. coli TatA are still able to function (Lee et al.,
2002). This was also demonstrated for the thylakoid TatA homologue, Tha4,
(Dabney-Smith et al., 2003).
There is some evidence that as well as functioning in the membrane, TatA may be
present in the cytoplasm in some bacteria. Soluble TatA homologues have been
recovered from the Gram-positive bacteria Streptomyces lividans (De Keersmaeker
et al., 2005) and B. subtilis (Pop et al., 2003). A recent study has also observed the
formation of cytoplasmic ‘tubes’ upon the overexpression of TatA in E. coli
(Berthelmann et al., 2008). The physiological relevance of these tubes is
questionable as E. coli TatA has previously been observed only in the membrane
(Sargent et al., 2001), where it is resistant to extraction by salt, alkali and urea (De
Leeuw et al., 2001). Another recent study demonstrated TatA tagged with yellow
fluorescent protein (YFP) and expressed at native levels localises exclusively to the
membrane (Leake et al., 2008).
As well as being essential for function, a recent study has indicated that TatA, in
conjunction with TatE, might be involved in the degradation of misfolded FeS
proteins, rejected by the Tat pathway (Matos et al., 2008). In wild-type cells the
misassembled NrfC was quickly degraded after rejection by the Tat pathway,
whereas it was stable in a tatA/E deletion strain.
1.3.4.2 TatB
E. coli TatB shares ~25% homology with TatA and is predicted to have the same
secondary structure, Figure 1.5. At 171 amino acids and 18.4 kDa, TatB is almost
double the size of TatA and has a longer APH and C-terminal domain. It is able to
interact with TatC to form the translocation receptor of the Tat pathway, §1.3.4.5.
Similar to TatA, the C-terminal domain of TatB is not essential for function and up
to 70 amino acids can be removed from the C-terminus without affecting function
(Lee et al., 2002). However TatB does differ from TatA in a number of ways. Unlike
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TatA, the TM domain of TatB is not believed to play a role in function and complex
formation (Lee et al., 2002). Although severely compromised, substitution of the TM
domain of TatB with the homologous TM domain from TatA does not completely
abolish function of the Tat pathway (Lee et al., 2002).
Although sequence alignments reveal that several amino acids are highly conserved
in TatB homologues, mutagenesis studies have so far not highlighted any residues as
being essential for function (Barrett et al., 2003a; Hicks et al., 2003; Lee et al.,
2006). Only when selected substitutions were co-expressed with mutated TatA was
any abolishment of function observed, indicating that TatA and TatB interact as part
of the translocation process (Barrett & Robinson, 2005).
Due to the similarity of TatA and TatB it is not always possible to distinguish them
in other organisms. Although in proteobacteria such as E. coli TatB typically has an
extended APH and C-terminal domain, this is not always the case. TatA homologues
are usually identified by an invariant phenylalanine and glycine in the hinge region
(Phe20 and Gly21 in E. coli TatA), and a highly conserved phenylalanine in the APH
(Phe39 in E. coli TatA) (Hicks et al., 2003). Whereas TatB homologues normally
contain an invariant glutamic acid in the TM domain (Glu8 in E. coli TatB) (Sargent
et al., 1999), and a proline after the hinge region glycine (Gly21 and Pro22 in E. coli
TatB) (Hicks et al., 2003; Weiner et al., 1998). These are not defining features, as
thylakoid Tha4 and Hcf106, and two identified TatA/B homologues from the
cyanobacterium Synechocystis, Slr1046 and Ssl2823, contain a FGP sequence in the
hinge region (Aldridge et al., 2008).
In some bacterial systems no TatB homologue is required and the Tat pathway
functions as a TatAC system (Dilks et al., 2003; Yen et al., 2002). This has led to the
hypothesis that in these systems the TatA/B homologue may be bifunctional and
takes the role of both TatA and TatB. This has been demonstrated for the TatAdCd
system from B. subtilis (Barnett et al., 2008). Expression of TatAd was able to
restore function in E. coli strains lacking either TatA/E or TatB. For Synechocystis,
both of the TatA/B homologues, Slr1046 and Ssl2823, could restore function in the
absence of TatA/E or TatB in E. coli (Aldridge et al., 2008), indicating the additional
feature of thylakoid membranes may mean the Tat components have to fulfil
multiple roles. In E. coli TatA mutants have been isolated which are capable of
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complementing strains lacking TatB (Blaudeck et al., 2005). All of the substitutions
in the bifunctional TatAs localised to the extreme N-terminal region of TatA,
highlighting this region as important for TatB function.
1.3.4.3 TatC
At 28.9 kDa TatC is the largest of the three Tat components in E. coli. Its 258 amino
acids form six TM domains and insert into the membrane with both the N- and C-
termini located in the cytoplasm, Figure 1.5, (Behrendt et al., 2004; Jeong et al.,
2004). TatC interacts with TatB to form the receptor complex of the Tat pathway and
is widely accepted to be the site of signal peptide recognition (Alami et al., 2003;
Cline & Mori, 2001). Several mutagenesis studies of TatC have been performed
(Allen et al., 2002; Barrett et al., 2005; Buchanan et al., 2002; Punginelli et al.,
2007), resulting in the detection of two residues important for function; a
phenylalanine in the second TM domain (Phe94), and a proline in the first
periplasmic loop (Pro48) which is also important for the assembly of Tat complexes.
1.3.4.4 TatD
Although tatD is in the same operon as tatABC it was originally thought that TatD
was not involved in the Tat pathway. TatD deletion strains showed no effect on the
translocation of Tat substrates and only DNase activity of TatD was identified
(Wexler et al., 2000). More recently it has been demonstrated that TatD plays a role
in the degradation of misfolded Tat substrates which have been rejected for export
(Matos et al., 2009). Mutated FeS proteins, which could not bind their cofactors,
were rapidly degraded in wild-type cells. However in tatD deletion strains, the
mutated proteins were not degraded and remained stable for several hours. The exact
role of TatD is still uncertain and it will be important to determine whether this
quality control is specific to FeS proteins or part of a more general quality control
mechanism.
1.3.4.5 Component organisation
In E. coli the three main components of the Tat pathway come together in the
cytoplasmic membrane to form two distinct types of complex; a TatABC complex
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and separate TatA complexes. The TatABC complex has been purified and shown to
contain equal amounts of TatB and TatC, with small and variable amounts of TatA
(Bolhuis et al., 2001). This complex was estimated to be ~600 kDa, so clearly
contains multiple copies of the Tat components. Complexes purified from a mutant
where the C-terminus of TatB was fused to the N-terminus of TatC were also
estimated to be ~600 kDa, indicating that TatB and TatC have a 1:1 stoichiometry
(Bolhuis et al., 2001). TatABC complexes from other eubacteria have also been
purified and are estimated to be of a similar size (Oates et al., 2003). Electron
microscopy reveals they form elliptical complexes with a maximum diameter of 13
nm (Oates et al., 2003). In the thylakoid Tat pathway Hcf106 and cpTatC also form a
complex of ~700 kDa, however no Tha4 is found associated (Cline & Mori, 2001).
The majority of TatA is found in separate homo-oligomeric complexes that range in
size from less than 100 kDa to well over 500 kDa (Gohlke et al., 2005; Leake et al.,
2008; Oates et al., 2005). Electron microscopy and random conical tilt
reconstructions of purified complexes reveal they form ring-like structures with a lid
structure and variable diameter (Gohlke et al., 2005). A recent study using confocal
microscopy to image TatA tagged with YFP at native levels observed that these
complexes were mobile in the membrane (Leake et al., 2008). Calculation of
diffusion rates for different sized complexes and fitting to proposed models for
complex conformation confirmed the complexes formed ring-like structures. This
has led to the hypothesis that the TatA complexes form the translocation pore
through which the Tat substrates are exported, with the heterogeneity of the
complexes corresponding to the need to export different sized substrates. Indeed the
calculated diameters of the TatA complexes, 30–70 Å (Gohlke et al., 2005),
correspond well to the size of E. coli Tat substrates (Berks et al., 2000; Sargent et al.,
2002). Counter to this hypothesis, it has been shown that TatA heterogeneity is
unaffected in export defective TatC mutants (Barrett et al., 2005; Oates et al., 2005).
The formation of such heterogeneous complexes by a single-span membrane protein
is highly unusual and the mechanism of complex assembly is still unknown. The
TatA complexes vary in size by multiples of 3 to 4 TatA molecules, suggesting
trimeric or tetrameric subunit organisation (Leake et al., 2008; Oates et al., 2005).
This agrees with cross-linking studies where TatA was shown to form trimers and
Chapter 1. Introduction
24
tetramers in E. coli membranes (De Leeuw et al., 2001). It was recently observed
that in the absence of TatB and TatC, TatA did not form large complexes, as
determined by in vivo confocal imaging (Leake et al., 2008). However, TatA did still
form smaller complexes, which were estimated to contain an average of four
monomers. It has been proposed that the TM domain of TatA has a key role in
oligomerisation (De Leeuw et al., 2001; Greene et al., 2007; Porcelli et al., 2002).
When expressed without its TM domain, TatA purifies as a soluble monomer and
loses some of its secondary structure (Porcelli et al., 2002). Additionally, a glutamine
in the TM domain (Gln8) has been highlighted as important for function (Greene et
al., 2007). Polar residues in TM domains have been shown to be involved in the
oligomerisation of membrane proteins (Gratkowski et al., 2001; Zhou et al., 2001),
as discussed in §1.4. A recent study of the thylakoid Tha4 used cross-linking to show
that Tha4 oligomers associate through their TM domains in unstimulated
membranes, and formed higher order oligomers when stimulated by the addition of a
Tat substrate (Dabney-Smith & Cline, 2009).
1.3.5 Proposed mechanism of translocation
Despite identification of the components and complexes involved in the Tat pathway,
the exact translocation mechanism is still unknown. Unlike the Sec pathway, it does
not use ATP hydrolysis but instead is driven by the PMF, which is composed of a pH
gradient (ΔpH) and an electric field gradient (Δψ). After transcription, folding and
insertion of any cytosolic cofactors, the signal peptide of the Tat substrate is thought
to interact with the membrane (Hou et al., 2006; Shanmugham et al., 2006). Since
the signal peptide becomes α-helical in the presence of membranes (San Miguel et
al., 2003), it is possible that this interaction enables the signal peptide to take on its
correct secondary structure in order to interact with the Tat translocon. The first step
in the translocation process is the targeting of the substrate to the Tat translocon,
Figure 1.7. This is an energy-independent mechanism (Alami et al., 2002; Musser &
Theg, 2000b; Yahr & Wickner, 2001) and, apart from the substrate specific
chaperones (§1.3.2), occurs without the assistance of additional factors (Alami et al.,
2002; Mould & Robinson, 1991). TatB and TatC in the TatABC complex are
believed to form the substrate recognition component of the Tat translocase. The RR-
motif of the substrate signal peptide initially interacts with TatC, and then TatB
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interacts more extensively with the substrate (Alami et al., 2003; Gerard & Cline,
2006). After recognition of the Tat substrate and binding, free TatA is recruited to
the TatABC complex in a PMF-dependent manner (Alami et al., 2003; Dabney-
Smith et al., 2006; Mori & Cline, 2002). It is widely believed that the TatA
complexes form a translocation pore through which the protein is exported (Gohlke
et al., 2005). In this model, the C-terminus of TatA flips into the periplasm, possibly
mediated by the insertion of the APH into the membrane (Gouffi et al., 2004), and
forms a hydrophilic channel through which the protein can pass, Figure 1.7. After
translocation, TatA disassociates from TatBC and the system returns to a resting
state.
Cytoplasmic
membrane
TatABC
PMF
Periplasm TatA
Cytoplasm
Figure 1.7 Proposed mechanism of transport via the Tat pathway. The signal peptide of the folded
Tat substrate, possibly with bound substrate, binds to the TatABC complex via TatC and then TatB.
TatA from separate complexes is recruited in a PMF dependent manner. The folded protein is
translocated across the membrane, possibly through a pore formed by TatA. Upon translocation the
signal peptide is cleaved and the mature protein is released into the periplasm.
The ability of the Tat pathway to translocate proteins using only the PMF is unusual
amongst protein translocation systems. Most research has concentrated on the
thylakoid Tat pathway, which was originally named the ΔpH pathway due to its 
reliance on the pH gradient of the PMF (Alder & Theg, 2003b; Mori & Cline, 2002;
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Mould & Robinson, 1991). Since only the ΔpH is required, it has been proposed that
proton transfer is coupled to protein transport and the counter movement of protons
drives translocation (Alder & Theg, 2003a; Musser & Theg, 2000a). It has been
calculated that on average 7.9 × 104 protons are released from the gradient per
translocated substrate, which is equivalent to 104 ATP molecules and is ~3% of the
total proton pumping capacity of chloroplasts (Alder & Theg, 2003a). Although this
reliance on the ΔpH is widely accepted, one study observed that in vivo the thylakoid
Tat pathway could be driven by the Δψ (Finazzi et al., 2003). This was also observed
in the bacterial Tat pathway, where it was demonstrated that two electric potentials
were required at different time points in the translocation process (Bageshwar &
Musser, 2007). The requirement for two Δψ suggests translocation is a two-step
process. The exact driving force of the Tat pathway may also depend on the
organism, as a recent study demonstrated that Tat dependent export of α-amylase in
the haloarchaeon Haloarcula hispanica is driven by the sodium motive force (Kwan
et al., 2008).
1.4 Membrane protein complex formation
It has been demonstrated that two different membrane protein complexes play an
important role in the Tat pathway. Understanding the formation of the TatABC and
TatA complexes could reveal important structural information and provide insight
into the mechanism of transport. The widely accepted model for membrane protein
folding and complex formation is known as the two-stage model (Popot &
Engelman, 1990; Popot & Engelman, 2000), Figure 1.8. According to this model,
membrane proteins fold in two energetically distinct steps. In the first step, the TM
domains of membrane proteins insert into the membrane and take on their α-helical
secondary structure, which has been demonstrated by the stable insertion and
secondary structure formation of TM domains when synthesised individually (Ding
et al., 2001; Lazarova et al., 2004). In the second stage lateral helix-helix interactions
drive the folding of functional, globular membrane proteins or membrane protein
oligomers. This has been demonstrated by the ability of membrane proteins split into
two or more fragments to assume their correct conformation (Kahn & Engelman,
1992).
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Figure 1.8 The two-stage model for membrane proteins. The TM domains of membrane proteins
insert into the membrane and form a stable α-helical secondary structure. Helix-helix interactions then
drive the assembly of individual proteins and protein complexes.
Several motifs have been identified that can drive the association of TM domains
(Russ & Engelman, 2000; Senes et al., 2000). One of the identified motifs is Gly-
Xaa-Xaa-Xaa-Gly (GxxxG), two glycine residues separated by three other amino
acids. The glycines in this motif appear on the same face of the helix and allow close
packing of helices. The presence of hydrophilic residues in TM domains has also
been shown to drive TM helix–helix association via electrostatic interactions and
formation of interhelical hydrogen bonds (Dixon et al., 2006; Freeman-Cook et al.,
2004; Zhou et al., 2001). The E. coli TatA protein contains a glutamine in its TM
domain which has been shown to be important for function, however it has not been
demonstrated if it is also important for complex formation (Greene et al., 2007).
Additionally the APH of TatA contains a GxxxG motif, which may be important for
helix packing if the APH inserts into the membrane.
Other factors have also been identified that may play a role in membrane protein
complex formation. The insertion and subsequent association of TM domains may
provide an environment which facilitates further folding events and stabilisation of
complexes (Engelman et al., 2003). The immediate environment of the TM domains
is less hydrophobic than the lipid bilayer and this may assist the insertion or
stabilisation of further parts of the protein.
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1.5 Aims of the work presented in this thesis
The overall aims of the work presented in this thesis were to gain further insight into
the specificity of the Tat pathway in Synechocystis, and to elucidate the importance
of the different structural components of E. coli TatA for function and complex
formation. In order to realise these aims, work was undertaken to answer the
following questions:
 Are there differences in the recognition of Tat substrates by the Tat pathways
in Synechocystis and E. coli?
The importance of the RR-motif in the signal peptide of Tat substrates has been
analysed in both bacteria and chloroplasts. To determine if the specificity of the
Synechocystis Tat pathway resembled that of E. coli, transport of a Tat substrate was
analysed in both bacteria using an export assay and bioimaging.
 Does the TM domain of E. coli TatA play a role in function and complex
formation?
A synthetic peptide of the E. coli TatA TM domain was analysed using a variety of
biophysical techniques to determine its membrane insertion and oligomeric state. The
TM domain was also analysed using the TOXCAT assay, which is used to assess
interactions between TM domains (Russ & Engelman, 1999). The role of a glutamine
residue in the TM domain was also analysed.
 Is the APH of E. coli TatA able to insert into membranes and contribute to
complex formation?
The ability of the APH of E. coli TatA to insert into membranes was assessed using a
synthetic peptide and the TOXCAT assay. The oligomeric state of the synthetic
peptide was also determined.
 Do parts of the C-terminal domain of E. coli TatA contribute to function and
complex formation?
Although not essential for function (Lee et al., 2002), the C-terminus of E. coli TatA
was analysed to identify any important motifs. Its role in the proofreading of Tat
substrates was also assessed.
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2.1 Suppliers of reagents and chemicals
Reagents used in this study were of the highest grade available and were supplied by
Fisher Scientific (UK), Sigma (UK) or VWR (UK), unless otherwise stated.
2.2 Bacterial strains
Table 2.1 Escherichia coli strains used in this study.
Strain Genotype Reference
DH5α supE44, lacU169(80lacZM15), hsdR17, recA1,
endA1, gyrA96, thi-1, relA1
(Sambrook &
Russell, 2001)
MC4100 F- lacU169 araD139 rpsL150 relA1 ptsF rbs
flbB5301
(Casadaban &
Cohen, 1979)
ΔABCDE MC4100; ΔtatABCDE, Arar (Bolhuis et al.,
2000)
ΔAE MC4100; ΔtatAE, Arar (Bolhuis et al.,
2000)
NT326 F−(argF-lac)U169, rpsL150, relA1, rbsR, flbB5301,
ptsF25, thi-1, deoC1, ΔmalE444, recA, srlA+
(Treptow &
Shuman, 1985)
The laboratory strain of Synechocystis sp. PCC 6803 (Rippka et al., 1979), which
exhibits a spreading morphology and does not utilise glucose, was used for all
cyanobacteria work.
2.3 Plasmids
Table 2.2 Previously generated plasmids used in this study.
Plasmid Details Reference
pBAD24 Cloning Vector araC, Ampr (Guzman et al., 1992)
pEXT22 Cloning Vector lacl Kanr (Dykxhoorn et al., 1996)
pBAD-ABC pBAD24, tatA tatB tatC StrepII™ tag (Bolhuis et al., 2001)
pBAD-Ah pBAD24, tatA hexahistidine tag (Bolhuis et al., 2000)
pJDT1 araC, Ampr, TorA-GFPmut3* (Thomas et al., 2001)
3K>Q pBAD-ABCs with Lys37, Lys40 and (Barrett & Robinson,
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Lys41 to Gln substitutions 2005)
pCM1 pBAD24, nrfC hexahistidine tag (Matos et al., 2008)
pCM2 pCM1 with Cys152 and Cys155 to Ala
substitutions
(Matos et al., 2008)
pCM3 pCM1 with Cys168 and Cys172 to Ala
substitutions
(Matos et al., 2008)
pCC-KAN New England Biolabs pMAL-c2 and –
p2 vectors (pBR322 + lacI and
Maltose binding protein)
(Russ & Engelman,
1999)
pCC-GpA pCC-KAN with glycophorin A (GpA)
transmembrane (TM) domain
(Russ & Engelman,
1999)
pCC-G83I pCC-GpA with Gly83 to Ile
substitution
(Russ & Engelman,
1999)
pCC-TatA pCC-Kan with TatA TM from Ile4 to
Lys23 inserted between the NheI and
BamHI sites
J. Oates (Department of
Chemistry, University of
Warwick)
psbA3_L38i_To
rA-GFP_omega
Spectr/Strepr, TorA-GFPmut3* (Spence et al., 2003)
Table 2.3 Plasmids generated in this study. The details of the primers used are given in §2.5.
Plasmid Template
plasmid
Primers used Features
tatA_NcoI_forA-20h pBAD24
tatA-20h_PstI_rev
TatA truncated by 20 residues from the
C-terminus with a C-terminal his tag
tatA_NcoI_forA-40h pBAD24
tatA-40h_PstI_rev
TatA truncated by 40 residues from the
C-terminus with a C-terminal his tag
tatA_NcoI_forA-45h pBAD24
tatA-45h_PstI_rev
TatA truncated by 45 residues from the
C-terminus with a C-terminal his tag
tatA_NcoI_forA-50h pBAD24
tatA-50h_PstI_rev
TatA truncated by 50 residues from the
C-terminus with a C-terminal his tag
tatA_NcoI_forAs pBAD24
tatAs_PstI_rev
TatA with a C-terminal strep tag
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tatA_NcoI_forA-40s pBAD24
tatA-40s_PstI_rev
TatA truncated by 40 residues from the
C-terminus with a C-terminal strep tag
tatA_NcoI_forA-45s pBAD24
tatA-45s_PstI_rev
TatA truncated by 45 residues from the
C-terminus with a C-terminal strep tag
A_nativeRBS_forX_A-
40h
pEXT22
tatA-40_XbaI_rev
TatA truncated by 40 residues with a C-
terminal his tag
A_nativeRBS_forX_A-
45h
pEXT22
tatA-45_XbaI_rev
TatA truncated by 45 residues with a C-
terminal his tag
tatA_K23_forAPH-
KG
pCC-Kan
tatA_G38_rev
TatA APH Lys23 to Gly38
tatA_K23_forAPH-
KF
pCC-Kan
tatA_F39_rev
TatA APH Lys23 to Phe39
tatA_K23_forAPH-
KK
pCC-Kan
tatA_K40_rev
TatA APH Lys23 to Lys40
tatA_K23_forAPH-
KM
pCC-Kan
tatA_M43_rev
TatA APH Lys23 to Met 43
tatA_L25_forAPH-
LG
pCC-Kan
tatA_G38_rev
TatA APH Leu25 to Gly38
tatA_L25_forAPH-
LF
pCC-Kan
tatA_F39_rev
TatA APH Leu25 to Phe39
tatA_L25_forAPH-
LM
pCC-Kan
tatA_K40_rev
TatA APH Leu25 to Lys40
tatA_L25_forAPH-
LM
pCC-Kan
tatA_M43_rev
TatA APH Leu23 to Met 43
2.4 Affinity tags
A hexahistidine (his) tag or Strep II™ tag (strep) tag (IBA, Germany) was
incorporated into constructs, where indicated, to enable detection of proteins.
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2.5 Primers
All primers were supplied by Invitrogen (UK). In the two tables below, which list
primers used and created for this study, restriction enzyme sites are shown in bold,
the nucleotides encoding the affinity tag are shown in italics, and nucleotides
identical to the genomic DNA are underlined.
Table 2.4 Previously designed primers used in this study.
Primer Sequence 5’ to 3’ Source
tatA_NcoI
_for
ATACCATGGGTGGTATCAGTATTTG Claire Barrett (Department of
Biological Sciences,
University of Warwick)
A_nativeR
BS_for
GGAAACAGAATTCGAGCTCGGTACC
CTACCACAGAGGAACATGTATGGGT
GGTATCAGTATTTGGC
Cristina Matos (Department of
Biological Sciences,
University of Warwick)
Table 2.5 DNA primers used for the preparation of E. coli TatA constructs.
Primer Sequence 5’ to 3’
tatA-20h_PstI_rev TATCCAGTCTGCAGCCTCCTTTAGTGATGGTGATGGTGA
TGCGCCTGCTTATCGGCG
tatA-40h_PstI_rev TATCCAGTCTGCAGCCTCCTTTAGTGATGGTGATGGTGA
TGCTTTGGTTCATCATCGCT
tatA-45h_PstI_rev TATCCAGTCTGCAGCCTCCTTTAGTGATGGTGATGGTGA
TGGCTCATTGCTTTTTTAAAGC
tatA-50h_PstI_rev TATCCAGTCTGCAGCCTCCTTTAGTGATGGTGATGGTGA
TGAAAGCCTTTGATCGACGC
tatAs_PstI_rev TATCCAGTCTGCAGCCTCCTTTATTTTTCAAACTGTGGG
TGCGACCACGCCGACACCTGCTCTTTATC
tatA-40s_PstI_rev TATCCAGTCTGCAGCCTCCTTTATTTTTCAAACTGTGGG
TGCGACCACGCCGACTTTGGTTCATCATC
tatA-45s_PstI_rev TATCCAGTCTGCAGCCTCCTTTATTTTTCAAACTGTGGG
TGCGACCACGCCGAGCTCATTGCTTTTTTA
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tatA-40_XbaI_rev TATCCAGTTCTAGATTAGTGATGGTGATGGTGATGCTTT
GGTTCATCATCGCT
tatA-45_XbaI_rev TATCCAGTTCTAGATTAGTGATGGTGATGGTGATGGCTC
ATTGCTTTTTTAAAGC
tatA_K23_for TATCCAGTGCTAGCAAAAAGCTCGGCTC
tatA_L25_for TATCCAGTGCTAGCCTCGGCTCCATCG
tatA_G38_rev TATCCAGTGGATCCCGCCTTTGATCGACG
tatA_F39_rev TATCCAGTGGATCCCAAAGCCTTTGATCGA
tatA_K40_rev TATCCAGTGGATCCCTTTAAAGCCTTTGATC
tatA_M43_rev TATCCAGTGGATCCCCATTGCTTTTTTAAAGC
2.6 DNA manipulation and cloning techniques
2.6.1 Preparation of plasmid DNA
Plasmid DNA was isolated using a QIAprep Mini-Prep kit (Qiagen, Germany). The
kit was used according to the manufacturer’s instructions, plasmid DNA was
recovered in 50 μL dH2O and stored at -20°C.
2.6.2 PCR
PCR was typically performed with 5 μL 10× enzyme buffer, 1 μL 10 mM dNTP mix,
1.5 μL 50 mM MgCl2, 1.25 μL of each primer (from 20 μM stock), 1 μL template
DNA (0.5 ng), 0.5 μL Taq polymerase (5 units/μL) and dH2O to a final volume of 50
μL.
The reactions were performed in a Biometra T3 Thermocycler with the following
cycling conditions:
94°C 4 min
94°C 30 sec
52°C 45 sec 35 cycles
72°C 2 min
72°C 10 min
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2.6.3 Agarose gel electrophoresis
Agarose gels were prepared by dissolving 1–2% (w/v) agarose in TBE buffer (89
mM Tris; 89 mM H3BO3; 20 mM EDTA, pH 8.0). Ethidium bromide was added (0.5
μg/mL final concentration) to allow visualisation of DNA. DNA samples were
prepared by adding 2 μL of loading dye (0.25% bromophenol blue, 40% w/v
sucrose). Gels were submerged in TBE buffer and electrophoresis was performed at
100–150 V until the dye front was at least half way through the gel. DNA was
visualised using a UV transilluminator and photographs of gels were taken on a gel
documentation system.
2.6.4 Purification of DNA by gel extraction
DNA was excised from agarose gels and extracted using a QIAprep Gel Extraction
kit (Qiagen, Germany), for large DNA fragments, or a QIAprep Minelute kit
(Qiagen, Germany), for small DNA fragments. Kits were used according to the
manufacturer’s instructions and DNA was recovered in 30 or 10 μL dH2O
respectively.
2.6.5 Restriction endonuclease digestion of DNA
Restriction endonuclease digestion of DNA was performed according to the enzyme
manufacturer’s directions. Reactions were typically incubated at 37°C for 2–3 hrs,
before being subjected to gel electrophoresis and purified as detailed in §2.6.4.
2.6.6 Ligation of DNA fragments
Ligation reactions were performed using T4 DNA ligase according to the
manufacturer’s instructions. Vector and insert DNA fragments were mixed in a 1:3
ratio and typically incubated at room temperature for 3 hours or over night at 4ºC.
2.6.7 Sequencing of plasmid DNA
Sequencing was performed by the Molecular Biology Service, University of
Warwick, using Big Dye Terminator v 3.1 Chemistry and run on a 3130xl Genetic
Analyser (Applied Biosystems).
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2.6.8 Sequencing primers used in this study
Table 2.6 Sequencing primers used in this study.
Primer
Name
Sequencing
Target
Sequence (5’ to 3’) Source
TatA tatA in
pBAD-ABCs
ACCTGACGCTTTTTA
TCGCAA
C. Barrett (Department of
Biological Sciences,
University of Warwick)
TatB tatB AAGCAGGCGGATACG
AATCA
C. Barrett (Department of
Biological Sciences,
University of Warwick)
SEQ1 5’ end of tatC AACCTGCTGCGGACG
CTGAA
C. Barrett (Department of
Biological Sciences,
University of Warwick)
SEQ5 3’ end of tatC ATCGGCATGGCATTC
GCCTAC
C. Barrett (Department of
Biological Sciences,
University of Warwick)
TatA for
pEXT
tatA in
pEXT-ABC
TCGGCTCGTATAATG C. Barrett (Department of
Biological Sciences,
University of Warwick)
pEXT22
SEQ_F
pEXT22 CGCTCAAGGCGCACT
CCCG
C. Matos (Department of
Biological Sciences,
University of Warwick)
seq_pJDT1
_TorA
pJDT1 GGCTAGCAGGAGGAA
TTCAC
A. Nenninger (Department of
Biological Sciences,
University of Warwick)
pCC-for TM insert in
pCC-KAN
CCTTCATCAGCCACT
GTAGTGAAC
J. Oates (Department of
Chemistry, University of
Warwick)
pCC-rev TM insert in
pCC-KAN
CAGTTCAGCGAGACC
GTTATAG
J. Oates (Department of
Chemistry, University of
Warwick)
2.6.9 Mutagenesis of plasmid DNA
Point mutations and deletions were introduced into plasmid DNA using Pfu DNA
polymerase and a QuikChange Site-Directed Mutagenesis kit (Stratagene, USA),
according to the manufacturer’s instructions. The amplified plasmid DNA was
transformed into supercompetent DH5α cells (§2.7.5)
2.6.10 Primers used for mutagenesis of plasmid DNA
Primers were designed to be used with the QuikChange Site-Directed Mutagenesis
kit, according to the manufacturer’s instructions. Mutations are underlined.
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Table 2.7 Primers used for mutagenesis of plasmid DNA.
Construct
Generated
Template Primer Sequence (5’ to 3’) Substitution/
Deletion
for CGATCTCTTTCAGGCATCACGT
CGGAAGTTTCTGGCACAACTCG
GCG
RRK pJDT1
rev CGCCGAGTTGTGCCAGAAACTT
CCGACGTGATGCCTGAAAGAGA
TCG
Arg18 to Lys
for CGATCTCTTTCAGGCATCACGT
AAGCGGCGTTTTCTGGCACAAC
TCGGCG
RKR pJDT1
rev CGCCGAGTTGTGCCAGAAAACG
CTTACGTGATGCCTGAAAGAGA
TCG
Arg17 to Lys
for CGATCTCTTTCAGGCATCAAAG
CGGCGTTTTCTGGCACAACTCG
GCG
KRR pJDT1
rev CGCCGAGTTGTGCCAGAAAACG
CCGCTTTGATGCCTGAAAGAGA
TCG
Arg16 to Lys
for CGATCTCTTTCAGGCATCACGT
AAGAAGTTTCTGGCACAACTCG
GCG
RKK pJDT1
rev CGCCGAGTTGTGCCAGAAACTT
CTTACGTGATGCCTGAAAGAGA
TCG
Arg17 and
Arg18 to Lys
for CGATCTCTTTCAGGCATCAAAG
CGGAAGTTTCTGGCACAACTCG
GCG
KRK pJDT1
rev CGCCGAGTTGTGCCAGAAACTT
CCGCTTTGATGCCTGAAAGAGA
TCG
Arg16 and
Arg18 to Lys
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for CGATCTCTTTCAGGCATCAAAG
AAGCGTTTTCTGGCACAACTCG
GCG
KKR pJDT1
rev CGCCGAGTTGTGCCAGAAAACG
CTTCTTTGATGCCTGAAAGAGA
TCG
Arg16 and
Arg17 to Lys
for CGATCTCTTTCAGGCATCAAAG
AAGAAGTTTCTGGCACAACTCG
GCG
KKK pJDT1
rev CGCCGAGTTGTGCCAGAAACTT
CTTCTTTGATGCCTGAAAGAGA
TCG
Arg16,
Arg17 and
Arg18 to Lys
for GGCTTTAAAAAAGCAATGAGCA
ATGATGAACCAAAGCAGGATA
D45N pBAD-
ABCs
rev TATCCTGCTTTGGTTCATCATT
GCTCATTGCTTTTTTAAAGCC
Asp45 to Asn
for GCTTTAAAAAAGCAATGAGCGA
TAATGAACCAAAGCAGGATAAA
AC
D46N pBAD-
ABCs
rev GTTTTATCCTGCTTTGGTTCAT
TATCGCTCATTGCTTTTTTAAA
GC
Asp45 to Asn
for CTTTAAAAAAGCAATGAGCGAT
GATCAGCCAAAGCAGGATAAAA
CCAGT
E47Q pBAD-
ABCs
rev ACTGGTTTTATCCTGCTTTGGC
TGATCATCGCTCATTGCTTTTT
TAAAG
Glu47 to Gln
for GATCAAAGGCTTTAAAAAAGCA
ATGAGCAATAATCAGCCAAAGC
AGGATAAAACCAGTCAGGATG
NNQ pBAD-
ABCs
rev CATCCTGACTGGTTTTATCCTG
CTTTGGCTGATTATTGCTCATT
GCTTTTTTAAAGCCTTTGATC
Asp45 and
Asp46 to
Asn, Glu47
to Gln
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for GATCAAAGGCTTTAAAAAAGCA
ATGAGCCTTCTTATGCCAAAGC
AGGATAAAACCAGTCAGGATG
LLM NNQ
rev CATCCTGACTGGTTTTATCCTG
CTTTGGCATAAGAAGGCTCATT
GCTTTTTTAAAGCCTTTGATC
Asp45 and
Asp46 to
Leu, Glu47
to Met
for GGGTGGTATCAGTATTTGGGCG
TTATTGATTATTGCCGTC
Q8A pBAD-
ABCs
rev GACGGCAATAATCAATAACGCC
CAAATACTGATACCACCC
Gln8 to Ala
for CATGGGTGGTATCAGTATTTGG
TGCTTATTGATTATTGCCGTCA
TCG
Q8C pBAD-
ABCs
rev CGATGACGGCAATAATCAATAA
GCACCAAATACTGATACCACCC
ATG
Gln8 to Cys
for GGTGCGTCGATCCAAGGCTTTC
AACAAGCAATGAG
3K>Q +
NNQ
NNQ
rev CTCATTGCTTGTTGAAAGCCTT
GGATCGACGCACC
Lys37, Lys40
and Lys41 to
Gln, Asp45
and Asp46 to
Asn, Glu47
to Gln
for GGTGCGTCGATCCAAGGCTTTC
AACAAGCAATGAG
3K>Q +
LLM
LLM
rev CTCATTGCTTGTTGAAAGCCTT
GGATCGACGCACC
Lys37, Lys40
and Lys41 to
Gln, Asp45
and Asp46 to
Leu, Glu47
to Met
for GAGCTAGCATCAGTATTTGGGC
GTTATTGATTATTGCCGTC
TC-Q8A pCC-
TatA
rev GACGGCAATAATCAATAACGCC
CAAATACTGATGCTAGCTC
TatA Gln8 to
Ala
for CGAGCTAGCATCAGTATTTGGT
GCTTATTGATTATTGCCGTCAT
CG
TC-Q8C pCC-
TatA
rev CGATGACGGCAATAATCAATAA
GCACCAAATACTGATGCTAGCT
TatA Gln8 to
Cys
Chapter 2. Materials and Methods
40
CG
for CTGCTTTTTGGCACCGGGATCC
TGATCAAC
TatA-19 pCC-
TatA
rev GTTGATCAGGATCCCGGTGCCA
AAAAGCAG
Deletion of
Lys23 in
TatA TM of
pCC-TatA
for GTACTGCTTTTTGGCGGGATCC
TGATCAAC
TatA-18 pCC-
TatA
rev GTTGATCAGGATCCCGCCAAAA
AGCAGTAC
Deletion of
Thr22 and
Lys23 in
TatA TM of
pCC-TatA
for CGTTGTACTGCTTTTTGGGATC
CTGATCAACC
TatA-17 pCC-
TatA
rev GGTTGATCAGGATCCCAAAAAG
CAGTACAACG
Deletion of
Gly21, Thr22
and Lys23 in
TatA TM of
pCC-TatA
for CATCGTTGTACTGCTTGGGATC
CTGATCAAC
TatA-16 pCC-
TatA
rev GTTGATCAGGATCCCAAGCAGT
ACAACGATG
Deletion of
Phe20,
Gly21, Thr22
and Lys23 in
TatA TM of
pCC-TatA
2.7 Growth and maintenance of E. coli
2.7.1 Media
Luria-Bertami (LB) medium (10 g/L bacto-tryptone, 5 g/L yeast extract, 10 g/L
sodium chloride) was used for the aerobic growth of E. coli in liquid media.
Antibiotics were added, when necessary, to the following concentrations: Ampicillin
100 μg/mL, Kanamycin 50 μg/mL. For the growth of NT326 E. coli cells containing
derivatives of pCC-KAN, Ampicillin was added to a final concentration of 200
μg/mL. LB medium with 16% (w/v) agar was used for the aerobic growth of E. coli
on plates. Anaerobic media (LB supplemented with 0.5% glycerol, 0.4%
Trimethylamine-N-oxide (TMAO) and 1 μM sodium molybdate) was used for the
anaerobic growth of E. coli.
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2.7.2 Maintenance
For the long term storage of E. coli strains and constructs generated in this study,
glycerol stocks were prepared by adding 400 μL 50% glycerol to 800 μL of an
overnight culture. These were frozen immediately on dry ice and stored at -80ºC.
2.7.3 Preparation of competent E. coli cells
A starter culture was prepared by inoculating 5 mL LB, containing antibiotics where
necessary, with E. coli cells and incubating overnight at 37°C with shaking at 250
rpm. 10 mL LB was inoculated with the starter culture and cells were incubated at
37°C with shaking at 250 rpm until OD600 = 0.3–0.4. Cells were pelleted by
centrifugation at 1700×g (3000 rpm, Jouan GR422) at 4°C for 10 min, resuspended
in 10 mL ice cold 100 mM MgCl2, and incubated on ice for 5 min. Cells were re-
pelleted, resuspended in 1 mL ice-cold 100 mM CaCl2 and incubated on ice for 2–24
hours before use.
2.7.4 Preparation of super competent E. coli cells
A starter culture was prepared by inoculating 5 mL LB with E. coli DH5α cells and
incubating overnight at 37°C with shaking at 250 rpm. 100 mL LB was inoculated
with the starter culture and cells were incubated at 25°C with shaking at 250 rpm
until OD600 = 0.3–0.4. Cells were incubated on ice for 30 min before being pelleted
by centrifugation at 1700×g, resuspended in 50 mL ice cold 50 mM CaCl2 and
incubated on ice for 1 hour. Cells were pelleted, resuspended in 3 mL ice cold 50
mM CaCl2 plus 20% glycerol, split into 100 μL aliquots and frozen immediately on
dry ice. Aliquots were stored at -80°C until needed.
2.7.5 Transformation of competent E. coli cells
100 μL competent cells was mixed with 1–5 ng DNA in 100 μL TCM (10 mM Tris-
HCl pH 7.5, 10 mM CaCl2, 10 mM MgCl2) and incubated on ice for 30 min. Cells
were incubated at room temperature for 10 min before adding 500 μL pre-warmed
LB and incubating at 37°C with shaking at 250 rpm for 1 hour. Cells were harvested
by centrifugation at 1700×g, 550 μL supernatant was removed, the pellet was
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resuspended in the remaining liquid and plated on LB-agar plates containing the
appropriate antibiotics. Plates were incubated overnight at 37°C.
2.8 Growth and maintenance of Synechocystis
2.8.1 Media
BG11 medium (Rippka et al., 1979) was used for the growth of Synechocystis in
liquid media. Spectinomycin was added to a final concentration of 50 μg/mL where
needed. Cultures were grown under normal growth illumination (30 μE/m2/s) at 30ºC
with constant shaking at 150 rpm. 16% (w/v) agar was used for the aerobic growth of
Synechocystis on plates.
2.8.2 Transformation of Synechocystis
The transformation protocol was based on (Porter, 1988). An exponentially growing
culture was resuspended to give a final cell concentration of 109 cell/mL. 10 μL
plasmid DNA was added to 150 μL culture and incubated under normal growth
illumination at 30ºC for 1 hour. Cells were plated on BG11 plates without antibiotic
and incubated under illumination for 16–18 hours before antibiotic was added under
the agar to the required concentration. Transformants appeared after 7–10 days and
were restreaked onto selective plates at least three times to ensure segregation.
2.9 Protein preparation
2.9.1 Plasmid induction
Typically the pBAD24 based constructs were induced with varying amounts of
arabinose (0–200 μM) for 3–4 hours. For TorA-GFP export assays, E. coli ΔABCDE
contained pEXT-ABC and pJDT1. The pJDT1 plasmid was induced for 2 hours with
200 μM arabinose. Cells were then washed three times by harvesting cells and
resuspending them in fresh LB medium without inducer. The pEXT-ABC plasmid
was then induced for 2 hours with 1 mM IPTG.
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2.9.2 Preparation of whole cell fractions
Whole cell fractions were prepared by harvesting 1 mL of a mid-exponential phase
culture and resuspending in 100 μL SDS PAGE sample buffer (§2.10.1). Samples
were incubated at 50ºC for 10 min before analysis by SDS PAGE (§2.10.1) or frozen
on dry ice and stored at -80ºC until required.
2.9.3 Fractionation of E. coli cells
Cells were separated into periplasmic, cytoplasmic and membrane fractions using a
procedure based on the EDTA/lysozyme/cold osmotic shock method (Randall &
Hardy, 1986). Typically cells were harvested and resuspended in 1 mL chilled buffer
I (100 mM tris-acetate pH 8.2; 0.5 M sucrose; 5 mM EDTA). 40 μL lysozyme (2
mg/mL) and 500 μL dH2O was added before incubation on ice for 5 min followed by
the addition of 20 μL MgSO4. The spheroplasts were pelleted by centrifugation at
20,800×g (14,000 rpm Eppendorf 5417R) and the supernatant was collected as the
periplasmic fraction. Spheroplasts were washed in 1 mL chilled buffer II (50 mM
tris-acetate pH 8.2; 0.25 mM sucrose; 10 mM MgSO4) and pelleted by
centrifugation. The supernatant was discarded and the spheroplasts were resuspended
in 1 mL chilled buffer III (50 mM tris-acetate pH 8.2; 2.5 mM EDTA). Spheroplasts
were lysed by sonication (3× 10 sec) and membranes were separated from the
cytoplasmic fraction by centrifugation at 265,000×g (70,000 rpm, Beckman TL100,
TLA100.3 rotor) for 30 min at 4°C. The membranes formed a pellet and the
supernatant was collected as the cytoplasmic fraction.
2.9.4 Solubilisation of E. coli membranes with detergent
Membranes were solubilised by resuspending in 500 μL detergent containing buffer
using a syringe and needle. For blue-native PAGE (§2.10.3) membranes were
solubilised in BN PAGE solubilisation buffer (50 mM bis-tris-HCl pH 7.0; 750 mM
aminocaproic acid; 2% digitonin). For fast protein liquid chromatography (FPLC)
membranes were solubilised in FPLC solubilisation buffer (20 mM Trizma-HCl pH
8.0, 10% glycerol, 150 mM NaCl, 2% digitonin). Membranes were incubated at 4ºC
with constant rotation for 16 hours. Insoluble material was removed by
centrifugation at 265,000×g (70,000 rpm) for 15 min at 4°C.
Chapter 2. Materials and Methods
44
2.9.5 Trichloroacetic acid (TCA) precipitation
Protein samples were concentrated for gel electrophoresis by TCA precipitation. 1
mL TCA was added and samples were incubated on ice for 30 min before
centrifugation for 15 min (12,100×g, 13,400 rpm, Eppendorf MiniSpin). The
supernatant was removed and 1 mL acetone was added and incubated on ice for 5
min before centrifugation for 10 min. The supernatant was removed and samples
were allowed to air dry at room temperature. Typically samples were resuspended in
80 μL SDS sample loading buffer (§2.10.1).
2.10 Protein resolution
2.10.1 SDS poly-acrylamide gel electrophoresis
SDS polyacrylamide gels were cast and run on a vertical gel electrophoresis system
(CBS) according to the manufacturer’s instructions, based on the method described
by (Laemmli, 1970). Typically 0.75 mm gels were prepared with a separating gel
(17.5% acrylogel solution (acrylogel 2.6 (40%) solution (BDH)); 375 mM Tris-HCl
pH 8.8; 0.1% SDS; 0.02% APS; 0.06% TEMED) and a stacking gel (5% acrylogel
solution; 125 mM Tris-HCl pH 6.8; 0.1% SDS; 0.6% APS; 0.06% TEMED).
Samples were prepared by mixing with SDS sample loading buffer (125 mM Tris-
HCl pH 6.8, 20% glycerol, 4% SDS, 0.02% bromophenol blue, 5% -
mercaptoethanol) and boiling for 10 min. Samples to be immunoblotted with Tat
antibodies were heated to 50ºC for 10 min.
A uniform running buffer (25 mM tris; 250 mM glycine; 0.1% SDS) was used for
electrophoresis. Gels were run until the dye front had migrated off the gel, typically 3
hours at 35 mA or 16 hours overnight at 3 mA.
Peptides were separated on NuPAGE® 12% Bis-Tris gels using the XCell
SureLock® mini-cell system and NuPAGE® MES SDS running buffer (Invitrogen),
according to the manufacturer’s instructions.
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2.10.2 Native poly-acrylamide gel electrophoresis
Native PAGE was performed as SDS PAGE (§2.10.1), with the same equipment and
solutions but without the inclusion of SDS. The gels were 10% separating gels with a
5% stacking gel.
2.10.3 Blue-native poly-acrylamide gel electrophoresis
The blue-native (BN) PAGE protocol was based on (Schägger & von Jagow, 1991)
using the same equipment as SDS-PAGE. A 1.5 mm gradient gel was prepared by
combining a 5% acrylamide solution (5% acrylogel; 50 mM Bis-Tris-HCl pH 7.0 (at
4ºC); 500 mM aminocaproic acid; 0.76% glycerol; 4% APS; 0.4% TEMED) with a
13% acrylamide solution (13% acrylogel; 50 mM Bis-Tris-HCl pH 7.0 (at 4ºC); 500
mM aminocaproic acid; 5% glycerol; 0.35% APS; 0.035% TEMED) in a gradient
maker. A stacking gel (4% acrylogel; 50 mM Bis-Tris-HCl pH 7.0 (at 4C), 0.5 mM
aminocaproic acid; 0.7% APS; 0.07% TEMED) was added. Gradient gels were
equilibrated at 4ºC before loading samples. Typically 1 µL of sample buffer (760
mM aminocaproic acid, 50 M Bis-Tris-HCl pH 7.0, 5% Serva G Coomassie blue)
was added to 10 μL of solubilised membrane.
Gels were initially run at 70 V at 4ºC with coloured cathode buffer (50 mM Tricine
pH 7.0, 15 mM Bis-Tris-HCl pH 7.0 (at 4C), 0.02% Serva G Coomassie blue) and
anode buffer (50 mM Bis-Tris-HCl pH 7.0 (at 4C)). When the gel front had
migrated half way through the gel the coloured cathode buffer was replaced with
clear cathode buffer (50 mM Tricine pH 7.0, 15 mM Bis-Tris-HCl pH 7.0 (at 4C))
and the gel was run for 16 hours overnight.
After electrophoresis the gel was equilibrated for 15 min in clear cathode buffer
containing 0.05% SDS before transfer to PVDF membrane.
2.10.4 Fast protein liquid chromatography (FPLC)
Typically membranes were isolated from a 50 mL E. coli culture and solubilised in
FPLC solubilisation buffer (§2.9.4). Clarified membranes were loaded onto a
Superose 6HR 10/30 gel filtration column (Amersham Pharmacia Biotech) and were
eluted with FPLC wash buffer (20 mM Trizma-HCl pH 8.0; 150 mM NaCl, 10%
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glycerol; 0.1% digitonin). 600 μL samples were collected and either analysed
immediately or stored at -20ºC until required.
2.11 Protein detection
2.11.1 Coomassie staining
After electrophoresis, the gel was placed in fixer (50% methanol, 10% acetic acid)
for 30 min, then in stain solution (10% acetic acid, 0.025% Coomassie G250) for 1
hour, followed by de-stain (20% methanol, 7% acetic acid) until the protein bands
were visible. The gels were dried for long term storage.
2.11.2 Silver staining
After electrophoresis the gel was placed in fixer (50% acetone, 1.25% TCA, 0.015%
formaldehyde) for 15 min, followed by washing in dH2O (3× quick washes, 1× 5
min, 3× quick washes). The gel was then placed in 50% acetone for 5 min, followed
by incubation in sodium thiosulphate solution (0.017% (w/v)) for 1 min. The gel was
washed in dH2O (3× quick washes) before being placed in the stain solution (0.26%
(w/v) silver nitrate; 0.37% formaldehyde) for 8 min. The gel was washed in dH2O
(2× quick washes) and then placed in developer (0.2 mM sodium carbonate; 0.004%
(w/v) sodium thiosulphate; 0.015% formaldehyde) until protein bands could be
visualised, typically 20–30 sec. Stopping solution (1% acetic acid) was then added
for 1–2 min. The gel was washed in dH2O and dried for long term storage.
2.11.3 Transfer of proteins to PVDF membrane
Proteins were transferred from an acrylamide gel to PVDF membrane (Amersham
Biosciences, UK) using a semi-dry Western blotting system (Sigma Aldrich, UK)
with Towbin transfer buffer (Towbin et al., 1979). The PVDF membrane was
prepared by soaking in methanol and then in Towbin transfer buffer. Transfer was
carried out by applying a constant current of 200 mA for 2 hours.
For BN PAGE, the PVDF membrane was soaked in methanol for 5 min, dH2O for 5
min and then clear cathode buffer (§2.10.3) with 0.05% SDS for 5 min. Proteins
were transferred from BN gels using the same apparatus as described above but with
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clear cathode buffer with 0.05% SDS. PVDF membranes were destained after
transfer by incubating in 25% methanol, 10% acetic acid with gentle agitation for 1
hour. The membranes were then washed with phosphate-buffered saline (PBS, 137
mM NaCl; 2.7 mM KCl; 10 mM Na2HPO4; 2 mM KH2PO4) containing 0.1% Tween
20 (PBS-T).
2.11.4 Detection of proteins by immunoblotting
After transfer, PVDF membranes to be immunoblotted with antibodies to the Strep
II™ tag were blocked with PBS-T containing 3% BSA for at least 1 hour. The
membranes were washed in PBS-T (typically 1× 15 min, 2× 5 min) before incubation
in PBS-T with 6 μg/mL avidin for 10 min. The Streptactin-horseradish peroxidise
(HRP) conjugate antibody (IBA) was added directly to the avidin solution according
to the manufacturer’s instructions and incubated, with agitation, for 2 hours.
PVDF membranes to be immunoblotted with other antibodies were blocked with
PBS-T containing 5% (w/v) dried skimmed milk powder for at least 1 hour. The
membranes were washed in PBS-T before incubation with PBS-T containing the
desired primary antibody for 1 hour. The membranes were washed before incubation
with the secondary antibody for 1 hour. The membranes were washed and immuno-
reactive bands were detected using the ECL (enhanced chemiluminescence) kit
(Amersham Biosciences) according to the manufacturer’s instructions. X-ray films
(super RX film, Fujifilm) were developed on an AGFA Curix 60 automatic
developer according to the manufacturer’s instructions.
Table 2.8 Antibodies used in this study.
Antibody Concentration Manufacturer/Source
anti-TatA 1 in 2000 Laboratory stock (Bolhuis et al.,
2000)
anti-TatB 1 in 1000 Laboratory stock (Bolhuis et al.,
2000)
anti-Maltose binding protein 1 in 2000 Sigma
Streptactin-HRP conjugate 1 in 12000 IBA
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anti-hexahistidine(C-term) 1 in 5000 Invitrogen
anti-mouse IgG (H+L), HRP
conjugate
1 in 5000 Promega
anti-rabbit IgG (H+L), HRP
conjugate
1 in 10000 Promega
2.11.5 TMAO reductase (TorA) activity assay
The presence of TMAO reductase (TorA) was detected using a protocol adapted
from (Silvestro et al., 1989). Periplasmic and cytoplasmic fractions were separated
by native PAGE (§2.10.2). Immediately after electrophoresis, gels were placed in
100 mM phosphate buffer pH 6.5 (saturated with nitrogen gas) with 0.25% (w/v)
methyl viologen. The gel was stained blue by adding freshly prepared sodium
dithonite (0.1% in 10 mM NaOH) and incubating for 15-30 min. Gels were then
transferred to 100 mM phosphate buffer pH 6.5 (saturated with nitrogen gas) with 40
mM TMAO until white bands appeared. The gels were scanned as the bands
developed.
2.12 TOXCAT methods
The TOXCAT assay was used to investigate the transmembrane (TM) domain and
amphipathic helix (APH) of TatA in a natural membrane as described previously
(Russ & Engelman, 1999). The TOXCAT assay is a system used to measure the
ability of a given TM domain, in isolation from the rest of the protein, to self-
associate in a natural membrane environment. A chimeric protein consisting of the α-
helical TM domain of interest inserted between the N-terminal dimerisation-
dependent DNA binding domain of ToxR, and the monomeric periplasmic anchor
maltose binding protein (MBP) is used, Figure 2.1. The chimera is expressed in E.
coli NT326 cells along with a chloramphenicol acetyltransferase (CAT) reporter
gene under the control of the ToxR-responsive ctx promoter. If the TM domains
interact, the ToxR domain is able to dimerise and activate the ctx promoter, leading
to the expression of CAT. The level of CAT expression in the cells expressing the
chimera is proportional to the strength of oligomerisation, and can be measured
quantitatively.
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Figure 2.1 The TOXCAT assay for TM domain oligomerisation. The TOXCAT chimera,
consisting of the TM domain inserted between the dimerisation-dependent DNA binding domain of
ToxR ( ) and the periplasmic anchor MBP ( ), is expressed in E. coli NT326 cells. TM domain
interactions enable the ToxR domain to dimerise ( ) and activate the expression of chloramphenicol
acetyltransferase (CAT) through the ctx promoter. Figure adapted from (Russ & Engelman, 1999).
Plasmids expressing TOXCAT chimera with different inserts were constructed,
Table 2.3, and transformed into E. coli NT326 cells. Checks were performed to
ensure the chimera was expressing and inserting into the membrane with the correct
orientation. The TM domain of Glycophorin A (GpA), which is know to strongly
dimerise, and its dimerisation defective mutant (G83I), were used as a positive and
negative controls respectively.
2.12.1 Chimera expression, insertion and orientation checks
2.12.1.1 Expression check
Cells expressing the chimera were grown until mid-exponential stage. Cell density
was normalised by taking 1 mL samples of OD600 = 0.1. Cells were harvested by
centrifugation before being resuspended in 80 µL of SDS loading buffer and
analysed by SDS-PAGE (§2.10.2)
Chapter 2. Materials and Methods
50
2.12.1.2 Maltose plate assay
Overnight cultures of NT326 cells containing the plasmid encoding the TOXCAT
chimera were streaked out on maltose minimal media plates (M9 salts (48 mM
Na2HPO4; 22 mM KH2PO4; 8.6 mM NaCl; 18.7 mM NH4Cl); 2 mM MgSO4; 100
μM CaCl2; 0.4% maltose; 15% (w/v) agar) and incubated at 37º for 2–3 days.
Colonies with a correctly inserted chimera were able to grow with maltose as the sole
carbon source.
2.12.1.3 Sodium hydroxide washes
Correct insertion of chimera in the membrane was confirmed using sodium
hydroxide washes based on (Chen & Kendall, 1995). Cells expressing the chimera
were grown until mid-exponential stage and an aliquot was harvested by
centrifugation. Cells were resuspended in 100 μL lysis buffer (24 mM MgCl2, 0.5
mg/mL DNase, 0.5 mg/mL lysozyme), incubated at room temperature for 1 hour, and
then cooled on ice. 150 μL ice cold dH2O was added and 125 μL was removed. 125
μL ice cold 0.1 M NaOH was added to the remaining sample, vortexed for 1 min,
and centrifuged at 13,400 rpm for 15 min. The pellet contained membrane proteins
and the supernatant contained soluble proteins. Soluble proteins were TCA
precipitated (§2.9.5) before analysis by SDS-PAGE.
2.12.1.4 Proteolysis of spheroplasts
Spheroplasts were prepared as described (§2.9.3) and resuspended in proteolysis
buffer (10 mM HEPES pH 7.6, 2 mM EDTA). The spheroplasts were then either
treated with Proteinase K (to a final concentration of 0.25 mg/mL) for 30 min on ice,
or broken open by 5× free-thaw cycles before treatment with Proteinase K.
2.12.2 Measurement of [CAT] activity
2.12.2.1 Disk diffusion assay
Cultures were grown to OD600 = 0.6 and were diluted 6× with LB. 100 μL was plated
on an LB Amp agar and allowed to dry. A Whatman Grade 1 filter paper disk
(diameter 30 mm) with 42 μL of 90 mg/mL chloramphenicol (CAM) in ethanol dried
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onto it was placed in the centre of the plate. The plate was incubated overnight at
37°C and the clear zone of inhibition of growth around the disk was recorded.
2.12.2.2 Quantitative CAT assay
Cultures were grown to OD600 = 0.6, and 200 μL was removed, pelleted and
resuspended in 500 μL 100 mM Tris-HCl pH 8.0. Cells were lysed by adding 20 μL
lysis mix (100 mM EDTA, 100 mM DTT, 50 mM Tris-HCl pH 8.0), a drop of
toluene and incubated at 30ºC for 30 min. Samples were prepared by taking 60 μL of
a 10× dilution of lysed cells. The levels of CAT expression were assayed using the
FAST CAT® Green (deoxy) Chloramphenicol Acetyltransferase assay kit
(Invitrogen) according to the manufacturer’s instructions. The fluorescence of the
samples was determined using a Perkin Elmer LS50B fluorimeter. Samples were
excited at 495 nm and emission at 525 nm was recorded. The fluorescence was
normalised using to the positive control, GpA.
2.13 Synthetic peptide purification
Synthetic peptides were ordered from the Keck Biotechnology Resource Laboratory,
Yale University, USA. The peptides were synthesised with an acetylated N-terminus
and an amidated C-terminus using F-moc chemistry. Peptides were purified by
reverse phase high performance liquid chromatography (HPLC) on a purpose built
dual pump system (Jasco). HPLC grade solvents were used for all purification steps.
2.13.1 Purification of the TatA TM domain peptide
A peptide corresponding to the TM domain of TatA (TatATM) was synthesised. The
sequence of the TatATM peptide was GGISIWQLLIIAVIVVLLFGTKKK,
corresponding to amino acids 2 to 24 of TatA with an additional lysine (underlined in
bold) on the C-terminus. The extra lysine was added to aid solubilisation of the
peptide. 5 mg of crude TatATM was solubilised in 1.5 mL Trifluoroacetic acid (TFA).
The solubilised peptide was loaded onto a C4 column (Jupiter C4 250 × 10 mm, 300
Å, 5 μm, Phenomenex) equilibrated in 70% buffer A (H2O + 0.1% TFA) and 30%
buffer B (Acetonitrile (ACN) + 0.1% TFA). The peptide was eluted at 2 mL/min
with the gradient given in
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Table 2.9, and absorbance was monitored at 280 nm. TatATM typically eluted after 44
min, Figure 2.2. The presence of TatATM in fractions was confirmed by mass
spectrometry (§2.14.1). Fractions containing the TatATM peptide were pooled and
lyophilised (§2.13.3).
Table 2.9 Gradient used for the purification of the TatATM peptide by HPLC.
Time (min) % Buffer A % Buffer B
0 70 30
15 70 30
20 50 50
50 20 80
55 0 100
65 0 100
70 70 30
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Figure 2.2 Reverse phase HPLC purification of the TatATM peptide. The TatATM peptide was
purified by reversed-phase HPLC using a linear acetonitrile gradient with 0.1% TFA on a
Phenomenex C4 column. The absorbance at 280 nm was recorded to determine when the peptide
eluted.
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2.13.2 Purification of the TatA APH peptide
A peptide corresponding to the TatA APH (TatAAPH), was synthesised. The sequence
of the TatAAPH peptide was: TKKLGSIGSDLGASIKGFKKAMSDDEP,
corresponding to amino acids 22 to 48 of TatA. 5 mg of crude peptide was
solubilised in 4 mL 10% ACN with 16 μL TFA. The solubilised peptide was loaded
onto a C4 column equilibrated in 90% buffer A (H2O + 0.1% TFA) and 10% buffer
B (ACN + 0.1% TFA). The peptide was eluted at 2 mL/min with the gradient given
in Table 2.10, and absorbance was monitored at 222 nm, Figure 2.3. The TatAAPH
peptide typically eluted between 35–37 min. The presence of TatAAPH in fractions
was confirmed by mass spectrometry (§2.14.1). Fractions containing the TatAAPH
peptide were pooled and lyophilised (§2.13.3).
Table 2.10 Gradient used for the purification of the TatAAPH peptide by HPLC.
Time (min) % Buffer A % Buffer B
0 90 10
10 90 10
12 80 20
32 60 40
45 0 100
55 0 100
65 90 10
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Figure 2.3 Reverse phase HPLC purification of the TatAAPH peptide. The TatAAPH peptide was
purified by reversed-phase HPLC using a linear acetonitrile gradient with 0.1% TFA on a
Phenomenex C4 column. The absorbance at 222 nm was recorded to determine when the peptide
eluted.
2.13.3 Lyophilisation of purified peptides
Pooled HPLC fractions containing peptide were frozen on dry ice to form a thin layer
in a round bottomed flask. The flask was briefly placed in liquid nitrogen before
being attached to a vacuum. The flask was left under vacuum until all the solvent had
been removed. Lyophilised peptide was dissolved in 2,2,2-trifluoroethanol (TFE),
aliquoted, dried under nitrogen to remove the organic phase and then stored at -20ºC
until required.
2.13.4 Peptide concentration determination
Peptide concentration was determined by measuring UV absorbance. Peptides were
dissolved in organic solvent or buffer and their absorbance was measured using a
spectrophotometer (Biomate, Thermo Scientific). The extinction coefficient at 280
nm of the TatATM (280 = 5500 M-1cm-1) was calculated using ProtParam, and the
peptide concentration was calculated using the Beer-Lambert law (1); A =
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absorbance, ε = extinction coefficient (M-1cm-1), b = optical path length (cm), c =
concentration (M).
bcA  (1)
Due to the lack of cysteine, tryptophan and tyrosine residues the TatAAPH peptide did
not absorb at 280 nm. The absorbance was measured at 205 nm and the concentration
was calculated using equation (2) (Scopes, 1974).
b
A
c


31
205 (2)
2.13.5 Detergent micelle concentration determination
The concentration of detergent micelles in a detergent solution was calculated using
equation (3); m = micelle concentration (M), d = detergent concentration (M), C =
critical micelle concentration (M), a = aggregation number.
d Cm
a

 (3)
For dodecylphosphocholine (DPC) an aggregation number of 56 and a critical
micelle concentration of 1 mM were used.
2.13.6 Preparation of liposomes
For 1,2-Dimyristoyl-snGlycero-3-Phosphocholine (DMPC) liposomes, the lipid and
peptide were codissolved in TFE at the required ratio, typically 10:1 lipid to peptide.
Samples were dried under nitrogen and then placed in a vacuum desiccator overnight
to ensure complete removal of the organic phase. The lipid/peptide film was hydrated
using the appropriate buffer, typically 50mM sodium phosphate buffer, pH 7.0, and
subjected to five freeze-thaw cycles using an ethanol/dry ice bath and a 40ºC water
bath. Finally samples were sonicated for 5 min at 40ºC.
For 1,2-Dipalmitoyl-sn-Glycero-3-Phosphocholine (DPPC) and 1,2-Dipalmitoyl-sn-
Glycero-3-[Phospho-rac-(1-glycerol)] (DPPG) liposomes, the lipid and peptide were
codissolved in chloroform and prepared in the same way as above with a 55ºC water
bath.
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2.14 Analysis of synthetic peptides
2.14.1 Mass spectrometry
Samples from the HPLC fractions were prepared by adding 10 μL 10% Formic acid
to 90 μL of the HPLC fraction. Samples were analysed using electrospray ionisation
mass spectrometry (ESI-MS) on a Bruker MicrOTOF. The positive ionisation mode
was used and detection was between 50 and 3000 m/z. Spectra were typically
recorded for 2 minutes, averaged and deconvoluted to determine the mass of the
main species.
2.14.2 Cross-linking
Cross-linking of the peptides in different concentrations of detergent was performed
with bis(sulfosuccinimidyl)suberate (BS3) (Pierce) or glutaraldehyde (TAAB)
according to the manufacturer’s instructions. Typically a 40 μL reaction containing
40 µM peptide, a 50-fold excess of cross-linker and varying amounts of detergent in
20 mM sodium phosphate buffer pH 8.0, was incubated at room temperature for 30
min. Reactions were quenched with 2 µM Tris-HCl pH 7.5.
2.14.3 Circular dichroism (CD)
Peptide samples were prepared with 50 mM sodium phosphate buffer pH 7.5, 100
mM NaCl and varying amounts of DPC (Avanti Polar Lipids) to a final concentration
of 80 µM. Measurements were taken in a J-815 spectropolarimeter (Jasco UK, Great
Dunmow, UK) using a 1 mm path-length quartz cuvette (Starna; Optiglass Ltd.,
Hainhault, UK). Circular dichroism (CD) spectra were recorded between 180 and
260 nm with a data pitch of 0.2 nm, a bandwidth of 2 nm, a scanning speed of 100
nm/min, and a response time of 1 s. Four scans were averaged and the spectrum of
buffer without peptide was subtracted to give the final spectra. Spectra of peptide in
liposomes were also measured. The high tension of the spectra was also recorded.
2.14.4 Oriented circular dichroism (OCD)
Lipid and peptide were codissolved in TFE with final concentrations of 10 mg/mL
and 1 mg/mL respectively. The lipid and peptide solution was then dried under
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nitrogen on a glass slide to form an even lipid-peptide multilamellar film. To ensure
complete removal of the organic phase, the glass slide was left in a desiccator
overnight. To hydrate the lipid bilayer the glass slide was placed in a custom built
chamber overnight with a small amount of water. The slide was placed in a custom
built orientable slide holder with the multilamellar film perpendicular to the incident
light. Oriented CD (OCD) measurements were taken using the same parameters as
for CD (§2.14.3) with a 10 nm bandwidth. To minimise artefacts arising from linear
dichroism the slide was rotated 360 in the plane perpendicular to the incident light,
taking measurements at 45º increments. The measurements were averaged and the
spectrum of sample without peptide was subtracted to give the final OCD spectra.
2.14.5 Linear dichroism (LD)
Liposomes with 0.5 mg/mL peptide were prepared using 50 mM sodium phosphate
buffer, pH 7.0. A 5:1 lipid to peptide ratio was used for the TatATM peptide analysis.
Linear dichroism (LD) spectra were acquired between 180 and 360 nm at room
temperature. An in-house built micro-volume Couette cell (Marrington et al., 2004;
Marrington et al., 2005) was used; equivalent models are commercially available
(Kromatek, Great Dunmow, UK). Samples were aligned by applying voltages of 3, 4
and 5 V, corresponding to 3k, 4k and 5k rpm. The acquisition parameters were the
same as those for CD (§2.14.3). A spectrum of the non-aligned sample was
subtracted from the aligned spectra to give the final LD signal. The spectra were
corrected for light scattering due to the liposomes using the method given in (Nordh
et al., 1986) (equation (4) and Figure 2.4), where LDT = background turbidity
dichroism, α = constant, λ = wavelength (nm), k = turbidity constant.
( )T kLD   (4)
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Figure 2.4 Linear dichroism light scattering correction. The method given in (Nordh et al., 1986)
(equation (4)) was used to calculate the light scattering due to the liposomes, which was subtracted
from the spectrum.
2.14.6 Attenuated total reflectance Fourier transform infrared
spectroscopy (ATR-FTIR)
Liposomes with a 30:1 lipid to peptide ratio were prepared with dH2O (§2.13.6), with
a final lipid concentration of 10 mg/mL. A Bruker Tensor spectrometer was used
containing a high-sensitivity MCT/A detector cooled with liquid nitrogen. Water
vapour and carbon dioxide were evacuated from the machine by purging using dry
compressed air from an external source. The sample was deposited onto a trapezoidal
germanium internal reflection element and bulk water was removed using a diffused
stream of nitrogen. 1000 interferograms were recorded and their average was used
for analysis. For deuterium exchange, deuterium saturated nitrogen gas was passed
over the sample for 22 hours and a spectrum was recorded. To obtain information on
the secondary structure of the peptide the spectra were analysed in the 1600–1700
cm-1 region, which corresponds to the amide I peak. The band-narrowing technique
of Fourier self-deconvolution was applied as well as a baseline correction using the
OMNIC spectra software (Thermo Scientific). Gaussian curves were fitted to the
resulting spectra using GRAMS software (Thermo Scientific).
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2.14.7 Intrinsic fluorescence
Samples with lipid were prepared as for LD (§2.14.5). Emission spectra were taken
on a Perkin Elmer LS50B fluorimeter exciting at 280 nm and recording between 300
and 400 nm, with an excitation slit of 2.5, an emission slit of 2.5 and a scan speed of
50. Spectra of peptide in TFE were also recorded. The fluorescence spectra of the
peptide in different environments were determined by subtracting spectra of the
buffer without peptide.
2.15 Confocal microscopy
Samples were prepared for imaging by adsorbing liquid culture onto 3% agar
containing growth medium. The agar was placed in an in-house built sample holder
and covered with a cover slip. Imaging was performed on a laser scanning confocal
microscope (LSCM) (Leica DMRE) equipped with a Leica TCS SP2 confocal unit,
an acousto-optical beam splitter (AOBS®) and a 100mW argon laser. A 63× oil-
immersion objective was used. For GFP, fluorescence excitation was at 488 nm and
detection was between 510 and 530 nm. The Synechocystis chlorophyll was used as a
thylakoid membrane marker. When excited at 488 nm chlorophyll fluorescence could
be detected between 600 and 700 nm.
2.16 Specialist software
CHI (Crystallography and NMR system (CNS) searching of helix interactions):
Model of the TatA APH (Adams et al., 1995; Adams et al., 1996).
Chromas: Analysis of sequencing data.
Clone manager: Design of cloning strategy and alignment of DNA sequences.
ClustalX: Alignment of protein primary sequences.
Dichroweb: Calculation of protein secondary structure from CD spectra (Whitmore
& Wallace, 2008). The CDSSTR algorithm (Sreerama & Woody, 2000) was used
with the SP175 reference set (Lees et al., 2006).
http://dichroweb.cryst.bbk.ac.uk/html/home.shtml
GRAMS Spectroscopy: Analysis of FTIR spectra (Thermo Scientific)
ImageJ: Analysis of images (Abramoff, 2004; Rasband, 1997–2008)
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OMNIC Spectra: Analysis of FTIR spectra (Thermo Scientific).
ProtParam: Analysis of protein sequences.
http://www.expasy.ch/tools/protparam.html
PSRIPRED: Protein secondary structure prediction (Jones, 1999; McGuffin et al.,
2000)
http://bioinf.cs.ucl.ac.uk/psipred/
TMSTAT: Analysis of TM domains to identify packing motifs (Senes et al., 2000).
http://bioinfo.mbb.yale.edu/tmstat/
VMD: Visualisation of CHI results (Humphrey et al., 1996).
http://www.ks.uiuc.edu/Research/vmd/
Volocity: Analysis of confocal microscopy images (Improvison, Perkin Elmer).
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3.1 Introduction*
Protein export is an essential feature of living cells and several protein translocation
pathways have been identified. In prokaryotes and chloroplasts the twin-arginine
translocase (Tat) pathway is able to transport proteins across the cytoplasmic and
thylakoid membranes, respectively. Studies suggest that the Escherichia coli and
chloroplast Tat pathways function in a similar manner, with both having a Tat
translocase consisting of three integral membrane proteins, TatA, TatB and TatC,
which are also known as Tha4, Hcf106 and cpTatC in chloroplasts. Deletion of any
of these components leads to a complete block of transport. The pathway was named
due to the highly conserved twin-arginine (RR) motif present in the signal sequence
of Tat substrates (Berks, 1996; Chaddock et al., 1995). In chloroplasts substitution of
either of the arginines, even with lysine, stops transport (Chaddock et al., 1995;
Henry et al., 1997), however the E. coli system is less stringent and single
substitutions with lysine can still support export (Buchanan et al., 2001; DeLisa et
al., 2002; Stanley et al., 2000).
Cyanobacteria pose an interesting subject when studying the Tat pathway. It is
widely accepted that they are the ancestors of plastids in higher plants and as such
may provide a link between thylakoid and bacterial Tat pathways. As Gram-negative
bacteria they contain a plasma membrane, however, like chloroplasts, they also
contain an internal thylakoid membrane, Figure 1.1B and C. Recent studies of the
cyanobacterium Synechocystis sp. PCC6803 have suggested that the thylakoid
membranes are discontinuous from the plasma membrane (Liberton et al., 2006;
Schneider et al., 2007). Despite having two separate membrane systems the
Synechocystis genome only contains one set of Tat apparatus, consisting of two
TatA/B-like proteins and a TatC homologue (Aldridge et al., 2008; Fulda et al.,
2000). Alignments of these proteins with the E. coli and chloroplast homologues
reveal that they are more closely related to the plant system, however both of the
* Work in this chapter was done in collaboration with Anja Nenninger and
Christopher Müller (Department of Biological Sciences, University of Warwick).
Mutagenesis and immunoblots were performed in equal collaboration and images in
Figure 3.3 were taken by Anja Nenninger.
Chapter 3. Comparison of the Tat Pathway in E. coli and Synechocystis
63
TatA/B homologues are able to restore export in E. coli strains lacking either TatA or
TatB (Aldridge et al., 2008).
Here we have examined the need for an RR-motif in Tat substrates in both E. coli
and Synechocystis with an aim to identifying any differences between the Tat
pathways in the two bacteria. A chimera consisting of the signal sequence of a Tat
substrate fused to green fluorescent protein (GFP) was used to compare export in E.
coli and Synechocystis. Confocal microscopy has been used to follow the targeting of
the GFP chimera in Synechocystis as this presents a powerful non-invasive tool for
determining cellular location of active GFP.
3.2 Importance of the twin-arginine motif in E. coli
Although named the twin-arginine pathway, several previous studies have
demonstrated that the RR-motif is not essential for export via the Tat pathway
(Buchanan et al., 2001; DeLisa et al., 2002; Stanley et al., 2000). Native Tat
substrates have also been identified which do not contain a RR-motif (Hinsley et al.,
2001; Ignatova et al., 2002). To enable comparison of the importance of the RR-
motif in E. coli and Synechocystis it was decided to analyse substitutions in the RR-
motif of the TorA-GFP construct, which consists of the signal sequence of the E. coli
Tat substrate trimethylamine N-oxide (TMAO) reductase (TorA) fused to GFP
(Thomas et al., 2001). It has been seen previously that when expressed in E. coli and
Synechocystis this construct is exported efficiently to the periplasm (Barrett et al.,
2003b; Spence et al., 2003; Thomas et al., 2001). The TorA signal peptide contains
the sequence SRRRFL, with the two arginines of the predicted RR-motif underlined.
Since there are three arginines in the signal sequence it was also decided to
determine if the arginine in the +1 position, relative to the RR-motif, could
compensate for the loss of the arginines in the RR-motif. Although previous studies
have assessed effects of substitutions in the RR-motif on similar constructs in E. coli
(DeLisa et al., 2002), it was decided to analyse these substitutions using our system
in E. coli as well as Synechocystis to allow direct comparison.
Multiple substitutions of arginine with lysine were introduced in the three arginines
in the signal sequence of TorA, with all seven possible substitutions obtained (RRK,
RKR, KRR, KKR, KRK, RKK, KKK). The substitutions were made by mutation of
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the pJDT1 plasmid (Thomas et al., 2001), which expresses TorA-GFP from the
pBAD24 plasmid. DH5α E. coli cells expressing the constructs were fractionated
into periplasmic, membrane and cytoplasmic (P, M, C) fractions, and analysed by
SDS-PAGE and immunoblotting with anti-GFP antibodies, Figure 3.1. The wild-type
TorA-GFP (RRR) was exported efficiently to the periplasm, as demonstrated by a
band corresponding to mature-sized GFP in the periplasm. The accumulation of
mature-sized GFP in the cytoplasm observed here has been seen in other studies
(Barrett et al., 2003b; Thomas et al., 2001), and has been attributed to proteolysis of
TorA-GFP when export is blocked. Substitution with lysine of one of the twin-
arginines or the arginine in the +1 position (RRK, RKR, KRR, KRK, RKK) had no
observable effect on the export of TorA-GFP to the periplasm, only a double
substitution of the RR-motif stopped export (KKK, KKR) with no visible
periplasmic band. This demonstrates that the Tat pathway in E. coli only needs a
single arginine in the RR-motif to be present in the signal sequence for export. An
arginine in the +1 position is not sufficient to compensate for the loss of the RR-
motif.
P M C P M C
KKKRRR
P M C P M C
P M C
RKK RKR
KRK
P M C P M C P M C
KKR KRR RRK
TorA-GFP
GFP
TorA-GFP
GFP
Figure 3.1 TorA-GFP export assay of the mutated TorA-GFP in E. coli. Immunoblots using an
anti-GFP antibody of periplasmic, membrane and cytoplasmic (P, M, C) samples from DH5α cells
expressing TorA-GFP from the pJDT1 plasmid (RRR) or TorA-GFP with the substitution of the RRR
with lysine (KKK, RKK, RKR, KRK, KKR, KRR, RRK). Intact TorA-GFP (TorA-GFP) and clipped
TorA-GFP (GFP) are indicated.
Chapter 3. Comparison of the Tat Pathway in E. coli and Synechocystis
65
3.3 Importance of the twin-arginine motif in Synechocystis
In order to compare the stringency of the Tat pathway in E. coli and Synechocystis,
export of TorA-GFP mutants was assessed in Synechocystis cells. Although TorA is
not a native Synechocystis Tat substrate, its signal sequence directs GFP to the
periplasm (Spence et al., 2003). Unlike E. coli which can be fractionated into
separate cell compartments with relative ease, fractionation of Synechocystis is a
much more involved process (Norling et al., 1998). To overcome this problem it was
decided to use a bio-imaging approach as this provides spatial information on the
location of the TorA-GFP in vivo. Since Synechocystis is a photosynthetic bacterium
its thylakoid membranes possess an intrinsic autofluorescence. Using a confocal
microscope to image an optical slice through the centre of a cell, exciting with a
wavelength of 488 nm and detecting in the 600–700 nm region, results in an annular
fluorescence which corresponds to the thylakoid membranes, shown in magenta in
Figure 3.2A. By detecting the fluorescence due to GFP in the 510–530 nm region it
is possible to determine the location of the TorA-GFP with respect to the thylakoid
membranes. Due to the fluorescent nature of the thylakoid membranes, they also
emit autofluorescence in the same region as GFP. It is possible to distinguish the
GFP and autofluorescence by comparison with wild-type cells, and also by the
localisation of the signal in the GFP region.
To obtain an accurate profile of Synechocystis cells expressing TorA-GFP, mixtures
of wild-type and TorA-GFP expressing cells were imaged, Figure 3.2A. A signal is
detected in the GFP region (shown in green) of both wild-type, indicated by an
arrow, and TorA-GFP expressing cells. In wild-type cells the signal intensity is much
less and cells expressing TorA-GFP can clearly be distinguished by their intense
green ‘halo’. To demonstrate more clearly the location of the TorA-GFP with respect
to the thylakoids the plot-profile tool in the ImageJ analysis software was used. A
line can be drawn across the image and the value of each pixel along the line is
plotted against position. A rectangle can also be selected; this gives the average of
the line plot-profiles in the rectangle. For example the plot-profile of a rectangle
height 5, width 100 will be the average of 5 line plot-profiles of length 100. By
overlapping plot-profiles of the GFP and auto-fluorescence channels we can
determine the relative position of the GFP. Plot-profiles of the GFP fluorescence and
autofluorescence were taken of wild-type and TorA-GFP Synechocystis, Figure 3.2B
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Figure 3.2 Comparison of confocal microscopy images of wild-type Synechocystis and cells
expressing TorA-GFP. A. Confocal microscopy image of a wild-type Synechocystis cell (arrow) and
two cells expressing TorA-GFP. Samples were excited with the 488 nm line of the argon laser, GFP
emission was detected between 510 and 530 nm (shown in green), and autofluorescence was detected
between 600 and 700 nm (shown in magenta). Overlays of the channels and a 3D reconstruction of a
z-stack are also shown. B. Plot profile of a wild-type cell in the region indicated by the white box and
arrow in A. The grey level in each channel was taken across the region defined by the white box and
plotted against distance. C. Plot profile of a cell expressing TorA-GFP in the region defined by the
white box in A.
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and C, in the regions indicated by the white boxes in the overlay of the GFP and
autofluorescence images, Figure 3.2A panel 3. The difference between the plot-
profiles of the two different cells can clearly be seen by comparison of the GFP
channels. In wild-type Synechocystis the GFP plot-profile has a very similar shape to
the auto-fluorescence plot-profile, with quite a low intensity. In contrast the TorA-
GFP expressing cell has a much higher GFP intensity, which does not coincide with
the autofluorescence but peaks outside, indicating a periplasmic location. The three-
dimensional reconstruction from a z-stack of half the cells, Figure 3.2A panel 4,
clearly demonstrates the continuous periplasmic location of the TorA-GFP.
Using the same methodology as for E. coli, the three arginines in the signal sequence
of TorA-GFP were substituted for lysine in the Synechocystis plasmid used
previously (Spence et al., 2003). Transformation of the plasmids resulted in RKR,
RKK, KRR, KKR and KKK TorA-GFP mutants. Cells were imaged in the same way
as above, and plot profiles of typical cells were measured, Figure 3.3. The green
‘halo’ typical of the TorA-GFP expressing cells was not observed for any of the
mutants, Figure 3.3. Plot-profiles of the GFP channel were very similar to the
autofluorescence channel, indicating that the TorA-GFP mutants were not exported,
Figure 3.3. Punctate regions of GFP were observed in the thylakoid and cytoplasmic
region of all the mutants. We concluded that these were aggregates of GFP, resulting
from the loss of export to the periplasm.
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Figure 3.3 Analysis of the export of mutated TorA-GFP in Synechocystis. Confocal microscopy
images of Synechocystis cells expressing TorA-GFP with the substitution of the RRR motif with
lysine (KKR, KRR, RKK, RKR, KKK). The GFP signal is shown in green and the autofluorescence is
shown in magenta. Overlays of the two channels are also shown. The 488 nm laser line of the argon
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laser was used to excite the samples, GFP emission was detected between 510 and 530 nm, and
autofluorescence was detected between 600 and 700 nm. Plot profiles of the GFP and
autofluorescence channels are shown. The grey level in each channel was measured across the region
defined by the white box and plotted against distance.
3.4 Discussion
Comparison of the Tat pathway from different bacteria has shown that the
composition and functional specificity varies from bacterium to bacterium. Here we
have sought to gain insight into the differences between the Tat pathway in E. coli
and Synechocystis by analysing the export of the Tat substrate TorA-GFP.
3.4.1 E. coli requires a single arginine in the twin-arginine motif
To assess the importance of the RR-motif in the export of proteins via the E. coli Tat
pathway, substitutions of RR-motif in TorA-GFP were analysed. Single substitutions
in the RR-motif and the additional arginine in the +1 position (RRK, RKR, KRR,
KRK, RKK) did not affect the export of TorA-GFP to the periplasm. Only complete
substitution of the RR-motif (KKR, KKK) stopped export. Similar results have been
seen in previous studies of TorA and other Tat substrates (Buchanan et al., 2001;
DeLisa et al., 2002; Stanley et al., 2000). It is worth noting that substitution of
arginine with lysine is conservative and substitution with other, non-polar residues
with a different charge have been seen to have a greater effect on translocation
(Buchanan et al., 2001). These results demonstrate that there is some flexibility in
the recognition of the RR-motif by the E. coli Tat apparatus. The cause of this
flexibility is as yet unidentified. One hypothesis is that other parts of the twin-
arginine signal sequence compensate for the loss of an arginine. This is supported by
the observation that substitution of the -1 and +2 residues, with respect to the RR-
motif, can severely affect export of Tat substrates (Mendel et al., 2008).
3.4.2 Synechocystis cannot tolerate substitutions in the twin-
arginine motif
Unlike E. coli, the Tat pathway in Synechocystis could not tolerate the conservative
single substitution with lysine in the RR-motif. The KRK, RKK and RKR
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substitutions all stopped the appearance of the green periplasmic ‘halos’, indicating a
loss of export. On loss of export, some GFP accumulated into small regions, as
indicated by punctate spots in the green channel. There is no evidence to suggest
these accumulations are physiologically relevant, and similar observations in E. coli
have been credited to aggregates (Mullineaux et al., 2006; Ray et al., 2005).
The strict requirement of a RR-motif is reminiscent to that of the Tat pathway in
plant thylakoid membranes. Alignments have demonstrated that the TatA/B
homologues from Synechocystis are more closely related to the Tha4/Hcf106
proteins in plant thylakoids (Aldridge et al., 2008), and phylogenetic studies cluster
the TatC homologue with the plant thylakoid cpTatC (Yen et al., 2002). These
observations, taken together with the endosymbiotic theory for the origin of plastids
in higher plants, suggest that that the Tat pathway in cyanobacteria is more closely
related to plant thylakoids than E. coli.
Originally it was intended to use imaging techniques such as fluorescence recovery
after photobleaching (FRAP) and light inducible GFP to track the movement of
TorA-GFP in cells. Bleaching experiments were performed on Synechocystis cells
expressing TorA-GFP, however due to the small size of the cells, ~3 μm, it was not
possible to bleach only the TorA-GFP in the periplasm. Previous FRAP experiments
on cyanobacteria demonstrated that a bleach area of 0.5–1 μm was possible
(Mullineaux, 2004), meaning any bleaching would include the thylakoid membrane.
Subsequent recovery in the GFP channel would therefore consist of both GFP and
autofluorescence signals, and parameters would be difficult to calculate. Due to these
experimental constraints it was decided to gain more information on the E. coli Tat
pathway by studying the TatA component using biochemical and biophysical
techniques, as detailed in Chapters 4 to 6.
In summary, here we have demonstrated that there are differences in the recognition
of twin-arginine signal sequences between E. coli and Synechocystis. These
differences suggest that the cyanobacterial Tat pathway is more closely linked to that
in thylakoids than proteobacteria.
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4.1 Introduction
In E. coli three proteins have been identified as being essential for translocation via
the Tat pathway; TatA, TatB and TatC (Bogsch et al., 1998; Sargent et al., 1998;
Weiner et al., 1998). The smallest of these is TatA, which is predicted to have an N-
terminal α-helical transmembrane (TM) domain, followed by an amphipathic α-helix
(APH) and a largely unstructured C-terminal region, Figure 1.6. Although a
relatively small protein (89 amino acids, predicted molecular weight 9.6 kDa), TatA
is able to form large homo-oligomeric complexes of varying size and diameter
(Gohlke et al., 2005; Oates et al., 2005). Just how this single membrane spanning
protein can form these complexes is still unknown. Previous research has shown that
when expressed without its TM domain TatA purifies as a soluble monomer (De
Leeuw et al., 2001; Porcelli et al., 2002). This, along with a study highlighting the
importance of a glutamine in the TM domain (Greene et al., 2007), has indirectly
indicated that the TM domain is involved in the formation of homo-oligomers.
TM domains of proteins are often found to play an important role in the formation of
complexes (Lemmon et al., 1992; Melnyk et al., 2001). Motifs have been identified
which drive TM domain helix-helix interactions and facilitate complex formation
(Russ & Engelman, 2000; Senes et al., 2000). These motifs include the presence of
polar residues, such as glutamine, in TM domains. Electrostatic interactions and
interhelical hydrogen bonds between hydrophobic residues can drive helix-helix
interactions and lead to the formation of stable complexes (Dixon et al., 2006;
Freeman-Cook et al., 2004; Zhou et al., 2001).
In this study the TM domain of TatA was analysed to determine if it had a role in the
oligomerisation of TatA. Short TM domains can often be problematic to express and
purify in sufficient quantities for subsequent analysis, so it was decided to use a
synthetic peptide to analyse the TatA TM domain. Synthetic peptides of TM domains
have been used in many studies and can give a good indication of the role of the TM
domain in the full length protein (Dixon et al., 2006; Iwamoto et al., 2005; Melnyk et
al., 2001). Here, a variety of biophysical techniques were used to determine the
secondary structure, ability to insert into lipid bilayers and propensity for self-
association of the TatA TM domain peptide. Helix-helix interactions were also
probed in a membrane environment using the TOXCAT assay (Russ & Engelman,
Chapter 4. Analysis of the E. coli TatA TM Domain
73
1999), which was specifically designed for the analysis of TM domain interactions.
The importance of the glutamine in the TatA TM domain for function and
oligomerisation was analysed using the TOXCAT assay, a functional TorA assay and
blue-native electrophoresis of the TatA complex.
4.2 Analysis of a TatA TM domain synthetic peptide
To analyse the TatA TM domain in vitro a synthetic peptide corresponding to the
TatA TM domain (TatATM) was synthesised as detailed in §2.13. The TatATM
peptide (GGISIWQLLIIAVIVVLLFGTKKK) corresponded to residues Gly2 to Lys24 of
TatA, with an additional C-terminal non-native lysine (underlined) to aid solubility
of this extremely hydrophobic peptide. Previous studies have shown that the addition
of non-native lysines do not affect the ability of strongly interacting TM domains to
oligomerise (Ding et al., 2001; Lazarova et al., 2004; Melnyk et al., 2001; Melnyk et
al., 2003). However there is evidence that lysines and other positively charged
residues may affect the interactions between more weakly interacting helices
(Iwamoto et al., 2005; Prodöhl et al., 2007), so their inclusion is not always
appropriate. Since TatA includes two native lysines, it was decided that the addition
of one further lysine should not disrupt any strong interactions.
The TatATM peptide was purified using reversed-phase high performance liquid
chromatography (HPLC) using a linear acetonitrile (ACN) gradient with 0.1%
trifluoroacetic acid (TFA) as detailed in §2.13.1. Fractions were checked for the
presence of pure peptide using electrospray ionisation mass spectrometry (ESI-MS),
before being pooled and lyophilised. The major species detected by ESI-MS, Figure
4.1, corresponded to pure peptide (2651 Da), with additional peaks corresponding to
sodium adducts (2673, 2695 Da). Sodium adducts have previously been observed in
the purification of TM peptides (Rijkers et al., 2005).
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Figure 4.1 Assessment of the purified TatATM peptide by electrospray ionisation mass
spectrometry. Pooled fractions from reversed-phase HPLC purification of the TatATM peptide were
checked for purity by ESI-MS. The major peak corresponded to the TatATM peptide (2651 Da), with
additional peaks corresponding to sodium adducts.
4.2.1 Determination of the TatATM peptide secondary structure
To determine the secondary structure of the TatATM peptide in detergent micelles and
lipid bilayers, circular dichroism (CD) spectra were obtained. CD spectra were
recorded for peptide solubilised in buffer containing 7.5 mM dodecylphosphocholine
(DPC) detergent, and peptide reconstituted into 1,2-Dimyristoyl-sn-Glycero-3-
Phosphocholine (DMPC) liposomes in a 10:1 lipid to peptide ratio, Figure 4.2.
Negative minima at 208 and 222 nm, characteristic of an α-helical secondary
structure, can be seen in the spectra. Fitting of the data using CDSSTR (Sreerama &
Woody, 2000) with the SP175 reference set (Lees et al., 2006) predicts that the
peptide is predominantly α-helical; ~69% α-helical in DPC and ~54% α-helical in
DMPC. Although these values are lower then expected there may be some
aggregation of this extremely hydrophobic peptide, which would decrease the α-
helical content of the sample. Additionally, the signal is not very accurate below 195
nm due to light scattering of the sample. This may affect the results from the fitting
program, which fits between 190 and 240 nm. Despite this, the data indicate that the
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TatATM peptide does have a largely α-helical secondary structure in both detergent
micelles and liposomes, which agrees with the predicted secondary structure of TatA.
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Figure 4.2 Secondary structure determination of the TatATM peptide by circular dichroism. A.
CD spectra of the TatATM peptide were recorded for the peptide solubilised in buffer containing 7.5
mM DPC detergent (light blue), and peptide reconstituted into DMPC liposomes in a 10:1 lipid to
peptide ratio (dark blue). Baselines of samples without peptide were subtracted to give the final
spectra. Data are reported in mean residue ellipticity (MRE) units. B. The high tension signals of the
CD spectra were also recorded.
4.2.2 Determination of the insertion of the TatATM peptide into
lipid bilayers
The exact cellular location of TatA is still a subject of some dispute. Whilst it is
widely considered to be a membrane protein a recent study has claimed that it forms
cytoplasmic tubules (Berthelmann et al., 2008). Furthermore, the TatA homologue in
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the Gram-positive Bacillus subtilis, TatAd, has been shown to be active in the
cytoplasm and membrane of cells (Pop et al., 2003). To ascertain that the TatATM
peptide does insert into lipid membranes, the solution-phase method of linear
dichroism spectroscopy (LD), oriented circular dichroism (OCD), attenuated total
reflectance Fourier transform infrared spectroscopy (ATR-FTIR) and intrinsic
tryptophan fluorescence were used.
4.2.2.1 Analysis of the TatATM peptide by linear dichroism
(LD)
The solution-phase method of LD (Dafforn & Rodger, 2004; Rodger et al., 2002) has
recently become a more viable technique for studying proteins due to advances
which have enabled the use of small sample volumes (< 50 µL) (Marrington et al.,
2004; Marrington et al., 2005). LD is a spectroscopic technique which measures the
difference in absorption of light polarised parallel to an orientation direction and
light polarised perpendicular to that direction (LD signal). In order to obtain a signal,
samples must be able to be aligned, which means they must have an asymmetric
characteristic in charge or shape. The study of membrane proteins by this method has
been facilitated by the use of liposomes, which can be orientated by shear flow in a
spinning Couette cell (Ardhammar et al., 1998; Rodger et al., 2002), Figure 4.3A.
The liposomes are elongated by the flow and align parallel to the direction of flow. If
the protein does not interact with the liposomes it will not align, Figure 4.3B, and
there will be no difference between absorption of light polarised parallel and
perpendicular, and hence no LD signal. If the protein interacts with the liposomes, an
LD signal can be seen, with positive and negative maxima which result from the
transition polarisations of the protein, and depend on its structure and mode of
interaction. For an ideal α-helical peptide, if the peptide inserts across the lipid
bilayer, perpendicular to the direction of flow, Figure 4.3C, it has been calculated
that the n → π* transition produces a positive maximum at ~220 nm, with the π → 
π* transition producing a negative maximum at ~ 210 nm and a positive maximum at
~190 nm (Dafforn & Rodger, 2004; Rodger et al., 2002). For an α-helical peptide
lying on the surface of the liposome, parallel to the direction of flow, Figure 4.3D,
the LD signal will be reversed, giving negative maxima at ~190 and ~220 nm, and a
positive maximum at ~210 nm.
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Figure 4.3 Linear dichroism of peptides in liposomes. A. In shear flow liposomes become
elongated and align with the direct of flow. The LD signal is the absorbance parallel to the flow
(arrow) minus the absorbance perpendicular to the flow. B. If the peptide does not associate with the
liposomes, it does not orientate and gives no LD signal. C. If the peptide inserts across the liposome
bilayer, it aligns perpendicular to the direction of flow. D. If the peptide associates with the surface of
the liposome it orientates parallel to the direction of flow. Figure adapted from (Hicks et al., 2008).
The interaction between the α-helical TatATM peptide and DMPC liposomes, and its
orientation within DMPC bilayers, was investigated by LD. DMPC liposomes were
prepared containing TatATM peptide and orientated in a Couette cell by spinning at
three different rotation speeds; 3000, 4000 and 5000 rpm. Spectra were recorded
between 190 and 360 nm and corrected for light scattering due to the liposomes,
Figure 4.4. The resulting spectra all show positive maxima at ~205 and 225 nm, and
a negative maximum at ~217 nm. It was assumed that the 225 nm maximum
corresponded to the n → π* transition and the 205 and 217 nm maxima corresponded
to the π → π* transition, thus indicating that the peptide was perpendicular to the 
direction of flow and inserted into the lipid bilayer, Figure 4.3C. Although the
wavelengths of the maxima are shifted from those calculated for an ideal α-helix
(190, 210 and 220 nm), this has been observed previously for peptides inserted into
liposome bilayers. The antibiotic gramicidin inserts into membranes and gives an LD
signal which has positive maxima at ~200 and 227 nm, and a negative maximum at
~213 nm (Rodger et al., 2002). Shifts have also been observed for the α-helical TM
domains of E5 (Oates et al., 2008) and invariant chain (Ii) when they insert into lipid
bilayer (A. J. Beevers, J. Oates and A. M. Dixon, unpublished work). Despite the
shift in maxima, it was concluded that the TatATM peptide was inserting into the
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liposome membranes. The increase in intensity of the peptide LD signal as rotational
speed increases is due to the increased orientation of the liposomes, showing that the
LD signal also depends on alignment.
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Figure 4.4 Linear dichroism spectra of the TatATM peptide in DMPC liposomes to determine
insertion. A. LD spectra were taken at three different rotating speeds; 3000, 4000 and 5000 rpm. A
spectrum of the sample without spinning was subtracted from the spectra of the sample with spinning
to give the LD signal, and then the spectra were corrected for light scattering. Numbers indicate the
wavelengths of the positive and negative maxima. B. The high tension signals of the LD spectra were
also recorded.
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4.2.2.2 Analysis of the TatATM peptide by oriented circular
dichroism (OCD)
To confirm the insertion of the TatATM peptide into DMPC lipid bilayers, the
spectroscopic technique of OCD was employed. This technique has been used
previously to analyse the insertion of the TM domain and APH of the Bacillus
subtilis TatA homologue, TatAd, (Lange et al., 2007). The determination of the
insertion of α-helices into lipid bilayers using this technique relies on the fact that the
π → π* transition component at ~208 nm is polarised parallel to the helical axis. 
When an α-helical peptide inserts into a oriented lipid bilayer, light propagating
along the axis of the helix (that is perpendicular to the lipid bilayer) is unable to be
absorbed. Thus a reduction of the negative band at ~208 nm indicates that the peptide
is inserted into the membrane.
To analyse the TatATM peptide using this technique, a multilamellar film consisting
of aligned lipid bilayers containing the peptide was placed on a quartz slide. The
slide was positioned in the spectropolarimeter with the incident light beam
perpendicular to the multilamellar film. To minimise artefacts due to sample
inhomogeneity, the slide was rotated through 360°, taking measurements every 45°.
The resulting spectra were averaged and a baseline of sample containing no lipid was
subtracted to give the resulting OCD spectra, Figure 4.5. Comparison with the
isotropic CD spectra of the peptide in liposomes, shows that the negative maximum
at 208 nm is reduced, indicating that it is inserted in the lipid bilayer. This agrees
with the LD analysis and the previous study of TatAd (Lange et al., 2007).
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Figure 4.5 CD and OCD measurements of the TatATM peptide in DMPC lipid bilayers to
determine insertion. The CD spectrum (dark blue) shows a typical α-helical peptide with negative
maxima at 208 and 222 nm. The loss of signal at 208 nm in the OCD spectrum (light blue) indicates
insertion of the peptide into the lipid membrane.
4.2.2.3 Analysis of the TatATM peptide by attenuated total
reflection Fourier transform infrared spectroscopy (ATR-FTIR)
The TatATM peptide was analysed using ATR-FTIR, a technique which can give
information on both secondary structure and insertion into lipid bilayers (Tatulian,
2003). ATR-FTIR measures the absorption of infrared light by the molecule and
promotion to higher vibrational/translational energy levels. Transitions are due to
stretching, bending, rocking, wagging or twisting of bonds within the molecule
(Harwood & Claridge, 1997). For peptides and proteins, specific transitions of
interest are the amide I and amide II vibrations of the amide bond. The amide I peak
ranges from 1600 to 1700 cm-1 and is directly related to the backbone conformation.
The amide II peak, which ranges from 1510 to 1580 cm-1, results primarily from in-
plane N-H bending and is often used for determination of the degree of the protein or
peptide’s accessibility to water since it is sensitive to deuterium exchange. For
proteins in an α-helical conformation, the mean frequency of the amide I peak is
1652 cm-1 and for the amide II peak is 1548 cm-1 (Nevskaya & Chirgadze, 1976). If
Chapter 4. Analysis of the E. coli TatA TM Domain
81
the protons which contribute to the amide II peak are accessible to deuterium
exchange, the amide II peak will shift due to the exchange of protons for deuterons.
This gives information on the insertion of proteins into lipid membranes; protons
within the lipid bilayer are protected from deuterium exchange, whilst protons
exposed outside the bilayer will exchange with deuterium.
As for the OCD study, DMPC lipid bilayers containing TatATM peptide were
prepared, in this instance on a germanium plate. Spectra, the average of 1000
interferograms, were recorded before and after exposure to deuterium soaked
nitrogen for 22 hours, Figure 4.6. Before exposure to deuterium, the FTIR spectrum
of the TatATM peptide revealed an amide I peak centred at 1658 cm-1, which became
more distinct after exposure. The peak at ~1693 cm-1, although in the β-sheet region,
most likely corresponds to a TFA adduct, an artefact of the peptide purification. The
lack of any equivalent observable break in the 1620–1630 cm-1 region would indicate
that at least the majority of this peak is not caused by β-sheet structure. The
disappearance of the peak after 22 hours of D2O exposure is probably due to either a
removal or possible deuterium exchange of the TFA, which makes the peak shift to a
lower wavenumber. The accessibility of the TFA to D2O would suggest that it was
exposed, possibly bound to the lysine residues on the C-terminus of the peptide.
To determine if the TatATM peptide inserted into the DMPC lipid bilayer, the amide
II peak, centred at 1544 cm-1, was compared before and after exposure to deuterium.
The amide II peak did not shift indicating that the protons belonging to the peptide
bonds were not accessible to deuterium exchange, being shielded by the lipid
membrane. Hence the peptide was inserted into the lipid bilayer. This confirms the
results from the LD and OCD analyses that the TatATM peptide is able to insert into
the lipid bilayers.
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Figure 4.6 ATR-FTIR spectra of the TatATM peptide in DMPC lipid bilayers. A. Spectra were
taken before (dark blue) and after (light blue) exposure to deuterium soaked nitrogen for 22 hours.
The peak at ~2500 cm-1 indicates the presence of D2O. B. Overlay of the spectra focusing on the
1800–1400 cm-1 range shows that the amide I and II peaks do not shift after exposure to deuterium
soaked nitrogen (arrows). A TFA adduct, which is an artefact from the peptide purification, is also
indicated by an arrow.
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To obtain an estimation of the secondary structure of the TatATM peptide, the amide I
peak was analysed. This is possible because the different types of secondary
structures result in amide I vibrations at different frequencies, reviewed in (Tatulian,
2003). The band-narrowing tool of Fourier self-deconvolution was used on the 1700–
1600 cm-1 region of the spectra and a baseline correction was also applied using
OMNIC Spectra software. Gaussian curves were then fitted to the data using
GRAMS software in order to estimate the secondary structure of the peptide, Figure
4.7. The predominant peak centred at 1657 cm-1 corresponded to an α-helical
conformation, with additional peaks at 1691, 1676 and 1630 cm-1 due to β-sheet and
a peak at 1648 cm-1 due to disordered structure. This is in agreement with CD
analysis §4.2.1 where the peptide was predicted to be predominantly α-helical. The
amount of β-sheet and disordered structure was larger than expected, however this
may correspond to the aggregation of some of this extremely hydrophobic peptide
caused by the sample preparation.
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Figure 4.7 Secondary structure calculation of the TatATM peptide using ATR-FTIR. The band-
narrowing tool of Fourier self-deconvolution was used on the amide I peak in the 1700–1600 cm-1
region of the spectra after exposure to deuterium. A baseline correction was also applied. Gaussian
curves were fitted to the peak and were assigned to different secondary structures according to
(Tatulian, 2003).
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4.2.2.4 Analysis of the TatATM peptide using intrinsic
fluorescence
The insertion of the TatATM peptide into DMPC lipid bilayers was also confirmed by
the intrinsic fluorescence properties of the native tryptophan (Trp7) in the sequence.
The emission of tryptophan is strongly affected by the polarity of its local
environment (Lakowicz, 2006). In an aqueous solution the fluorescence maximum of
a tryptophan from an unfolded protein occurs at ~350–353 nm, shifting to ~340–342
nm for tryptophans on the surface of folded proteins and ~330–332 nm for
tryptophans in a hydrophobic environment (Burstein et al., 1973). Hence the
insertion of tryptophan residues into a hydrophobic lipid bilayer can be detected by a
blue-shift of the maximum emission peak (Christiaens et al., 2002; Macek et al.,
1995).
Fluorescence spectra, with excitation at 280 nm, were recorded for the TatATM
peptide in DMPC liposomes and trifluoroethanol (TFE), and emission spectra were
recorded between 300 and 400 nm, Figure 4.8. In the polar solvent TFE the emission
maximum occurred at ~345 nm, indicating Trp7 was not in a completely aqueous
environment. However, in the presence of liposomes the maximum shifted to ~333
nm. This blue-shift indicates that Trp7 in the TatATM peptide is located in the
hydrophobic lipid bilayer, confirming the results using other biophysical techniques.
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Figure 4.8 Fluorescence emission spectra of the TatATM peptide in DMPC liposomes.
Fluorescence spectra of the TatATM peptide in DMPC liposomes (dark blue) and TFE (light blue)
were recorded with excitation at 280 nm. The fluorescence of the sample without peptide was
subtracted. Data were normalised and a line of best fit was calculated (black).
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4.2.3 In vitro oligomerisation of the TatATM peptide
The TatATM peptide has been shown to be α-helical and is able to insert into DMPC
lipid bilayers. As previously mentioned, it has been suggested that the TatA TM
domain is involved in the oligomerisation of TatA (De Leeuw et al., 2001; Greene et
al., 2007; Porcelli et al., 2002). To assess the ability of the TatA TM domain to form
homo-oligomers, the TatATM peptide was studied using SDS-PAGE and chemical
cross-linking.
4.2.3.1 Analysis of the TatATM peptide oligomeric state by
SDS-PAGE
In order to assess the ability of the TatATM peptide to form oligomers, a range of
concentrations of peptide were analysed by SDS-PAGE. This method has been
widely used to assess the oligomeric state of TM domains (Jenei et al., 2009;
Lemmon et al., 1992; Melnyk et al., 2001; Oates et al., 2008). When the SDS-PAGE
gel was stained with Coomassie blue, a single band at ~4 kDa could be seen, Figure
4.9A. Only at the highest concentrations could a weak second band at ~6 kDa been
seen. Silver stain analysis of the same gel, a technique which is 1 to 2 orders of
magnitude more sensitive than Coomassie stain (Switzer et al., 1979), revealed more
clearly the presence of the second, higher molecular weight band, Figure 4.9B. The
two bands on the TatATM peptide SDS-PAGE gel, 4 and 6 kDa, do not agree exactly
with the predicted monomer (m) and dimer (d) masses of 2.65 and 5.3 kDa,
respectively. Similar anomalous migration has been observed for other membrane
proteins (Melnyk et al., 2001; Rath et al., 2009; Therien et al., 2001), and is thought
to be caused by conformational effects and the binding of detergent. This is also seen
for full length TatA, Figure 4.17B, where it runs as a band of ~15 kDa, much larger
than the predicted mass of 9.6 kDa. Despite the difficulties in obtaining accurate
mass approximations from SDS-PAGE, the two bands were assigned to monomer
and dimer. The existence of two distinct bands implies that the exchange between the
two states is slow in relation to the timescale of the experiment and is reversible
(Lemmon et al., 1992). This suggests that there is a monomer-dimer equilibrium for
the TatATM peptide.
Chapter 4. Analysis of the E. coli TatA TM Domain
86
3
kDa
[TatATM] (µM)
A B
6
200100502510 200100502510MW MW
[TatATM] (µM)
m
d
Figure 4.9 SDS-PAGE analysis of the TatATM peptide to determine oligomeric state. The
TatATM peptide was analysed over a range of concentrations (stated below each lane) with a
molecular weight marker (M). A. The Coomassie stained gel revealed the peptide is mainly a
monomer (m) (monomer MW = 2.65 kDa) with a hint of a dimer (d) at higher concentrations. B.
Silver staining the same gel revealed more clearly the presence of dimers.
4.2.3.2 Analysis of the TatATM peptide oligomeric state by
chemical cross-linking
SDS is widely considered to denature proteins, and whilst some peptides are able to
retain their secondary structure in the presence of SDS and form stable oligomers
(Lange et al., 2007; Melnyk et al., 2001; Oates et al., 2008; Therien et al., 2001), TM
domain interactions may be disrupted by this relatively denaturing detergent (Jenei et
al., 2009). In order to determine if the TatATM peptide was able to form higher
oligomers in less denaturing detergents such as DPC, chemical cross-linking was
performed.
The peptide was solubilised in DPC detergent micelles at different peptide:detergent
micelle ratios to investigate the effect of detergent concentration on oligomeric state.
Cross-linking was performed with Bis(sulfosuccinimidyl)suberate (BS3) or
glutaraldehyde, which react with the NH2 groups of lysine side chains, as well as the
terminal NH2 of the peptide, provided that they are within 11.4 Å of each other. After
cross-linking, samples were analysed by SDS-PAGE and visualised by staining with
silver nitrate, Figure 4.10. When no cross-linker was added, the peptide ran as a
monomer and dimer (4:1 no x), as seen previously when no DPC detergent was
added, Figure 4.9. When cross-linker was added, bands of higher order oligomers
corresponding to up to pentamer could be seen. Due to the faintness of the bands, the
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existence of higher order oligomers could not be ruled out. In all reactions the major
band corresponded to monomer, with the amount of monomer increasing as the
concentration of detergent increased (4:1, 1:1, 1:12.5). This agrees with previous
research, which has shown that increasing detergent concentration can destabilise
TM domain oligomers (Fisher et al., 1999; Jenei et al., 2009).
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Figure 4.10 Cross-linking analysis of the TatATM peptide in detergent micelles. Cross-linking was
performed in DPC detergent micelles at different peptide: detergent micelle concentration ratios,
indicated below each lane. Reactions were performed with BS3 or glutaraldehyde cross-linkers, as
indicated. Two reactions were quenched with 2 µM Tris-HCl pH 7.5 before addition of cross-linker
(4:1 preQ), one reaction was performed without cross-linker (4:1 no x) and an additional reaction was
performed in SDS. Molecular weight markers are shown in the left hand lane (MW). Proteins were
visualised by staining with silver nitrate. Oligomeric states are indicated on the right (n = 1, n = 2,…).
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Cross-linking was also performed in 100 mM SDS (SDS). A similar ‘ladder’ of
higher order oligomers as seen with DPC detergent was observed. Although cross-
linking in SDS can be used as a negative control (Jenei et al., 2009) it was not
unexpected to see these higher order oligomers since the TatATM peptide is able to
form SDS stable dimers. As a negative control, cross-linking was performed with
samples which had been quenched before addition of cross-linker (4:1 preQ).
Surprisingly higher order oligomer bands could still be visualised. This may be due
to insufficient quenching. Similar ‘ladders’ have been seen in previous studies
(Alfadhli et al., 2002; Geisse et al., 2002).
4.3 Analysis of the TatA TM domain using the TOXCAT assay
Analysis of the TatATM peptide in vitro revealed the presence of dimers and higher
order oligomers, but with a large population of monomers. To analyse these
interactions in a natural membrane environment, as opposed to detergent micelles
which can be highly denaturing (Fisher et al., 2003), the TOXCAT assay was used
(Russ & Engelman, 1999), described in detail in §2.12. In this system a chimeric
protein consisting of the α-helical TM domain of interest inserted between the N-
terminal dimerisation-dependent DNA binding domain of ToxR, and the monomeric
periplasmic anchor maltose binding protein (MBP) is used. The chimera inserts into
the membrane and interaction between the helical TM domain leads to the expression
of chloramphenicol acetyl transferase (CAT), which can be measured. The levels of
CAT expression correspond to the strength of interaction between the TM domains.
The TM domain of Glycophorin A (GpA), which is known to strongly dimerise, and
its dimerisation defective mutant (G83I), are typically used as a positive and negative
control, respectively.
Previous studies using the TOXCAT assay (Jenei et al., 2009; Langosch et al., 1996;
Li et al., 2004) have shown that the length of the TM domain insert can affect ToxR-
based transcriptional activity. For this reason, it was decided to insert different
lengths of the TatA TM domain into the TOXCAT chimera, Figure 4.11. Five
TOXCAT chimera with TM domain inserts of 16 to 20 residues were constructed
(TM16–TM20) and expressed in malE deficient NT326 cells, which do not express
any endogenous MBP. Various controls were performed to determine the expression
level, correct insertion and orientation of TM16–TM20. The GpA and G83I TOXCAT
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chimera, both of which correctly insert into the membrane, were used for
comparison.
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Figure 4.11 TatA TM domain TOXCAT constructs used in this study. A. The first 50 residues of
the TatA primary sequence (TatA) with the predicted TM domain (blue) and APH (red); and the five
different lengths of TatA TM domain inserted into the TOXCAT chimera (TM20–TM16). The Gln8 is
also highlighted (orange). B. The TM20 TOXCAT chimera consisting of the α-helical TM domain
inserted between the N-terminal dimerisation-dependent DNA binding domain of the ToxR protein
( ) and the periplasmic anchor MBP ( ).
To check the expression levels of TM16–TM20, and the positive and negative
controls, Western blots of whole cells expressing the chimera were performed, Figure
4.12A. Expression levels were comparable to GpA and G83I. The correct insertion of
the TOXCAT chimera in the membrane was confirmed by sodium hydroxide washes
(Chen & Kendall, 1995), Figure 4.12B. Cells expressing the chimera were treated
with ice-cold sodium hydroxide and then centrifuged. Cytoplasmic and periplasmic
proteins as well as proteins loosely associated with the membrane were found in the
supernatant (S), whilst proteins stably associated with the membrane remained in the
pellet (M). Western blots of the supernatant and pellet, as well as untreated whole
cells (W) reveal that GpA and TM20 are located exclusively in the pellet. This
indicates that the chimera is inserted across the membrane. The correct orientation of
the chimera was confirmed by protease sensitivity in a spheroplast assay and malE
complementation on agar plates (Russ & Engelman, 1999). For the spheroplast assay
spheroplasts (Sp) were prepared from cells expressing the TOXCAT chimera. These
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were then either treated with Proteinase K (Sp’) or broken open by freeze-thaw
before protease treatment (B’). If the chimera is correctly inserted, MBP should be
located on the outside of the spheroplast and accessible to Proteinase K. When
treated with protease, the MBP is cleaved and will run as a lower molecular weight
band than the intact chimera. Analysis of cells expressing TM20 show that the MBP
is cleaved by treatment with protease, Figure 4.12C, as demonstrated by the
existence of the lower molecular weight band in lanes Sp’ and B’. This indicates that
the TM20 is inserted in the correct orientation. This was also confirmed by malE
complementation on agar plates. NT326 cells, which lack MBP, cannot transport
maltose into the cytoplasm for metabolism, hence cannot grow on plates where the
only carbon source is maltose. If the TOXCAT chimera is correctly inserted, the
MBP is located in the periplasm and cells are able to grow on maltose. NT326 cells
expressing TM16–TM20 and GpA were able to grow on M9 agar plates containing
0.4% maltose, whilst NT326 cells not expressing the chimera were unable to grow,
Figure 4.12D. These checks confirm that the TM16–TM20 chimera are expressed at
comparable levels to GpA and G83I, and insert across the cell membrane with the
correct topology.
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Figure 4.12 Expression, insertion and orientation checks for the TatA TM domain TOXCAT
chimera. A. Immunoblot using anti-MBP antibodies of whole NT326 cells expressing the TatA TM
TOXCAT constructs (TM16–TM20). The chimera expression levels were compared with the chimera
containing the TM domain of GpA, which is known to strongly dimerise, or its dimerisation defective
mutant (G83I). Arrow indicates the TOXCAT chimera. B. Immunoblot using anti-MBP antibodies of
NaOH washes. Cells expressing the TOXCAT chimera were treated with ice-cold NaOH, then
centrifuged to separate the supernatant (S), which contained cytoplasmic, periplasmic and loosely-
membrane associated proteins, from the pellet (M), which contained proteins stably associated with
the membrane. Untreated whole cells (W) were also analysed. Cells not expressing the chimera
(NT326) were used as a negative control. Arrow indicates the TOXCAT chimera C. Immunoblot
using anti-MBP antibodies of protease sensitivity of spheroplasts assay. Spheroplasts (Sp) of cells
were treated with Proteinase K (Sp’) or broken open by freeze-thaw before treatment with Proteinase
K. Arrow indicates TOXCAT chimera and asterisk indicates MBP cleaved by proteolysis. D. malE
complementation assay. malE deficient NT326 cells containing the TatA TM and GpA TOXCAT
chimera were grown on M9 agar plates containing 0.4% maltose.
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The levels of CAT expression in NT326 cells expressing TM16–TM20 were initially
estimated by a disk diffusion assay. Expression of CAT gives cells resistance to the
antibiotic chloramphenicol (CAM). By placing a disk soaked in CAM onto the centre
of an agar plate of cells, an antibiotic gradient is formed with the highest
concentration closest to the disk. Only cells expressing high levels of CAT are able
to grow close to the disk, hence the zone of inhibition of growth (ZOI) can give an
initial indication of the CAT expression levels. The ZOI was recorded for the five
TatA TM constructs and compared to the positive and negative controls of GpA and
G83I, respectively, Figure 4.13. TM16–TM20 were able to grow closer to the disk
than G83I, however not as close as GpA, indicating an intermediate level of TM
domain interaction.
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Figure 4.13 Disk diffusion assay for the TatA TM domain. NT326 cells expressing the TatA TM
domain TOXCAT constructs (TM16–TM20) were grown on agar plates with a chloramphenicol soaked
disk in the centre, along with the positive and negative controls of GpA and G83I respectively. The
zone of inhibition of growth (ZOI) was recorded (black circles and lines) and is given in the table
along with the standard deviation (SD) of different measurements.
Chapter 4. Analysis of the E. coli TatA TM Domain
93
CAT expression levels for the constructs were measured more accurately using the
quantitative CAT assay as detailed in §2.12.2.2. Since TM17–TM19 gave similar disk
diffusion results, Figure 4.13, only TM16, TM18 and TM20 were analysed using this
method, alongside GpA and G83I as controls. The resulting [CAT] activity was
normalised to GpA, Figure 4.14. All three lengths of TatA TM domain (TM16, TM18,
TM20) yielded relatively low levels of CAT in the assay ([CAT]TM16 = 33%,
[CAT]TM18 = 27% and [CAT]TM20 = 38% of GpA) suggesting that there is some level
of interaction between TatA TM domains, but that the strength of this interaction is
relatively weak when compared to the positive control, GpA. This is in keeping with
the fact that GpA forms SDS stable dimers (Lemmon et al., 1992), whereas the TatA
TM domain is mainly monomeric in SDS.
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Figure 4.14 Quantitative CAT assay of TatA TM domain interactions. Levels of chloramphenicol
acetyltransferase (CAT) activity in NT326 cells expressing the TOXCAT chimera with the different
length TatA TM domain insert (TM16, TM18, TM20) were assayed (as detailed in §2.12.2.2) along with
GpA and its dimerisation defective mutant (G83I) as positive and negative controls, respectively.
CAT activity was normalized to GpA. Error bars show the standard deviation of three separate
measurements.
4.4 The role of the glutamine (Gln8) in the TatA TM domain
A recent cysteine scanning study of the TM domain and APH of TatA highlighted a
glutamine residue, Gln8, in the TM domain which was important for function, Figure
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4.11A (Greene et al., 2007). Substitution of this residue with cysteine or alanine
severely affected the export of the Tat substrate TorA to the periplasm. The presence
of hydrophilic residues in TM domains, and specifically glutamine residues, has been
shown to drive TM helix-helix association via electrostatic interactions and
formation of interhelical hydrogen bonds (Dixon et al., 2006; Freeman-Cook et al.,
2004). We therefore set out to test whether this residue plays a role in helix-helix
interactions within the TatA complex.
4.4.1 Analysis of the TatA Gln8 using the TOXCAT assay
The role of Gln8 in TatA TM domain oligomerisation was studied by mutagenesis of
this residue and subsequent remeasurement using the TOXCAT assay. The Gln8 in
TM20, which gave the highest [CAT] activity ([CAT]TM20 = 38% of GpA), Figure
4.14, was substituted by cysteine (Q8C) and alanine (Q8A). Control experiments
were carried out to ensure the chimera were expressed at similar levels to GpA and
G83I and inserted with the correct topology as detailed in §2.12.1. The Gln8 mutants
were expressed at similar levels to the TM20 TOXCAT chimera, Figure 4.15A, and
inserted into the membrane with the correct orientation as assessed by malE
complementation, Figure 4.15B.
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Figure 4.15 Expression, insertion and orientation checks for the Gln8 mutant TOXCAT
chimera. A. Immunoblot using anti-MBP antibodies of whole NT326 cells expressing the TatA TM
TOXCAT construct (TM20) and the Gln8 mutants (Q8A, Q8C). The expression levels were compared
with the chimera containing the TM domain of GpA, which is known to strongly dimerise, and its
dimerisation defective mutant (G83I). Arrow indicates the TOXCAT chimera. B. malE
complementation assay. malE deficient NT326 cells containing the TatA TM and GpA TOXCAT
chimera were grown on M9 agar plates containing 0.4% maltose.
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Levels of CAT expression were measured as detailed in §2.12.2.2. The resulting
signals were normalised to GpA and compared with wild-type TM20, Figure 4.16.
Although these substitutions lead to a slight decrease in [CAT] activity compared to
TM20 levels ([CAT]Q8A = 24% and [CAT]Q8C = 28%), the result is only significant
within the error for Q8A.
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Figure 4.16 Quantitative CAT assay of Gln8 mutants. Levels of CAT activity in NT326 cells
expressing the TatA TOXCAT chimera (TM20) and TM20 with the Gln8 substituted with alanine or
cysteine (Q8A, Q8C) were assayed (as detailed in §2.12.2.2) along with GpA and its dimerisation
defective mutant (G83I) as positive and negative controls, respectively. CAT activity was normalized
to GpA. Error bars show the standard deviation of three separate measurements.
4.4.2 Analysis of the functional role of the Gln8
Since the Gln8 substitutions did not dramatically reduce the level of TatA TM
domain oligomerisation as measured by the TOXCAT assay, these substitutions were
analysed in full length TatA using a different expression system from the previous
study mentioned above (Greene et al., 2007). The Gln8 of TatA was substituted with
alanine or cysteine in the arabinose inducible plasmid pBAD-ABC, and the mutants
were analysed for effects on the function of the Tat pathway.
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The function of the mutated TatA was analysed by a native gel based trimethylamine
N-oxide (TMAO) reductase (TorA) activity assay. TorA is a 90 kDa E. coli
molybdoenzyme which is translocated across the plasma membrane by the Tat
pathway. It catalyses the reduction of TMAO to trimethylamine and has been shown
to be functional in the cytoplasm and periplasm, thus lending itself to analysis of the
functionality of the Tat pathway (Santini et al., 1998). In this study cells were
separated into periplasmic and cytoplasmic fractions, and then subjected to native
PAGE. The presence of TorA in the gel was confirmed by an enzyme linked redox
reaction (Silvestro et al., 1989). The gel was stained blue by reduced methyl
viologen then incubated with TMAO. In the presence of TorA the TMAO was
reduced and consequently the methyl viologen was oxidised, revealing a ‘white’
band.
The E. coli tat deletion strain (ΔABCDE) cells containing pBAD-ABC or mutated
pBAD-ABC were grown in the presence or absence of arabinose before
fractionation. Cells were grown with or without arabinose in order to analyse any
concentration-dependent effects of the substitutions. A previous study (Bolhuis et al.,
2001) has shown that induction with low levels of arabinose (5 µM) provides near
wild-type levels of TatABC, and Tat component levels are slightly lower than wild-
type levels if arabinose is omitted. An approximately 25-fold increase over wild-type
levels is observed when the pBAD-ABC plasmid is induced with 50 µM
concentrations, which is similar to the expression levels reported in other studies of
plasmid-borne Tat proteins (Buchanan et al., 2002). In this study, when grown in the
absence of arabinose, the plasmid borne Tat components were expressed at very low
levels, when compared to the wild-type MC4100 cells, with moderate overexpression
shown in the presence of arabinose, Figure 4.17B.
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Figure 4.17 TorA export assay of the TatA Gln8 mutants at different expression levels.
Periplasmic and cytoplasmic samples (P,C) were prepared from wild-type E. coli cells (MC4100),
from ΔABCDE cells, and from ΔABCDE cells expressing wild-type TatABC from plasmid pBAD-
ABC (ΔABCDE+ABC), or the same vector with TatA Gln8 substituted with alanine or cysteine (Q8A,
Q8C), grown in the absence or presence of arabinose (uninduced, induced). A. Native polyacrylamide
gels of periplasmic and cytoplasmic samples were stained for TorA activity. White bands indicate the
presence of TorA, TorA* indicates a slower migrating cytoplasmic form of TorA. B. Immunoblots of
membrane samples using TatA and TatB antibodies. Arrows indicate TatA and TatB. Asterisks denote
unidentified TatA adducts caused by the Gln8 to Cys substitution.
In the TorA assay of the control samples, Figure 4.17A, TorA is clearly apparent in
the periplasm (P) of MC4100 cells and no export is evident in ΔABCDE cells, where
a slowly migrating form of TorA (TorA*) is observed in the cytoplasm (C) (Barrett
et al., 2003a; Barrett & Robinson, 2005). When arabinose was omitted from the
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growth medium, resulting in low expression levels, wild-type TatA (ABCDE
+ABC) was able to support export of TorA to the periplasm, but no export was
detectable with the mutated forms (Q8A, Q8C). This result agrees with the previous
work, using a different expression system, which highlighted the Gln8 as being
important for function (Greene et al., 2007). However, when arabinose was used to
induce the expression of the Tat components, the TatA Q8A and Q8C mutants were
both able to support export of TorA to the periplasm, as indicated by white bands in
the periplasmic lanes of Figure 4.17A. Although this is a quantitative assay, the
export levels of the mutants, even when induced, seem to be reduced, indicating that
the substitution is still having an effect at higher expression levels.
This result suggests that the Gln8 is important but not essential for functional
activity. When the mutated TatA is expressed at higher levels, the increased
concentration (~25-fold increase over wild-type) is able to compensate for the effect
caused by the lack of the Gln8. This is not totally unexpected as the Gln8 mutants
still oligomerise in the TOXCAT assay. A previous cysteine-scanning study (Greene
et al., 2007) showed that the same substitutions blocked export completely, but it is
possible that the mutants were expressed at very low concentrations in that study.
Furthermore, Greene et al. used a different assay system to that used in this study.
Previous research has shown differences in the conclusions drawn from the results of
these two different assays (Barrett et al., 2003a).
4.4.3 Analysis of the Gln8 in the TatA TM domain by blue-native
PAGE
Blue-native (BN) PAGE has been used in several studies to analyse the size of wild-
type and mutant Tat complexes (Barrett et al., 2005; Behrendt et al., 2007; Oates et
al., 2005; Orriss et al., 2007). By moderately overexpressing the Tat components, it
is possible to gain information on the oligomeric state of TatA mutants. High protein
concentrations are needed for determination of protein oligomeric state, so due to
low expression levels, there is currently no technique sensitive enough to visualise
TatA oligomers at wild-type levels. Moderate overexpression of the Tat components
has been used in several studies of TatA (Berthelmann et al., 2008; Gohlke et al.,
2005; Oates et al., 2005).
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Membranes isolated from ΔABCDE cells expressing the wild-type and mutated
pBAD-ABC plasmid were analysed by BN-PAGE. Immunoblots were performed
with anti-TatA antibodies to detect the TatA complexes, Figure 4.18. Expression of
the Tat components was at a similar level to the functional, induced samples in the
TorA assay, Figure 4.17B. The ‘ladder’ of bands corresponding to different sized
wild-type TatA complexes can clearly be seen (∆ABCDE+ABC). The TatA mutants
were both still able to form oligomers identical to the wild-type TatA (Q8A, Q8C),
indicating that at these expression levels substitution of the Gln8 does not have an
effect on complex formation.
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Figure 4.18 Blue-native PAGE analysis of the Gln8 mutants. Membranes solubilised in digitonin
were subjected to blue-native gel analysis (as described in §2.10.3) and immunoblotted using anti-
TatA antibodies. The mobility of molecular mass markers in kDa are indicated on the left.
4.5 Discussion
The work presented in this chapter sought to analyse the role of the TatA TM domain
and a glutamine residue in the TM domain (Gln8) in the formation of TatA
complexes. The importance of the TM domain in oligomerisation and function of
TatA has been demonstrated indirectly in previous studies (De Leeuw et al., 2001;
Greene et al., 2007; Porcelli et al., 2002). However, at the start of this study there
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was no direct evidence to support the hypothesis that the TatA TM domain, and more
specifically the Gln8, were involved in oligomerisation.
4.5.1 The TatAT M peptide is α-helical and inserts into lipid
bilayers
A number of approaches were used to investigate the role of the TatA TM domain. A
synthetic peptide corresponding to the TatA TM domain was synthesised, purified
and analysed in vitro using a variety of techniques. CD showed that the TatATM
peptide has a predominantly α-helical secondary structure in DPC detergent micelles
and DMPC liposomes. The secondary structure of the TatATM peptide in DMPC lipid
bilayer films was confirmed by ATR-FTIR, with the appearance of amide I and
amide II peaks characteristic of an α-helical structure. This agrees with the predicted
secondary structure and with a study of the predicted TM domain of the TatA
homologue from the Gram-positive B. subtilis, TatAd (Lange et al., 2007).
Due to the lack of consensus on the exact cellular location of TatA from E. coli
(Berthelmann et al., 2008; De Leeuw et al., 2001; Leake et al., 2008; Sargent et al.,
2001), it was important to confirm that the TatATM peptide inserted into lipid
bilayers. Several approaches were used to analyse the insertion of the TatATM peptide
into DMPC lipid bilayers. LD and fluorescence spectroscopy demonstrated for the
first time that the TatATM peptide inserts into DMPC liposomes, and OCD and
deuterium exchange ATR-FTIR showed that this insertion is replicated in lipid
bilayer films. Although these analyses do not demonstrate that TatA is a membrane
protein, it does show that in vitro the predicted TM domain does preferentially and
spontaneously insert into membranes.
4.5.2 TatA TM domains interacts relatively weakly with one
another
SDS-PAGE analyses revealed that the TatATM peptide exists in a monomer-dimer
equilibrium. Chemical cross-linking with both BS3 and glutaraldehyde in less
denaturing detergents stabilised the formation of these dimers and revealed the
existence of higher order oligomers. Increasing the amount of detergent micelles
present did not affect the formation of the higher order oligomers, however the
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relative amount of monomer did increase. Detergents have been shown to have a
destabilising effect on oligomers (Fisher et al., 1999; Fisher et al., 2003; Jenei et al.,
2009), with the dissociation constant increasing as the detergent concentration
increases, resulting in a preference for monomeric peptide. Surprisingly, the higher
order oligomers were still detectable in reactions which had been quenched with an
excess of Tris-HCl buffer before addition of cross-linker. This could have been due
to insufficient quenching or cross-linking occurring before the reaction had been
properly quenched. Although this does bring in to question the validity of the
perceived higher oligomers, their existence for both of the cross-linkers does suggest
they are not artefacts, and the problem lies with the quenching of the reaction.
Similar ‘ladders’ of oligomers have been observed using these cross-linkers (Alfadhli
et al., 2002; Geisse et al., 2002) where the equilibrium of the banding was related to
the cross-linker concentration.
Helix-helix interactions of the TM domain were also analysed in a native membrane
environment using the TOXCAT assay, which has been highly effective in the study
and quantification of TM interactions (Dixon et al., 2006; Freeman-Cook et al.,
2004; Russ & Engelman, 1999; Zhou et al., 2001). Varying the length of the TM
domain inserted into the TOXCAT chimera had little effect for the TatA TM domain,
with all chimera tested yielding low but significant levels of interaction when
compared to the positive and negative controls of GpA and G83I, respectively.
4.5.3 The TatA Gln8 is not essential for function or complex
formation
The effects of the glutamine in the TatA TM domain on function and complex were
analysed by substitution with alanine and cysteine in the TOXCAT assay and full
length TatA expressed from the pBAD24 plasmid. Although substitution of the Gln8
with alanine or cysteine in the TOXCAT assay did result in a small reduction in
[CAT], it was only significant within the error for the Q8A substitution. This small
drop in strength of association was not as large as seen previously for glutamine
substitutions (Dixon et al., 2006; Freeman-Cook et al., 2004), and indicates that
substitution of the Gln8 does not severely disrupt the ability of the TM domain to
form homo-oligomers.
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Analysis of the Gln8 mutants (Q8A, Q8C) in full length TatA revealed concentration
dependent effects. At low expression levels, the TatA mutants were not able to
export the Tat substrate TorA (in agreement with previous reports). However, at
higher expression levels, increased concentration of TatA is able to compensate for
the effects of the mutants and reinstate functional activity. These results are not in
full agreement with a previous cysteine scanning study (Greene et al., 2007), where
substitution of the Gln8 with alanine or cysteine abolished export of TorA. These
differences could be explained by the difference in expression systems and assays
used. Furthermore, in the previous study it is possible that the expression levels were
quite low and in this case would agree with the results presented here. Different
results have also been reported for the different assay systems (Barrett et al., 2003a;
Weiner et al., 1998) and may be due to the sensitivity of the assays. The Gln8
substitutions did not have any visible effect on the formation of oligomers, as
assessed by BN-PAGE. However it is worth noting that the mutated TatA complexes
analysed were functional. Due to the sensitivity of BN-PAGE, it was not possible to
analyse functionally deficient mutated TatA complexes.
The results presented in this chapter suggest that although the TatA TM domain does
have a propensity to interact, it is only partly involved in the formation of the wide
range of TatA complexes. These results agree with a recent study of the TatA plant
homologue, Tha4, where it has been shown that both the TM and C-terminal
domains are involved in oligomerisation in thylakoid membranes (Dabney-Smith &
Cline, 2009). Other regions of the TatA protein may be involved cooperatively with
the TM domain in homo-interactions and formation of complexes. Analysis of the
TatATM peptide has shown that the wide variety of techniques give comparable
results, thus demonstrating that these techniques are suitable for the analysis of short,
very hydrophobic peptides. Combination of the data clearly show, for the first time,
that the TatA TM domain preferentially inserts into lipid bilayers, and goes some
way to proving that TatA is a membrane protein.
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Chapter 5. Analysis of the Escherichia col i TatA
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5.1 Introduction
As mentioned previously, the secondary structure of E. coli TatA is predicted to have
an N-terminal TM domain, followed by a second α-helical domain and a largely
unstructured C-terminal domain, Figure 1.6. Plotting the sequence of the second
helical domain on a helical wheel, Figure 5.1, reveals the amphipathic nature of the
helix, with the bulk of the nonpolar residues all located on the same helical face. The
role of the APH is poorly understood, and it has not been widely studied in isolation
from the rest of the protein.
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Figure 5.1 Helical wheel of the TatA APH. Residues Lys25 to Ala42 of TatA, corresponding to the
predicted APH, mapped onto a helical wheel. Nonpolar residues are shown in yellow, polar uncharged
residues in green, basic residues in blue and an acidic residue in red. The hydrophobic nonpolar
residues are mainly located together on one face of the helix.
A recent cysteine scanning analysis has shown that the APH is very sensitive to
single substitution of amino acids (Greene et al., 2007), and a triple mutation of three
of the lysines in the sequence also blocks export (Barrett & Robinson, 2005).
Deletion of the C-terminus of TatA does not affect function, however deletion of
only an additional ten residues of the APH leads to a loss of export (Lee et al., 2002).
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Research suggesting that TatA may have a dual topology has led to the hypothesis
that the APH is able to insert into the membrane as part of the translocation process
(Chan et al., 2007; Gouffi et al., 2004), possibly with the hydrophilic face of the
helix forming a channel through which the Tat substrate can be exported. It has also
been shown that TatA expressed without its TM domain is still able to interact with
lipid monolayers (Porcelli et al., 2002), although it was not determined if the APH
was inserting into the monolayer or simply lying on the surface. The secondary
structure of the APH from the B. subtilis TatA homologue, TatAd, has also been
shown to depend on detergent and the composition of lipids present (Lange et al.,
2007).
Here, the E. coli TatA APH was characterised using in vitro and in vivo techniques.
Since synthetic peptides corresponding to amphipathic helices have been used
previously in order to analyse their role in isolation (Brass et al., 2002; Cornut et al.,
1996; Srinivas et al., 1992), it was decided to use a synthetic peptide of the TatA
APH. Several biophysical techniques were used to analyse the behaviour of the
synthetic peptide corresponding to the TatA APH in a variety of aqueous, detergent
and lipid environments. The secondary structure and possible insertion of the APH
into lipid bilayers were investigated. The insertion into native E. coli membranes was
also analysed using the TOXCAT assay (Russ & Engelman, 1999).
5.2 Analysis of a TatA APH synthetic peptide
A synthetic peptide of the TatA APH (TatAAPH) corresponding to residues Thr22 to
Pro48 of TatA (TKKLGSIGSDLGASIKGFKKAMSDDEP) was synthesised as
detailed in §2.13. The TatAAPH peptide was purified by reverse-phase HPLC using a
linear ACN gradient with 0.1% TFA. The purity of the peptide was confirmed by
ESI-MS, Figure 5.2. The major peak corresponded to pure peptide (2822 Da), with
additional peaks corresponding to sodium adducts (2845, 2866 Da). These adducts
were also seen in the purification of the TatATM peptide §4.2.
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Figure 5.2 Assessment of the purified TatAAPH peptide by electrospray ionisation mass
spectrometry. Pooled fractions from reversed-phase HPLC purification of the TatAAPH peptide were
checked for purity by ESI-MS. The major peak corresponded to the TatAAPH peptide (2822 Da), with
additional peaks corresponding to sodium adducts.
5.2.1 Secondary structure of the TatAAPH peptide
A previous study of the B. subtilis TatA homologue, TatAd, has shown that the
secondary structure of TatAd expressed without its TM domain depends on the
buffer, detergent and lipid composition (Lange et al., 2007). In this study, CD was
used to assess the secondary structure of our TatAAPH peptide in a variety of solution
conditions, Figure 5.3 and Figure 5.4. The TatAAPH peptide was soluble in aqueous
buffer solution, demonstrating that no detergents or lipids are needed for
solubilisation of this peptide. A CD spectrum was initially acquired for the TatAAPH
peptide dissolved in sodium phosphate buffer. As shown in Figure 5.3, the 208 and
222 nm negative maxima, corresponding to an α-helical secondary structure are not
present. Instead the major negative maximum is at 203 nm, indicating a
predominantly random coil secondary structure in aqueous solution. Next, increasing
concentrations of DPC detergent micelles were added to the peptide, Figure 5.3. The
concentrations were calculated to give peptide:detergent micelle ratios as detailed in
§2.13.5. For samples containing a small concentration of detergent micelles (e.g.
10:1 peptide:micelle), the secondary structure remained largely random coil.
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However, as the concentration of micelles was increased (peptide:micelle = 1:1,
1:6.25), the CD spectra revealed an increase in the α-helical content of the peptide
(as evidenced by the negative maxima at 208 and 222 nm). Fitting of the data using
CDSSTR (Sreerama & Woody, 2000) with reference set SP175 (Lees et al., 2006)
reveals that the sample containing a 1:6.25 peptide:micelle ratio has an α-helical
content of ~68%.
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Figure 5.3 Analysis of the secondary structure of the TatAAPH peptide in different
concentrations of detergent. A. CD spectra of the TatAAPH peptide in buffer or buffer containing
different concentrations of DPC detergent calculated to give the peptide:detergent micelle ratio
indicated (10:1, 1:1, 1:6.25). B. The high tension signals of the CD spectra were also recorded.
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The E. coli membrane is made up of different lipids, of which the main components
are the zwitterionic phosphatidylethanolamine (PE) 69%, and the negatively charged
phosphatidylglycerol (PG) 19% (Ames, 1968). In the study of TatAd mentioned
above (Lange et al., 2007), phosphatidylcholine (PC) and PG lipids were used in the
assessment of the secondary structure of a TM deletion. PC, like PE, is zwitterionic
and has been widely used in the analysis of peptides (Adair & Engelman, 1994;
Oates et al., 2008; Sharpe et al., 2002). We investigated the effect of various lipids
on secondary structure by acquiring CD spectra of the TatAAPH peptide in different
mixtures of PC and PG lipids, Figure 5.4A. In the presence of DMPC, the peptide
adopts a predominantly random coil conformation, as determined by the fitting
program CDSSTR using the SP175 reference set, Figure 5.4C. When different ratios
of 1,2-Dipalmitoyl-sn-Glycero-3-Phosphocholine (DPPC) and 1,2-Dipalmitoyl-sn-
Glycero-3-[Phospho-rac-(1-glycerol)] (DPPG) were added, the peptide took on a
primarily α-helical structure, Figure 5.4C. This indicates that the TatAAPH peptide
requires the presence of anionic phospholipids to fold into a helix.
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Figure 5.4 Analysis of the secondary structure of the TatAAPH peptide in different compositions
of lipid. A. CD spectra of the TatAAPH peptide reconstituted into liposomes with different
compositions of lipid; DMPC with a positively charged headgroup, and different ratios of DPPC and
DPPG with positively and negatively charged headgroups respectively. B. The high tension signals of
the CD spectra were also recorded C. Graph showing the percentage of α-helix, β-sheet and random
coil in the secondary structure of the TatAAPH peptide as calculated using CDSTTR using reference set
SP175.
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5.2.2 Analysis of membrane association of the TatAAPH peptide
Although it has been shown that TatA expressed without its TM domain is still able
to interact with lipid monolayers (Porcelli et al., 2002), the mode of interaction has
not been determined. Previously used methods were not able to differentiate between
insertion into the membrane and association with the surface of a monolayer. Here
we again used LD and ATR-FTIR to determine the nature of the interaction between
the TatA APH and lipid membranes (i.e. orientation with respect to the bilayer).
5.2.2.1 LD analysis of the TatAAPH peptide
As discussed in §4.2.2.1, LD can be used to determine if an α-helical peptide is
inserted or lying on the surface of liposomes via the sign of the LD signal. Since the
TatAAPH peptide is only α-helical when there are negatively charged lipids present,
Figure 5.4, liposomes were prepared with a DPPG:DPPC ratio of 70:30. This lipid
composition was chosen to allow comparison with the membrane association study
of the TatAd APH (Lange et al., 2007). DMPC liposomes were also prepared to
determine if the peptide would associate with the membrane when in a random coil
conformation. Samples were aligned by spinning at two different speeds, 3000 and
5000 rpm, a spectrum of the sample without spinning was subtracted to give the LD
signal and the spectra was corrected for light scattering due to the liposomes, Figure
5.5. In the presence of DMPC, no LD signal for the peptide was observed, indicating
that the peptide does not associate with DMPC liposomes. Conversely, in peptide
samples containing DPPG/DPPC liposomes, an LD signal was observed which
increased with the speed of rotation. The increase in signal results from an increase
in alignment (or orientation) and hence indicates that the observed signal results from
liposome-associated peptide. Since there were no clear maxima in the LD spectra it
was not possible to determine if the TatAAPH peptide was inserted into DPPG/DPPC
liposomes. However, since a signal was observed, the TatAAPH peptide did show
association with the liposomes.
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Figure 5.5 Linear dichroism spectra of the TatAAPH peptide in liposomes. A. LD spectra were
taken at two different rotating speeds; 3000 and 5000 rpm, in DMPC liposomes, or liposomes with a
DPPG:DPPC ratio of 70:30. A spectrum of the sample without spinning was subtracted from the
spectra of the sample with spinning then corrected for light scattering to give the LD signal. B. The
high tension signals of the LD spectra were also recorded.
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5.2.2.2 ATR-FTIR analysis of the TatAAPH peptide
As mentioned in §4.2.2.3 ATR-FTIR can be used to determine both the secondary
structure of peptides and their insertion into lipid bilayers. Since the CD analyses
showed that the TatAAPH peptide was only α-helical when both zwitterionic and
negatively charged lipids were present, lipid bilayers with a DPPG:DPPC ratio of
70:30 were again prepared with peptide. Spectra were recorded before and after
exposure to deuterium soaked nitrogen, Figure 5.6. In the spectra of the sample
before exposure to deuterium, amide I and amide II peaks can be seen at 1667 and
1523 cm-1 respectively, Figure 5.6B.
To determine if the peptide inserted into the lipid bilayer the amide II peak was
compared in the spectra before and after exposure to deuterium. After exposure,
there is a loss of the amide II peak at 1523 cm-1 due to it being shifted to a lower
wavenumber, where it was masked by peaks corresponding to bonds in the lipid,
Figure 5.6B. The shift indicates that the protons were exchanged for deuterons and
hence the stretching vibrations were shifted to a lower wavenumber due to the
increased mass. The amide I peak maximum also shifted slightly from 1667 to 1649
cm-1, which also indicates deuterium exchange. These shifts indicate that the peptide
was lying on the surface of the lipid bilayer and was accessible to deuterium
exchange.
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Figure 5.6 ATR-FTIR spectra of the TatAAPH peptide in DPPG/DPPC lipid bilayers. Liposomes
were prepared with a 30:1 lipid to peptide ratio, with a DPPG:DPPC lipid ratio of 70:30. A. Spectra
were taken before (red) and after (orange) exposure to deuterium soaked nitrogen for 22 hours. The
peak at ~2500 cm-1 indicates the presence of D2O. B. Overlay of the spectra focusing on the 1800–
1400 cm-1 region shows that the amide I and II peaks shift after exposure to deuterium soaked
nitrogen (arrows), with the amide II shifting out of the 1800–1400 cm-1 range.
The secondary structure of the peptide in the sample was determined by peak fitting
the amide I peak. In the spectrum acquired before exposure to deuterium soaked
nitrogen, the amide I peak can be seen at 1667 cm-1. The band-narrowing technique
of Fourier self-deconvolution and a baseline correction were applied to the 1700–
1600 cm-1 region corresponding to the amide I peak from the spectrum before
exposure to deuterium using OMNIC Spectra software. Gaussian curves were fitted
to the resulting peak using GRAMS software, Figure 5.7. The major peak
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corresponded to an α-helical secondary structure, however there was significant
amount of β-sheet present as well. Although CD estimated that the peptide was
predominantly α-helical, the sample preparation for ATR-FTIR may affect the
secondary structure of the peptide. Since it was not able to insert a proportion of it
may have formed aggregates, which result in a β-sheet signal.
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Figure 5.7 Secondary structure determination of the TatAAPH peptide using ATR-FTIR. The
band-narrowing tool of Fourier self-deconvolution was used on the amide I peak in the 1700–1600
cm-1 region of the spectra before exposure to deuterium. A baseline correction was also applied.
Gaussian curves were fitted to the peak and were assigned to different secondary structures according
to (Tatulian, 2003).
5.2.3 Oligomeric state of the TatAAPH peptide
Several motifs have been identified in TM domains which promote helix-helix
interactions by allowing close helix packing (Russ & Engelman, 2000; Senes et al.,
2000). One of the identified motifs is the Gly-Xaa-Xaa-Xaa-Gly (GxxxG) motif,
where two glycine residues are separated by three other amino acids. Analysis of the
TatAAPH peptide using TMSTAT (Senes et al., 2000) revealed the presence of a
GxxxG motif, Figure 1.6, indicating that the APH may be involved in helix-helix
interactions. This motif is highly conserved in TatA homologues, Appendix A (Hicks
et al., 2003). Substitution of either of these glycine residues with cysteine, knocks
out function of TatA (Greene et al., 2007), and substitution of the second glycine
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with serine or aspartic acid disrupts TatA oligomerisation, as assessed by chemical
cross-linking (Hicks et al., 2005). To assess the ability of the TatAAPH peptide to
form oligomers, SDS-PAGE and chemical cross-linking were used.
5.2.3.1 Analysis of the TatAAPH peptide oligomeric state by
SDS-PAGE
In order to assess the ability of the TatAAPH peptide to form homo-oligomers, a range
of concentrations of peptide were analysed by SDS-PAGE. Staining of the gel with
Coomassie blue revealed the presence of a single band, running at ~4 kDa, Figure
5.8A, which was assigned to monomer (m). When the same gel was stained using the
more sensitive silver stain technique, no additional bands of higher molecular weight
were seen, Figure 5.8B.
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Figure 5.8 SDS-PAGE analysis of the TatAAPH peptide. The TatAAPH peptide was analysed over a
range of concentrations (stated below each lane) with a molecular weight marker (MW). A. The
Coomassie stained gel revealed a single band corresponding to monomer (m) (monomer MW = 2.65
kDa) B. Silver staining the same gel confirmed the presence of a single band.
5.2.3.2 Analysis of the TatAAPH peptide oligomeric state by
chemical cross-linking
As mentioned previously, §4.2.3, SDS can be a highly denaturing detergent and
could disrupt any weak interactions. To detect any helix-helix interactions of the
TatAAPH peptide in less denaturing detergents (in this case DPC), chemical cross-
linking with the soluble BS3 was performed before analysis by SDS-PAGE, Figure
5.9. Since we had observed that detergent concentration affects the secondary
structure of the TatAAPH peptide, §5.2.1, cross-linking was performed in different
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peptide:detergent micelle ratios with DPC detergent (10:1, 1:1, 1:6.25). A reaction
was set up with no cross-linker added (1:6.25 no x) and an additional reaction was
performed in 100 mM SDS (SDS), as negative controls. At low detergent
concentrations, when the peptide is predominantly random coil (10:1), bands
corresponding to higher order oligomers of up to four peptides could be seen (n = 1,
n = 2,…). As the detergent concentration was increased, these higher order bands
disappeared and the peptide existed predominantly as monomers and dimers (1:1,
1:6.25). When no cross-linker was added or the reaction was performed in SDS, only
monomers were observed. Since the higher order oligomers are only seen when
TatAAPH peptide is mainly random coil, it is likely that they result from non-specific
aggregation of the peptide. BS3 reacts with the NH2 groups of lysines, as well as the
terminal NH2 of the peptide. Since the TatAAPH peptide contains five lysines, this
increased the likelihood of non-specific cross-linking.
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Figure 5.9 Cross-linking analysis of the TatAAPH peptide in detergent micelles. Cross-linking was
performed in DPC detergent micelles at different peptide:detergent micelle concentration ratios,
indicated below each lane. Reactions were performed with BS3 with one reaction performed without
cross-linker (6.25:1 no x). An additional reaction was performed in 100 mM SDS (SDS). Molecular
weight markers are shown in the left hand lane (MW). Proteins were visualised by staining with silver
nitrate. Oligomeric states are indicated on the right (n = 1, n = 2,…)
5.3 TOXCAT analysis of the TatA APH
The TOXCAT system was developed to analyse the strength of helix-helix
interactions in TM domains (Russ & Engelman, 1999). Although insertion of the
TatAAPH peptide into synthetic lipid bilayers had not been observed using ATR-FTIR
or LD, §5.2.2, it was decided to analyse the TatA APH in a natural membrane using
the TOXCAT assay. The TOXCAT chimera is optimised to assist the insertion of
protein fragments into the inner membrane of E. coli, via the periplasmic MBP
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domain and a cytoplasmic ToxR DNA binding domain. Inserting the APH sequence
into this chimera may result in a ‘forced’ membrane insertion, and would allow us to
determine if the APH has any ability to insert into membranes as previously
hypothesized (Chan et al., 2007; Gouffi et al., 2004).
To test these hypotheses, six TOXCAT chimera containing different lengths of the
APH were constructed, Figure 5.10. The GxxxG motif identified by TMSTAT,
§5.2.3, is also highlighted. Different insert lengths were analysed as previous studies
have shown that the length of insert can affect the strength of the TOXCAT signal
(Jenei et al., 2009; Langosch et al., 1996; Li et al., 2004). Since the APH is not
predicted to form a TM domain, the insert sequence was also varied to include
different proportions of hydrophilic and hydrophobic amino acids, which may affect
any possible insertion.
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APHLF
APHLM
MGGISIWQLLIIAVIVVLLFGTKKLGSIGSDLGASIKGFKKAMSDDEPKQ…
KKLGSIGSDLGASIKGFK
KKLGSIGSDLGASIKGF
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LGSIGSDLGASIKGFKKAM
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Figure 5.10 TatA APH TOXCAT constructs. A. The first 50 residues of the TatA primary sequence
(TatA) with the predicted TM domain (blue) and APH (red); and the six different TatA APH sections
inserted into the TOXCAT chimera (APHKK, APHKF, APHKG, APHLF, APHLM, APHKM,). The GxxxG
motif is highlighted (purple). B. The APHKK TOXCAT chimera consisting of the α-helical APH
inserted between the N-terminal dimerisation-dependent DNA binding domain of the ToxR protein
( ) and the periplasmic anchor MBP ( ).
Checks were performed to determine the expression levels, insertion and orientation
of the APH TOXCAT chimera as detailed in §2.12.1.1, Figure 5.11. To check the
expression levels, whole NT326 cells expressing the chimera were compared with
the positive and negative controls of GpA and G83I, respectively, Figure 5.11A.
Surprisingly the expression levels of the APH chimera (APHKK, APHKF, APHKG,
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APHLF, APHLM, APHKM) were much higher than the controls. The expression levels
were also much higher than the TatA TM domain TOXCAT chimera analysed in
§4.3.
Sodium hydroxide washes were performed in order to determine the localisation of
the APH TOXCAT chimera, Figure 5.11B. If the chimera is inserted correctly across
the membrane it should only be present in the whole cell (W) and membrane (M)
fractions, not the soluble (S) fraction. Immunoblots using anti-MBP antibodies
revealed that unlike the G83I construct, which is correctly inserted, the APH
constructs were present in both the membrane and soluble fractions. In the whole cell
and membrane fractions a second, faster migrating, unidentified band was also
detected for the APH constructs. Sodium hydroxide washes of membranes remove
any weakly associated proteins, with only strongly associated and integral membrane
proteins remaining in the membrane fraction. This suggests that the majority of the
APH chimera is strongly associated with the membrane, with a smaller but
significant percentage only associating weakly with the membrane.
To establish the location of the MBP domain of the APH chimera, spheroplasts (Sp)
from cells expressing the chimera were treated with Proteinase K (Sp*), or lysed by
freeze-thaw before treatment with Proteinase K (B*), Figure 5.11C. If the MBP
domain of the chimera is located in the periplasm, then it is accessible to Proteinase
K. Upon treatment, it is cleaved from the chimera and runs at a lower molecular
weight than the full length chimera. All of the APH constructs gave the same results,
with the disappearance of the intact chimera band in the treated spheroplast fractions,
indicating that the MBP domain of the chimera was located in the periplasm.
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Figure 5.11 TOXCAT insertion checks for the TatA APH constructs. A. Immunoblot using anti-
MBP antibodies of whole NT326 cells expressing the TOXCAT chimera with the different APH
inserts (APHKK, APHKF, APHKG, APHLF, APHLM, APHKM), with GpA and its dimerisation defective
mutant (G83I) as controls. Arrow indicates the TOXCAT chimera. B. Immunoblot using anti-MBP
antibodies of sodium hydroxide washes. Cells expressing the TOXCAT chimera were treated with
ice-cold NaOH, then centrifuged to separate the supernatant (S), which contained cytoplasmic,
periplasmic and loosely-membrane associated proteins, from the pellet (M), which contained proteins
stably associated with the membrane. Untreated whole cells (W) were also analysed. Cells not
expressing the chimera (NT326) were used as a negative control. Arrow indicates the TOXCAT
chimera. C. Immunoblot using anti-MBP antibodies of protease sensitivity of spheroplasts assay.
Spheroplasts (Sp) of cells were treated with Proteinase K (Sp’) or broken open by freeze-thaw before
treatment with Proteinase K. Arrow indicates TOXCAT chimera and asterisk indicates MBP cleaved
by proteolysis. D. malE complementation assay. malE deficient NT326 cells containing the TatA
APH and G83I TOXCAT chimera were grown on M9 agar plates containing 0.4% maltose.
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The cellular location of the MBP domain was also analysed by malE
complementation on M9 minimal media agar plates containing 0.4% maltose. If the
MBP deficient NT326 cells expressing the chimera are able to grow, the chimera is
correctly inserted across the membrane with the MBP in the periplasm. Cells
expressing the G83I chimera grew, however none of the cells expressing the APH
constructs showed any growth after several days, Figure 5.11D. This indicates that
the MBP domain of the APH constructs was not able to function in the periplasm.
These results suggest that the APH constructs were not able to insert correctly into
the membrane.
Although the APH constructs appeared not to insert correctly across the membrane
bilayer by monitoring the MBP, a disk diffusion assay was performed to compare
any possible expression of CAT with the positive and negative controls, GpA and
G83I respectively, Figure 5.12, thus providing information on the location of the
ToxR domain. The zone of inhibition of growth (ZOI) was recorded for the controls
and the APH constructs, Figure 5.12. As expected, the APH constructs did not show
any CAT expression, instead displaying large ZOIs characteristic of cells not
expressing the TOXCAT chimera (Russ & Engelman, 1999).
The analysis of the APH using the TOXCAT assay demonstrated, in agreement with
the results from LD and ATR-FTIR, that the APH has a high propensity to associate
with lipid membranes but has little or no propensity to insert across membranes.
These data suggest that the previously reported hypothesis that the APH has a dual
topology (Gouffi et al., 2004) is not very likely.
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Figure 5.12 Disk diffusion assay for the TatA APH. NT326 cells expressing the TatA APH domain
TOXCAT constructs (APHKK, APHKF, APHKG, APHLF, APHLM, APHKM) were grown on agar plates
with a chloramphenicol soaked disk in the centre. The zone of inhibition (ZOI) of growth was
recorded (black circles and lines) and compared to the positive and negative controls of GpA and
G83I. The standard deviation (SD) of the measurements is also shown.
5.4 Discussion
Although the TatA APH has been shown to be important for function (Greene et al.,
2007; Lee et al., 2002), its exact role in the Tat pathway is still unknown. The aim of
this study was to analyse the TatA APH in isolation using in vitro and in vivo
techniques, to gain a better understanding of its role in the Tat pathway.
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5.4.1 The secondary structure of the TatAAP H peptide depends on
detergent concentration and lipid composition
The first approach used to study the APH was the in vitro analysis of a synthetic
peptide corresponding to the APH of TatA. Unlike the peptide corresponding to the
TatA TM domain, studied in §4.2, the TatAAPH peptide was soluble in aqueous
buffer. However CD analysis of the TatAAPH peptide revealed that it did not have the
predicted α-helical secondary structure in aqueous buffer but instead took on a
random coil conformation. The formation of α-helix could be induced by addition of
increasing amounts of detergent. This behaviour could be explained by the
amphiphilic nature of the peptide. Since it is soluble in the aqueous buffer the
secondary structure might be relaxed, however these are not the correct conditions to
induce secondary structure formation. Upon the addition of detergent, the peptide
appears to fold into an α-helix on the surface of the detergent micelles. Hence only
when there is an excess of detergent micelles can the majority of the peptide form the
α-helical secondary structure.
Similarly, the secondary structure of the TatAAPH peptide in the presence of
liposomes varied depending on the compositions of lipids. The peptide only adopted
α-helical secondary structure in the presence of anionic phospholipids. Again it was
concluded that this was due to the amphiphilic nature of the peptide. When there was
a charge on the liposomes, as is present in natural E. coli membranes (Ames, 1968),
the peptide formed an α-helical secondary structure and LD confirmed that it was
associating with the membrane. The requirement of anionic phospholipids indicates
that there an electrostatic interaction between the peptide and the lipid bilayer,
potentially between positively charged lysine residues of the APH and the negatively
charged lipid headgroups. These results suggest that the peptide associates with the
lipid bilayer in a two stage process: firstly the positively charged Lys residues drive
association of the APH with the negatively charged bilayer; the peptide then folds
into an α-helix to maximize these contacts (in an α -helix, all three lysine residues lie
on the same helical face, Figure 5.1 and Figure 6.7).
Interestingly, it has previously been shown that anionic phospholipids are required in
E. coli for the Tat pathway to function efficiently (Mikhaleva et al., 1999). When the
percentage of anionic phospholipids was reduced to low levels, the export of the Tat
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substrate TorA was greatly reduced. This may be linked to incorrect folding of the
APH of TatA, and possibly TatB, which has a similar predicted secondary structure.
5.4.2 The TatAAPH peptide does not form SDS stable oligomers
The ability of the TatAAPH peptide to form oligomers in vitro was analysed by SDS-
PAGE and chemical cross-linking. Unlike the TatATM peptide which forms stable
dimers in SDS, no higher order oligomers were observed for the TatAAPH peptide at
any of the concentrations analysed. Higher order oligomers were observed when
chemical cross-linking was performed, however the formation of these oligomers
was disrupted by increasing the detergent concentration. This increase in detergent
concentration corresponds to an increase in α-helical content, so the peptide did not
form oligomers when in an α-helical conformation. Therefore it was concluded that
these oligomers were due to non-specific interactions caused by the high number of
lysine residues in the TatAAPH peptide.
5.4.3 The TatA APH is not able to insert into synthetic lipid
membranes or the inner membrane of E. coli
Although the TatAAPH peptide was seen to associate with the lipid bilayers using LD,
the nature of the association could not be determined due to the lack of a clear signal.
However, ATR-FTIR clearly showed that the peptide was unable to insert into
DPPG/DPPC lipid bilayers under the conditions used. The complete shift of the
amide II peak indicated that the peptide was accessible to deuterium exchange and
was therefore lying on the surface of the lipid bilayer. This agrees with an OCD
study of the APH from TatAd (Lange et al., 2007).
The ability of the APH to insert into E. coli membranes in vivo was assessed using
the TOXCAT assay (Russ & Engelman, 1999). Although not designed for
amphipathic helices, TOXCAT was used in this study to establish whether the TatA
APH could be ‘forced’ to insert into a natural E. coli membrane. When the
expression, insertion and orientation checks were performed for the six different
TatA APH TOXCAT chimera, they suggested that while the bulk of the chimeric
protein was strongly associated with the membrane, some of the chimera were found
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in the soluble fraction as well. The MBP domain was correctly located in the
periplasm, however it was not able to function and facilitate the take up of maltose.
One hypothesis is that the entire ToxR’-APH-MBP chimera was exported to the
periplasm and remained strongly associated with the membrane. Due to the high
expression levels the cell was saturated with the chimera, so some was present in the
soluble fraction. The MBP may have not been able to function properly due to its
uncharacteristic association with the membrane, and hence could not complement the
malE deficient NT326 cells. In the absence of any anti-ToxR antibodies to determine
the cellular location of ToxR, it was not possible to test this hypothesis. Since the
ToxR’-APH-MBP chimera did not insert correctly into the membrane it was not
possible to test the significance of the GxxxG motif in APH helix-helix interactions.
Although insertion of the APH was not observed in this study there may be other
conditions under which it is able to insert. It has been seen that an electrical potential
is required for the export of SufI by the Tat pathway (Bageshwar & Musser, 2007).
This change in environment or interactions with other proteins involved in the Tat
pathway may induce the APH to insert into the membrane as part of the translocation
process.
The work presented in this chapter has demonstrated that the structure of the TatAAPH
peptide depends on its environment, only taking on an α-helical structure in excess
detergent or in the presence of negatively charged lipids. Unlike the TatATM peptide,
no insertion of the TatAAPH peptide was observed with any of the techniques used.
The APH could not be ‘forced’ into the inner membrane of E. coli by inserting it into
the TOXCAT chimera either. This indicates that although the APH associates with
membranes it does not spontaneously insert into them. If the APH does insert into the
membrane as part of the translocation process it is likely that other factors are
involved which facilitate insertion.
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6.1 Introduction
Unlike the TatA TM domain and APH, which are both highly conserved in bacterial
homologues (Yen et al., 2002), the C-terminus varies considerably in both
composition and length, Appendix A. Secondary structure predictions of E. coli TatA
assign the C-terminal region, starting at Ser44, as largely unstructured, Figure 1.6.
The role of this region in the Tat pathway is still unknown, although it has been
shown to be non-essential for function (Lee et al., 2002). Truncation of E. coli TatA
from the C-terminus has shown that up to 40 amino acids can be deleted without
affecting the translocation of the Tat substrate TorA. If the role of TatA is purely in
translocation of Tat substrates across the membrane, it is uncertain as to why the C-
terminal region remains in all homologues when it is not needed for function. Since
some Gram-positive bacteria only contain a TatA-like protein and no TatB, it is
possible that the C-terminus of TatA is an evolutionary remnant, and may simply
enable TatA to perform the role of TatB in a TatA/TatC system. However, contrary
to this hypothesis is the observation that the C-terminus of E. coli TatB is also non-
essential for function of the Tat pathway (Lee et al., 2002). Additionally,
substitutions identified in E. coli TatA which enable it to take on the role of TatB
have all been located in the extreme N-terminus of TatA.
Recent research has suggested that TatA may have a dual role in the Tat pathway
(Matos et al., 2008; Matos et al., 2009). It was observed that the Tat apparatus has a
role in proofreading of two iron-sulphur (FeS) proteins, NrfC and NapG. TatA and
TatE were highlighted as playing a part in the rejection for translocation and
subsequent degradation of these two mutated FeS proteins. This apparent dual role of
TatA may involve different domains of the protein.
Here, a number of different approaches were used to analyse the role of the C-
terminal domain and identify important residues. Several new TatA constructs were
prepared for these analyses, as shown in Figure 6.1. Analysis of a novel C-terminal
truncation led to the identification of the minimal functional subunit of TatA.
Examination of this truncation mutant highlighted an acidic motif, which was
mutated to determine its role in function and complex formation. Possible
interactions between this negatively charged region and three positively charged
lysines in the TatA APH were also investigated through further mutational studies.
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The TatA truncations were used to investigate the role of the C-terminus in
proofreading of the FeS protein NrfC.
A
B TM APH
TatA-50h
TatAh/s
TatA-20h
TatA-40h/s
D46N
E47Q
NNQ
LLM
TatA-45h/s
D45N
3K>Q
3K>Q+NNQ
3K>Q+LLM
h/s
h
h/s
h/s
h
Q
NNQ
LLM
N
N
Q QQ
NNQQ QQ
LLMQ QQ
MGGISIWQLLIIAVIVVLLFGTKKLGSIGSDLGASIKGFKKAMSDDEPKQ.....QAD.....QV
10 20 30 40 50 70 89
Figure 6.1 TatA sequence and constructs used in this study. A. The primary sequence of E. coli
TatA. An acidic motif identified in this study is highlighted (green), and three lysines in the APH
which have been shown to be important for function and complex formation are underlined (Barrett et
al., 2005). B. TatA constructs used in this study, with the TM domain and the APH highlighted (blue
and red, respectively). Full length TatA and C-terminal truncations by 20, 40, 45 and 50 amino acids
were tagged with His-6 (h) or Strep-II™ (s) tags (TatAh/s, TatA-20h, TatA-40h/s, TatA-45h/s, TatA-
50h). Substitutions were introduced in the acidic motif after the APH (D45N, D46N, E47Q, NNQ,
LLM), the three lysines in the APH (3K>Q) and double substitutions in both these regions
(3K>Q+NNQ, 3K>Q+LLM).
6.2 Truncation analysis to identify the region of TatA essential for
function
As previously mentioned, the role of the C-terminus of TatA has been analysed by
sequentially truncating the protein from the C-terminus in steps of 10 amino acids
(Lee et al., 2002). By assaying for periplasmic activity of the Tat substrate TorA,
investigators were able to determine that, although still functional when truncated by
40 amino acids, TatA lost its functional activity when truncated by 50 amino acids,
suggesting the stretch of amino acids from residue 39 to residue 49 is crucial for
function. To try and narrow down the essential residues in this region, it was decided
to construct a novel truncation of 45 amino acids from the C-terminus, containing
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either a His-6 or Strep II™ C-terminal tag, Figure 6.1B, (A-45h/s). The inclusion of a
tag was necessary due to the location of the anti-TatA antibody binding epitope lying
between residues 49 and 69 of TatA, Figure 6.2A. Previous research has shown that a
C-terminal His-6 tag on TatA does not affect its function (Bolhuis et al., 2000),
however it was decided to make an additional truncation with a StrepII™ tag to test
whether tags would affect function. To allow comparison of our system with the
previous truncation study using a different expression system (Lee et al., 2002),
truncations of TatA by 20, 40 and 50 residues with a C-terminal His-6 or StrepII™
tag were also prepared, Figure 6.1B, (A-20h/s, A-40h/s, A-50h).
The expression levels of the truncations expressed from the pBAD24 plasmid in cells
lacking TatA and TatE (∆AE) were checked by performing immunoblots with the
relevant antibodies, Figure 6.2A–C. Proteins truncated by 45 or 50 amino acids were
expressed at lower levels than the other truncations, although they were still
expressed at levels comparable to TatA in wild-type cells.
In order to investigate the truncations’ effect on function, the TorA activity assay
was used, Figure 6.2D. In the control samples, TorA activity is clearly apparent in
the periplasm of wild-type MC4100 cells, as indicated by a white band in the
periplasmic (P) lane, and no export is evident in AE cells. Analysis of the tagged
truncations shows that the A-20 and A-40 mutants support export of TorA, whereas
the A-50 truncation mutant does not. These results agree with previous research for
plasmid-borne, overexpressed TatA (Lee et al., 2002), confirming that our tagged
proteins were behaving in the same manner as previously studied untagged versions.
These results also demonstrate that the choice of tag does not affect the functional
activity of the truncations, with both His-6 and StrepII™ truncations producing the
same results.
The additional TatA mutants prepared in this study, A-45h and A-45s, in which 45
amino acids were deleted from the C-terminus, also abolished export via the Tat
pathway. This absence of function identified a stretch of five residues (Asp45-Lys49)
important for function.
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Figure 6.2 Analysis of the function of TatA truncations from the C-terminus. Immunoblots of
whole ∆AE cells expressing full length TatA, TatA truncated by 20, 40, 45 or 50 amino acids from the
C-terminus with a C-terminal His-6 tag (Ah, A-20h, A-40h, A-45h, A-50h) using (A) anti-TatA
antibodies and (B) anti-His-6 antibodies. No bands are seen for A-40h, A-45h and A-50h in the anti-
TatA immunoblot due to the binding epitope being removed by truncation. C. Immunoblot of whole
∆AE cells expressing full length TatA, TatA truncated by 40 or 45 amino acids from the C-terminus
with a Strep II™ tag (As, A-40s, A-45s) using anti-Strep II™ antibodies. D. Periplasmic and
cytoplasmic samples (P,C) were prepared from wild-type E. coli cells (MC4100), ΔAE cells (ΔAE),
and ΔAE cells expressing the full length and tagged truncations of TatA. A native polyacrylamide gel
was stained for TorA activity; white bands indicate the presence of TorA, TorA* indicates a slower
migrating cytoplasmic form of TorA.
6.3 Determination of the oligomeric state of the TatA truncations
In order to assess the effect of the C-terminal truncations on the ability of TatA to
form complexes of variable size, fast protein liquid chromatography (FPLC) on a
Superose-6HR pre-packed gel filtration column was used. This technique uses the
interactions between proteins and the gel matrix to separate proteins according to
Chapter 6. Analysis of the E. coli TatA C-terminus & identification of an acidic motif
130
molecular weight. Large proteins cannot enter the gel, and hence elute first, whereas
smaller proteins enter the gel and elute in later fractions. This method has been used
previously to assess the size of Tat complexes from E. coli and B. subtilis (Barnett et
al., 2008; Bolhuis et al., 2001).
Membranes from ∆AE cells expressing full length TatA or TatA truncated by 40 or
45 amino acids with a His-6 C-terminal tag were isolated by fractionation and
solubilised in digitonin detergent, before injection onto the column. Elution fractions
were collected and immunoblots of the peak elution fractions were performed using
anti-His-6 antibodies, Figure 6.3A. The relative intensity of each band was quantified
using ImageJ analysis software, normalised to the maximum value and plotted
against the fraction number, Figure 6.3B. The full length TatA and TatA truncated by
40 amino acids were found across a wide range of fractions, as demonstrated by
bands in multiple lanes. This indicates that they are forming oligomeric complexes of
variable size, which is in agreement with a previous study where untagged E. coli
TatA was analysed (Barnett et al., 2008). In contrast, the TatA truncated by 45 amino
acids eluted in a much sharper peak at a later time point, suggesting it is forming a
smaller, discrete complex. It is worth noting that the expression levels of the three
constructs were variable, with A-45h expressed at much lower levels. Although
attempts were made to normalise the amount of protein loaded onto the column,
direct comparison between the elution profiles may not be accurate.
Despite the problems with expression levels, gel filtration analysis of the truncations
points towards the importance of the stretch of five residues (Asp45–Lys49) for
complex formation. In the absence of these residues, TatA no longer elutes across all
fractions but mainly elutes as a single, lower molecular weight complex.
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Figure 6.3 Gel filtration analysis of the complex size of TatA, TatA-40 and TatA-45 with a His-
6-tag. Digitonin solubilised membranes from ∆AE cells expressing full length TatA or TatA truncated
by 40 or 45 amino acids from the C-terminus with a C-terminal His-6 tag (Ah, A-40h, A-45h) were
applied to a Superose-6HR gel filtration column. A. Immunoblots using anti-His-6 antibodies of the
peak elution fractions for the three different TatA constructs. Ah, A-40h and A-45h are labelled. B.
The relative intensities of the bands in the immunoblots were measured using ImageJ software,
normalised to the maximum value and plotted against the fraction number, Ah (blue ●), A-45h (red ■)
and A-45h (green ▲).
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6.4 Identification of an acidic motif important for function and
complex formation
Analysis of the five residues highlighted by the TatA truncation analyses revealed
three consecutive acidic residues after the predicted APH (DDE sequence
highlighted in Figure 6.1A). Alignment of TatA homologues from other Gram-
negative bacteria showed this region of acidic residues straight after the APH
represents a highly conserved acidic ‘motif’, Figure 6.4 and Appendix A. The term
acidic motif is used here, not to refer to absolute conservation of the sequence DDE,
but to describe a sequence of two to four acidic amino acids after the predicted APH.
This acidic motif varies in composition and length but it is almost always present in
the sequences analysed.
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--MGGISIWQLLIIAVIVVLLFG-TKKLGSIGSDLGASIKGFKKAMSDDE----PKQDKTSQDADFT...
MH-FPLPWQLILILL-VILVIFG-ASKLPEVGKGLGEGIRNFKKALSGE ---------EKGKEVK...
MGFGGISIWQLLIILLIVVMLFG-TKRLKSLGSDLGDAIKGFRKSMDNEE ----------KAPPVE...
---MNLGWTEILLIGGIALLLFG-PSKLPNLGRSLGESIRGFKKGLNED ---------ADEKEAK...
MGGWSSPSHWLIILL-IVVLLFG-AKKIPELAKGLGKGIKTFKDEMNN ---------VAKNTQK...
--MGSMSWIHWVIVLGIVALLFGGRGKLSSIMGDAAKGIKAFKDGLKDESS------------SEVA...
--MGGISIWQLVIIAVIVVLLFG-TKKLGSIGSDLGASIKGFKKAMSDDE----SKQDKTSQDADFT...
--MFGLSPAQLIILLVVILLIFG-TKKLRNAGSDLGAAVKGFKKAMKEDE---------KVKDAEFK...
MGFN---IWSLLIILLIVALLFG-TKKLRNIGGDLGGAIRGFKESMREG ----------EEAQKR...
MGGFTSIWHWVIVLL-VIVLLFG-AKKIPELAKGLGSGIKNFKKAVKDD ---------EAKNEPK...
MGLSGISPLSLLLILAIIVALFG-TSKLKTIGSDLGEAIKNFRKAMNSEET----------NDTQK-...
--MGGISITQLLIIVAIVVLLFG-TKKLRTLGSDLGESVKGFKKAMADDN---------KEKDAEFK...
MGIFDWKHW--IVILIVVVLVFG-TKRLKNLGSDVGEAIKGFRKAVNTE --------KKDQPAA...
MGIS---VWQLLIILLIVVMLFG-TKRLRGLGSDLGSAINGFRKSVSDGET ---------------...
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--MGSIGWAQLLIIAVIVVLLFG-TNKLRTLGSDLGASIKGFKKAMGDDSQTPPTNVDKTSNDADF-...
Escherichia coli
Aquifex aeolicus
Azotobacter chroococcum
Bdellovibrio bacteriovorus
Campylobacter jejuni
Caulobacter crescentus
Enterobacter cloacae
Haemophilus influenzae
Halorhodospira halophila
Helicobacter pylori
Legionella pneumophila
Pasteurella multocida
Pseudomonas aeruginosa
Pseudomonas stutzeri
Rhizobium loti
Rickettsia prowazekii
Salmonella typhimurium
Vibrio cholerae
Xylella fastidiosa
Yersinia pestis
...
...
Figure 6.4 Sequence alignment of TatA homologues from Gram-negative bacteria. Sequences of
TatA homologues from Gram-negative bacteria were identified and aligned using ClustalX. The
alignment shows the TM domain, the APH and the region immediately following the APH. An acidic
region after the predicted APH is boxed in red. The full alignment is shown in Appendix A.
The importance of the acidic motif to function and structure was analysed by
mutagenesis of TatA. Each of the three residues was substituted individually with a
structurally similar but uncharged residue (D45N, D46N, and E47Q), and a triple
substitution was also prepared (NNQ), Figure 6.1B. Similar to aspartic acid and
glutamic acid, asparagine and glutamine are able to hydrogen bond and form strong
non-covalent interactions. For this reason, a second triple substitution which would
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be unable to hydrogen bond to other residues was prepared (LLM), Figure 6.1B. The
mutants were prepared by mutating the tatA gene in the pBAD-ABC plasmid.
Expression levels of the mutants expressed from the pBAD-ABC plasmid in cells
lacking the Tat components (∆ABCDE) were checked by performing immunoblots
using anti-TatA antibodies, Figure 6.5A. The expression levels of the mutants were
comparable to that of wild-type TatA expressed from the pBAD-ABC plasmid. The
functional effect of the substitutions were analysed using the TorA assay, Figure
6.5B. The single substitutions do not appear to affect the function of the Tat pathway,
with the majority of the TorA activity found in the periplasmic as in the wild-type
positive control (MC4100). The NNQ triple mutant does seem to affect function,
with the majority of the TorA activity found in the cytoplasm, and only a faint band
apparent in the periplasm. The LLM mutant has an even more severe effect on
function, with no TorA band appearing in the periplasm even after extended periods
of time.
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Figure 6.5 Analysis of the role of the acidic motif in TatA function. The affects of five different
substitutions of the acidic motif of TatA (Asp45→Asn, D45N; Asp46→Asn, D46N; Glu47→Gln, 
E47Q; Asp46 and Asp46→Asn and Glu47→Gln, NNQ; Asp45 and Asp46→Leu and Glu47→Met, 
LLM) were analyzed by a TorA activity assay and a TorA-GFP export assay. A. Immunoblots of
whole wild-type cells (MC4100), ∆ABCDE cells (∆ABCDE) and ∆ABCDE cells expressing the
mutated TatA (D45N, D46N, E47Q, NNQ, LLM) using anti-TatA antibodies to check expression
levels. B. Cytoplasmic, membrane and periplasmic samples (C, M, P) were prepared and run on a
native polyacrylamide gel, which was stained for TorA activity. White bands indicate the presence of
TorA, TorA* indicates a slower migrating cytoplasmic form of TorA. C. Immunoblots using an anti-
GFP antibody of C, M, P samples from ∆ABCDE cells expressing TorA-GFP from the pJDT1 plasmid
(∆ABCDE), ΔABCDE cells expressing TorA-GFP and wild-type TatABC from the pEXT-ABC
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plasmid (∆ABCDE+ABC), and ΔABCDE cells expressing TorA-GFP and mutated TatABC from the
pEXT-ABC plasmid (NNQ, LLM). Intact TorA-GFP and clipped TorA-GFP (GFP) are indicated. D.
The fluorescence of periplasmic samples of ∆ABCDE cells expressing TorA-GFP from the pJDT1
plasmid and the TatA mutants was recorded from 505 to 550 nm, exciting at 488 nm. The resulting
fluorescence was normalised to ∆ABCDE+ABC.
Since the white bands in the TorA assay develop over time, the assay can only be
used to assess export qualitatively. In order to analyse more accurately the export
efficiency of the triple mutants, the more quantitative TorA-GFP export assay was
also used, Figure 6.5C and D. In this assay the TorA-GFP chimera, consisting of the
TorA signal sequence fused to GFP, is expressed from the pBAD24 plasmid and
exported via the Tat pathway. The efficiency of export can be assessed by
immunoblotting using anti-GFP antibodies (Barrett & Robinson, 2005) and
measuring fluorescence of the GFP using a fluorimeter. ∆ABCDE cells expressing
the TorA-GFP chimera and wild-type or mutated TatA from the pEXT-ABC plasmid
were fractionated into cytoplasmic, membrane and periplasmic fractions (C, M, P).
Immunoblots revealed that for cells expressing the wild-type TatA (∆ABCDE+ABC)
and the TatA carrying the NNQ substitution, the Tat pathway was still able to export
the TorA-GFP, as demonstrated by a mature-sized GFP band in the periplasm, Figure
6.5C. The intensity of the band for the NNQ mutant was clearly lower than that
observed for wild-type TatA, indicating less efficient export. This difference was
quantified by measuring the fluorescence of the periplasmic sample due to the
presence of GFP. Samples were excited at 488 nm, the optimal excitation wavelength
for GFP, fluorescence emission was recorded between 505 and 550 nm, and the
resulting fluorescence was normalised to the positive control, ∆ABCDE+ABC,
Figure 6.5D. The GFP fluorescence maximum at 513 nm of the NNQ mutant was
47% of the wild-type TatA, showing that the NNQ mutant is only able to export at
less than 50% of wild-type levels. Immunoblots of the LLM mutant show that it
completely prevents export via the Tat pathway, with no visible TorA-GFP in the
periplasm. The accumulation of mature-sized GFP in the cytoplasm is due to
proteolysis of TorA-GFP when export is blocked (Barrett et al., 2003; Thomas et al.,
2001). No fluorescence was detected by the fluorimeter in the periplasm of the LLM
mutant samples. These data reveal the importance of the acidic motif in the function
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of TatA and demonstrate that function can be restored in at least part by the
substitution of polar residues such as glutamine and asparagine.
In order to investigate the possible link between TatA function and complex
formation, blue-native gel analyses were performed on the TatA acidic motif
mutants, Figure 6.6. For the single mutants, D45N, D46N and E47Q, which were all
functional in the TorA assay, a banding pattern identical to the wild-type TatA
(∆ABCDE+ABC) was observed, indicating that they do not affect the ability of TatA
to form variable sized complexes. Conversely, the triple mutants, NNQ and LLM,
appear to severely destabilise the formation of TatA complexes as judged by this
approach. Although there are still multiple bands present, indicating oligomer
formation, these are fewer, much less well defined and appear at different molecular
weights to the wild-type bands. This effect might be caused by the increase in
predicted pI from 5.73 for the wild-type TatA, to 8.96 for the triple mutants. For BN-
PAGE the pI should ideally be no greater than 8.6 (Schägger et al., 1994). Proteins
with pIs of 9.3 or above result in broad banding patterns, and their slower migration
results in inaccurate molecular mass assignment. However, the pI of the triple
mutants is only just outside the ideal range and, although there is a broadening of
bands, there are visibly fewer bands present. These observations, taken together with
the absence of this effect for the single mutants, imply that the change in banding
pattern for the triple mutants is not an artefact, and results from complex disruption
in vivo. The acidic motif appears to be not only important for function but also for
the correct formation of TatA complexes.
Chapter 6. Analysis of the E. coli TatA C-terminus & identification of an acidic motif
137
∆
AB
CD
E
+A
BC
NN
Q
LL
M
669
440
232
140
kDa D
45
N
D4
6N
E4
7Q
669
440
232
140
kDa
Figure 6.6 Assessment of the role of the acidic motif in TatA complex formation using blue-
native PAGE. Membranes from ΔABCDE cells expressing wild-type (ΔABCDE+ABC) or mutated
TatA (NNQ, LLM, D45N, D46N, E47Q) from the pBAD-ABC plasmid solubilised in digitonin were
subjected to blue-native gel analyses and immunoblotted using anti-TatA antibodies. The mobility of
the molecular weight markers is indicated.
6.5 Probing possible interactions between the acidic motif and
lysines in the APH
Charged and polar regions on the surface of proteins can play an important role in
stabilising protein-protein interactions, reviewed in (Sheinerman et al., 2000). Since
substitution of the acidic motif destabilised the formation of TatA complexes, it was
proposed that this negatively charged region may interact with a positively charged
region in the protein. Previous studies have highlighted the importance of three
positively charged residues in the APH (Lys37, Lys40 and Lys41) (Barrett et al.,
2005; Barrett & Robinson, 2005). Substitution of these residues with polar,
uncharged glutamine, disrupted TatA function and complex formation. Plotting the
APH on a helical wheel reveals that these three residues are located on the same face
of the helix, Figure 6.7A. Their proximity to one another in the predicted three-
dimensional structure can be seen more clearly when the APH is modelled as an α-
helical domain, Figure 6.7B. The existence of a positively charged region in the APH
and a negatively charged region nearby led to the hypothesis that the there was a
charge interaction between these two regions which stabilised TatA complex
formation.
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Figure 6.7 Spatial analysis of the three lysines in the TatA APH. A. Helical wheel plot of the TatA
APH, the three lysines which have been shown to be important for function (Barrett et al., 2005), are
highlighted in red (K37, K40, K41). B. Three dimensional model of the TatA APH prepared using the
programme CHI (CNS searching of helix interactions (Adams et al., 1995; Adams et al., 1996)),
showing the α-helical secondary structure and the three lysines. Arrows indicate the axes.
The possible interaction between these two oppositely charged regions of TatA was
probed by mutagenesis studies. As well as the triple substitution in the TatA acidic
motif (NNQ or LLM), the lysines forming the positively charged region were also
mutated to glutamine (Lys37, Lys40 and Lys41→Gln; 3K>Q), resulting in the
mutants NNQ+3K>Q and LLM+3K>Q, Figure 6.1B. A TorA activity assay was
used to assess the functional activity of these mutants, Figure 6.8A. As seen
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previously (Barrett et al., 2005; Barrett & Robinson, 2005) the 3K>Q substitution is
not able to export TorA to the periplasm. Similarly there is no white band in the
periplasm for the NNQ+3K>Q and LLM+3K>Q mutants, indicating they were also
not functional. The more quantitative TorA-GFP export assay was also used to assess
the functional activity of the NNQ+3K>Q and LLM+3K>Q mutants, Figure 6.8B.
No mature sized GFP band was observed for either of these mutants, leading to the
conclusion that they were unable to function. These results demonstrate that
substitution of the positively charged region is not able to compensate for the
deleterious effect of the substitution of the acidic motif, and indeed completely
blocks the low levels of export seen for the NNQ mutant.
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Figure 6.8 Mutation of the acidic motif and three lysines cannot restore TatA function. The
effects of substitution of the acidic motif and the three essential lysines were analyzed by a TorA
activity assay and a TorA-GFP export assay. A. Cytoplasmic, membrane and periplasmic samples (C,
M, P) were prepared from wild-type cells (MC4100), ∆ABCDE cells (∆ABCDE), and ∆ABCDE cells
expressing wild-type TatA (∆ABCDE+ABC) or mutated TatA (Lys37, Lys40, Lys41→Gln, 3K>Q;
Lys37, Lys40, Lys41→Gln, Asp45, Asp46→Asn, Glu47→Gln, NNQ+3K>Q; Lys37, Lys40,
Lys41→Gln, Asp45, Asp46→Leu and Glu47→Met, LLM+3K>Q) from the pBAD-ABC plasmid and
run on a native polyacrylamide gel, which was stained for TorA activity. White bands indicate the
presence of TorA, TorA* indicates a slower migrating cytoplasmic form of TorA. B. Immunoblots
using an anti-GFP antibody of C, M, P samples from ∆ABCDE cells expressing TorA-GFP from the
pJDT1 plasmid (∆ABCDE), ΔABCDE cells expressing TorA-GFP and wild-type TatABC from the
pEXT-ABC plasmid (∆ABCDE+ABC), and ΔABCDE cells expressing TorA-GFP and mutated
TatABC from the pEXT-ABC plasmid (NNQ+3K>Q, LLM+3K>Q). Intact TorA-GFP and clipped
TorA-GFP (GFP) are indicated.
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6.6 The role of the TatA C-terminus in the proofreading of NrfC†
Although truncation analysis has led to the identification of an acidic motif in the
TatA C-terminus, the role of the final 40 residues of TatA is still unclear. Whilst the
main role of TatA appears to be in the translocation process, recent research has
highlighted the importance of the Tat apparatus in proofreading and degradation of
FeS proteins (Matos et al., 2008; Matos et al., 2009). An unidentified proofreading
mechanism in the Tat pathway prevented mutations of the FeS Tat substrates, NrfC
and NapG, from being exported. TatA, TatD and TatE were shown to be involved in
the degradation of the substrates rejected by the Tat pathway.
Since the TatA C-terminus does not contribute to export it is possible the
proofreading and degradation abilities of TatA arise from unidentified properties of
the C-terminus. Consequently, removing the C-terminus of TatA might affect the
proofreading abilities of the Tat pathway and stop rejection of misfolded and
misassembled proteins. To test this hypothesis, the TatA truncation mutants were
assessed for their ability to export wild-type and mutated NrfC, using the same
methods as in previous studies (Matos et al., 2008; Matos et al., 2009).
NrfC forms part of the formate-dependent nitrite reductase complex and is a member
of the CooF family of FeS proteins (Cole, 1996). Based on strong homology to
formate dehydrogenase-N subunit β, which has had its three-dimensional structure
solved (Jormakka et al., 2002), the cysteine residues involved in the four predicted
[4Fe-4S] centres were identified, Figure 6.9. Matos et al. had shown that the
preprotein, pre-NrfC, with a C-terminal His-6 tag expressed from the arabinose
inducible vector pBAD24 is exported via the Tat pathway. Upon export to the
periplasm the signal sequence is cleaved off and it is processed to the mature size,
which runs as a lower molecular weight band. The proofreading ability of the system
was demonstrated by the use of two NrfC mutants, M1 and M2. In M1, two of the
cysteine residues involved in FeS centre 2 were substituted with alanine, as indicated
† Work in §6.6 was done in collaboration with Cristina F. R. O Matos (Department
of Biological Sciences, University of Warwick). The NrfC constructs were provided
by Cristina F. R. O. Matos and the immunoblots were performed in equal
collaboration.
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by asterisks in Figure 6.9. In M2, one cysteine residue from each of FeS centres 1
and 2 was substituted with alanine, as indicated by arrows in Figure 6.9. Expression
of these mutants in wild-type cells led to their rejection by the Tat pathway and
resulted in degradation.
1 1 1 2
MTWSRRQFLTGVGVLAAVSGTAGRVVAKTLNINGVRYGMVHDESLCIGCTACMDAC
3 3 3 4
REVNKVPEGVSRLTIIRSEPQGEFPDVKYRFFRKSCQHCDHAPCVDVCPTGASFRD
4 4 4 3 2 2
AASGIVDVNPDLCVGCQYCIAACPYRVRFIHPVTKTADKCDFCRKTNLQAGKLPA
2 1
CVEACPTKALTFGNLDDPNSEISQLLRQKPTYRYKLALGTKPKLYRVPFKYGEVSQ
* *
Figure 6.9 Predicted FeS ligands targeted for mutagenesis in NrfC. The primary sequence of E.
coli pre-NrfC with the signal peptide underlined. The cysteine residues predicted to be involved in the
formation of four [4Fe-4S] centres are highlighted, and are numbered with the FeS centres 1–4 that
they belong to, based on strong homology to formate dehydrogenase-N subunit β. Residues
substituted with alanine in the M1 and M2 NrfC mutants are indicated by asterisks and arrows,
respectively. Figure adapted from (Matos et al., 2008).
Two TatA truncations were assessed for their ability to export both wild-type and
mutated NrfC. TatA truncated by 40 or 45 amino acids from the C-terminus with a
His-6 tag for detection (A-40h, A-45h) were expressed from the pEXT22 vector,
which is compatible with pBAD24. Expression of the constructs was confirmed by
immunoblots of ∆AE cells expressing the truncations and pre-NrfC, Figure 6.10A.
To assess the ability of the truncations to export wild-type and mutated NrfC, ∆AE
cells co-expressing a truncation and an NrfC construct were separated into
cytoplasmic, membrane and periplasmic fractions, and immunoblotted, Figure 6.10B.
A-40h was able to export the wild-type NrfC, as demonstrated by a mature sized
band in the periplasmic lane. As expected A-45h was unable to export wild-type
NrfC, with no NrfC detected in the periplasm. This confirms the conclusions in §6.2
concerning the function of these truncations, and demonstrates that the results were
not dependent on choice of substrate. None of the truncations were able to export
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either of the NrfC mutants, NrfCM1 and NrfCM2, as demonstrated by the absence of a
mature NrfC band in the periplasmic lane. This indicates that the C-terminus of TatA
has no direct role in the proofreading of NrfC, as the Tat system is still able to reject
these misfolded/misassembled proteins.
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A-45h Pre
Mat
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C M P
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Figure 6.10 Analysis of the role the TatA C-terminus in the proofreading of NrfC. A.
Immunoblots of whole ∆AE cells expressing TatA truncated by 40 or 45 amino acids with a C-
terminal His-6 tag (A-40h, A-45h), using anti-His-6 antibodies. Arrows indicate the TatA constructs.
B. Cytoplasmic, membrane and periplasmic samples (C, M, P) were prepared from ∆AE cells
expressing the TatA constructs and wild-type or mutated His-6 tagged NrfC (NrfC, NrfCM1, NrfCM2).
Immunoblots using anti-His-6 antibodies were performed. The precursor and mature forms of the
NrfC constructs are indicated (Pre, Mat).
6.7 Discussion
The exact role of the C-terminus of TatA is still unknown, with previous research
demonstrating the final 40 residues are not involved in the translocation of TorA
(Lee et al., 2002). The work presented here has sought to identify the minimal
functional subunit of TatA and important features in the C-terminus, with an aim to
determining its role in the Tat pathway.
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6.7.1 An acidic motif in TatA is important for function and
complex formation
Previous work has highlighted residues Phe39 to Lys49 as being important for
function of TatA (Lee et al., 2002). In order to pinpoint the important residues in this
region a new C-terminal truncation of TatA by 45 amino acids was prepared. This
truncation was unable to export the Tat substrates TorA and NrfC, allowing us to
narrow down the important residues to a region just after the APH. Gel filtration
analyses also indicated that the identified residues were important for complex
formation, with the 45 residue truncation predominantly present in a single peak.
Analysis of this region revealed an acidic motif which is highly conserved in TatA
homologues from Gram-negative bacteria. This motif generally contains 2 to 4 acidic
residues of varying composition, Figure 6.4. In contrast, this motif is not as
ubiquitous in Gram-positive bacteria, Appendix A, which may be linked to recent
findings that TatAd from B. subtilis does not form a variety of different sized
complexes and instead forms a smaller, more homogeneous, complex (Barnett et al.,
2008).
Single substitutions in the DDE acidic motif of TatA with structurally similar but
uncharged residues did not appear to affect function or complex formation.
Substituting all three residues with polar, uncharged amino acids (NNQ) led to a
reduction in the export of TorA and TorA-GFP by more than 50%. An additional
triple substitution with uncharged, hydrophobic residues (LLM) prevented the Tat
pathway from functioning. The triple substitutions also affected the formation of
ordered TatA complexes. Blue-native gel analyses revealed that both of the triple
mutants resulted in fewer, broad bands, when compared to wild-type TatA. Although
the predicted pI of the mutants was outside the ideal range for blue-native analyses,
the broadening and disappearance of bands points towards destabilisation of the TatA
complexes. It is possible that a subset of the NNQ mutant may still form the correct
complexes, which allows export but these are masked by the majority of the protein
forming the incorrect complexes.
These results suggest that the negative charge of the acidic motif, whilst important
for efficient function of the Tat pathway, is not essential. Instead we suggest that the
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acidic motif is ideally composed of extremely hydrophilic residues or those with the
ability to hydrogen bond.
6.7.2 Mutations of the lysine residues in the APH and the acidic
motif cannot reinstate function
It has been previously observed that three lysines in the APH are important for
function and complex formation (Barrett et al., 2005; Barrett & Robinson, 2005).
Plotting these residues on a helical wheel and creating a three-dimensional model of
the APH highlighted their proximity to one another. To test whether this positively
charged region was interacting with the negatively charged acidic motif, mutants
consisting of the acidic motif triple mutation and substitution of the lysines with
glutamines were tested for functional activity. No export of TorA or TorA-GFP by
the mutants was detected, demonstrating that the introduction of the additional
substitutions was not able to restore function of the Tat pathway.
Although no export was seen, this does not demonstrate conclusively that the APH
lysines do not interact with the acidic motif. Simply by mutating the oppositely
charged regions to uncharged residues with the ability to hydrogen bond may not be
sufficient to restore TatA function. The interactions may be more specific, requiring
more than just the ability to hydrogen bond. Additionally, the mutations may cause
some conformational changes which prevent the two regions from coming together
and contributing to the formation of stable complexes. Other techniques must be used
to rule out charge interactions between these two regions.
6.7.3 Truncation of TatA does not affect the affect the
proofreading capabilities of the Tat pathway
To determine if the C-terminus of TatA was involved in the proofreading of Tat
substrates, TatA truncation mutants were analysed for their ability to export wild-
type and mutated NrfC. None of the truncation mutants exported mutated NrfC,
demonstrating that the Tat pathway still retained its ability to proofread in the
absence of the TatA C-terminus. Although this demonstrates that the C-terminus is
not directly responsible for proofreading, it does not rule out the possibility that it is
involved in some manner. It is probable that proofreading in the Tat pathway is a
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highly regulated system, as export of misfolded/misassembled proteins would be a
waste of resources and could have a detrimental affect on the cell. Indeed it has been
suggested there are two stages of checks; a transport quality control stage to ensure
only correctly folded proteins are exported, and a proofreading stage to confirm
correct cofactor insertion (Sargent, 2007). If this is the case, then several factors
could be involved in ensuring Tat substrates are acceptable for export. Soluble,
substrate-specific chaperones have been identified for molybdoproteins such as TorA
and DmsA (Ilbert et al., 2003; Jack et al., 2004; Oresnik et al., 2001). TatA may
function cooperatively with other proteins in the Tat pathway or these chaperones, to
ensure only correctly assembled proteins are exported. Thus, if the C-terminus of
TatA was involved, its deletion alone would not be sufficient to reinstate export of
mutated Tat substrates.
The involvement of TatA in the degradation of proteins rejected by the Tat pathway
was not investigated here. The involvement of the Tat apparatus in the proofreading
and degradation of rejected proteins is a very recent discovery, and more work must
be done to determine the exact role of the different components.
In conclusion, the work presented here has led to the identification of an acidic motif
after the APH of TatA. These acidic residues are important for both function and
complex formation. Initial attempts to identify possible interactions between the
motif and an adjacent positively charged region did not demonstrate any charge
interactions. More work must be done to identify the exact role of the acidic motif
and how its mutation affects the Tat pathway. Truncation of TatA from the C-
terminus did not show any effect on the proofreading capabilities of the Tat pathway.
However this additional role of TatA is a very recent discovery and much more work
must be done to determine how the Tat pathway is able to recognise, reject and
degrade misassembled protein.
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The Tat pathway differs from the majority of protein transport systems, since it is
able to translocate folded proteins, often with cofactors bound. Substrates that are
exported via this pathway can be identified by an invariant twin-arginine motif in
their signal peptide, which gives the pathway its name. Since its discovery it has
generated much interest due to several factors. The ability to export folded proteins
using only the membrane proton motive force (PMF) may enable this pathway to be
used in biotechnological protein production of heterologous proteins not compatible
with the Sec pathway (Brüser, 2007). Furthermore, the lack of a Tat pathway in
animal and fungal cells and the importance of selected Tat substrates in virulence
suggest it could be a suitable target for novel antimicrobial compounds (De Buck et
al., 2008). Despite being the focus of many pieces of research, our knowledge of the
mechanism of the Tat pathway is still behind that of other major transport systems,
such as the Sec pathway (Driessen & Nouwen, 2008). Initial research identified three
integral membrane proteins – TatA, TatB and TatC – that are essential for function of
the Tat pathway in E. coli. They form two distinct types of complex; a TatABC
complex and separate TatA complexes of varying size, which are believed to form
the membrane receptor and translocation pore, respectively. The mechanism by
which these complexes recognise and translocate Tat substrates across the membrane
is still unknown. The work presented in this thesis sought to gain further
understanding of the Tat pathway, using a combination of bioimaging, biochemical
and biophysical techniques to answer the following questions:
 Are there differences in the recognition of Tat substrates by the Tat pathways
in Synechocystis and E. coli?
 Does the TM domain of E. coli TatA play a role in function and complex
formation?
 Is the APH of E. coli TatA able to insert into membranes and contribute to
complex formation?
 Do parts of the C-terminal domain of E. coli TatA contribute to function and
complex formation?
This chapter brings together the work undertaken in order to address these questions
and summarises how the results of the work has furthered our knowledge of the Tat
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pathway. Furthermore, a model for the assembly of TatA complexes suggested by
these results is discussed.
7.1 Differences in the E. coli and Synechocystis Tat pathways
Although components of the Tat pathway have been identified in the cyanobacterium
Synechocystis sp. PCC6803 (Aldridge et al., 2008; Fulda et al., 2000), it is not
known if it differs from the more widely studied E. coli and chloroplast thylakoid
systems. Since cyanobacteria possess an internal thylakoid membrane system in
addition to a plasma membrane, they may contain characteristics of both bacterial
and chloroplast Tat pathways. In Chapter 3 work was undertaken to determine if the
two bacteria differed in their requirement for a twin-arginine motif in the signal
peptide of Tat substrates. Export of TorA-GFP with different substitutions in the
twin-arginine motif was examined in both bacteria. Unlike E. coli, where a single
conservative substitution of arginine with lysine in the twin-arginine motif does not
block export, both of the twin-arginines are essential for export in Synechocystis.
This indicates a closer similarity to the chloroplast thylakoid Tat pathway, where
single substitutions of either arginine block translocation (Chaddock et al., 1995).
Bioimaging was used in this study of Synechocystis as it presents a non-invasive, in
vivo technique, which can be used to obtain data about the cellular location of
fluorescent molecules. Due to the added complexity of the thylakoid membranes, it is
difficult to separate the different cellular compartments of Synechocystis and
confocal microscopy provides an alternative when determining cellular location. This
technique has been successfully used in a recent study to identify the location of
native Tat substrates and one of the TatA/B homologues in Synechocystis (Aldridge
et al., 2008). There are, however, a number of factors that must be considered when
analysing Synechocystis with confocal microscopy. Due to the photosynthetic nature
of the cells they can react to the laser and give off quite intense fluorescence, so
images must be taken and analysed with care. It was originally intended to also use
imaging techniques such as fluorescence recovery after photobleaching (FRAP) and
light inducible GFP to track the movement of TorA-GFP in Synechocystis cells.
However this proved difficult due to the small size of the cells compared to the laser
used for bleaching. Due to these experimental constraints it was decided to change
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direction and concentrate on the E. coli Tat pathway, by studying the TatA
component using biochemical and biophysical techniques.
7.2 TatA function and complex formation in E. coli
The E. coli TatA presents an interesting subject for study due to its ability to form
complexes of varying size (Gohlke et al., 2005; Leake et al., 2008; Oates et al.,
2005). It is essential for function of the Tat pathway, and more recently was also
identified as playing a role in the targeting of misassembled Tat substrates for
degradation (Matos et al., 2008). Despite many studies focusing on TatA and the
other components of the Tat pathway, it is still not known how TatA functions and
forms complexes of variable diameter. The work presented in Chapters 4, 5 and 6
sought to analyse the role of the different domains of TatA, with a view to
identifying the essential regions.
It has been suggested that the TM domain of TatA plays a key role in the formation
of complexes (De Leeuw et al., 2001; Greene et al., 2007; Porcelli et al., 2002). The
evidence presented for this so far is indirect so we sought to analyse the role of the
TM domain directly, using a synthetic peptide and the TOXCAT assay (Russ &
Engelman, 1999). Although predicted to be membrane protein there is still some
controversy over the cellular localisation of TatA. One recent study claimed it
formed cytoplasmic tubes (Berthelmann et al., 2008), whereas another demonstrated
it was only present in the cytoplasmic membrane of E. coli (Leake et al., 2008). The
TatATM peptide was analysed for its ability to insert into lipid bilayers using a variety
of biophysical techniques. In all of the conditions tested the TatATM peptide was able
to insert spontaneously into membrane, giving support to the hypothesis that TatA is
a membrane protein.
Interactions between the TatA TM domain were analysed directly in vitro using the
TatATM peptide, and in a natural membrane environment using the TOXCAT assay.
Both of these approaches demonstrated relatively weak interactions. The weak nature
of these interactions was not unexpected, as the need to form complexes of variable
size may require promiscuous interactions, which have the ability to change with the
oligomeric state. The weakness of these interactions also suggests that there may be
factors other than the TM domain which drive complex formation.
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Substitution of a TM domain glutamine, Gln8, which had previously been shown to
play a role in function (Greene et al., 2007), did not significantly disrupt the helix-
helix interactions of the TM domain in the TOXCAT assay, and did not have a
visible effect on complex formation, as assessed by blue-native PAGE. The
substitution did however have an effect on function, although this was shown to
depend on the expression levels of TatA. The ability of the cell to overcome the
deleterious effects of the substitution, suggests that although important, the
glutamine is not essential and other factors can compensate for its loss at higher
expression levels. This demonstrates again that the TM domain may not be the only
factor driving complex formation.
Previous research has indicated that TatA may have a dual topology (Chan et al.,
2007; Gouffi et al., 2004), which has led to the hypothesis that the TatA APH inserts
into the membrane as part of the translocation process in order to form a hydrophilic
pore through which proteins can pass. Analysis of TatAAPH peptide revealed it was
able to associate with lipid bilayers but no insertion was detected. This was also seen
when the APH was analysed using the TOXCAT assay. Despite the inability of the
APH TOXCAT chimera to insert correctly, they did show strong association with the
membrane. Although insertion of the APH into lipid bilayers was not observed here,
there may be conditions under which it may insert. The Tat pathway is driven by the
PMF, with the electrochemical component playing an important role in E. coli
(Bageshwar & Musser, 2007). Under the conditions required for transport it might be
possible to detect insertion, however at the present time it is not well understood how
the components of the PMF drive translocation. The identification of the key
components and how they work will be a crucial point to establish in order for the
mechanism of the Tat pathway to be determined.
It was also observed that the local environment of the APH has a strong effect on its
secondary structure. Analysis of the TatAAPH peptide demonstrated it was only α-
helical in excess detergent or in the presence of negatively charged lipids. The E. coli
cytoplasmic membrane contains a significant proportion of negatively charged lipids.
These results therefore indicate that the APH must be in the proximity of the
cytoplasmic membrane in order to form the correct secondary structure for function.
This is in agreement with a recent study of the TatAd APH from the Gram-positive
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B. subtilis (Lange et al., 2007), demonstrating some key similarities between the
different bacteria.
The C-terminal domain of TatA is unstructured and can be removed without
affecting function. Analysis of the important regions of E. coli TatA highlighted a
stretch of three acidic residues immediately after the APH. Alignments with TatA
homologues from other Gram-negative bacteria showed that this region of several
negatively charged amino acids was conserved. Removal of the negative charges did
not completely abolish function, suggesting that the motif may optimally consist of
extremely hydrophilic residues, or those with the ability to hydrogen-bond.
Substitution of the acidic residues also affected complex formation, as judged by
blue-native PAGE. TatA without the acidic motif was no longer able to form distinct
complexes. Previously, a region of positively charged amino acids had been
identified (Barrett et al., 2005; Barrett & Robinson, 2005), however preliminary
investigations could not determine if there was a charge interaction between these
two regions. Since there is currently no three-dimensional structure of TatA, it is
difficult to determine which areas of the protein may come into contact in the
formation of complexes. This highlights the need for high resolution structures of all
the Tat pathway components and the complexes they form in order to fully
understand the interactions between the proteins and how they function.
Recently a role of TatA in the proofreading of FeS proteins was established (Matos
et al., 2008). Using the same methods, it was demonstrated that removal of the C-
terminal domain of TatA could not restore the export of mutated NrfC. The role of
the Tat components in proofreading is a very recent discovery and the quality control
mechanisms of the Tat pathway are still poorly understood. It is likely that further
factors are involved and only upon their identification can the exact role of TatA be
determined.
7.3 New model for the assembly of TatA complexes
The results presented here can be summarised in a new model for TatA complex
formation, Figure 7.1. In this model, the TM domain of TatA inserts into the
membrane, bringing the APH into close contact with the membrane and enabling it
to take on its α-helical secondary structure, Figure 7.1A. Weak interactions between
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the TM domains enable the TatA monomers to come together to form higher order
oligomers, Figure 7.1B. Additional interactions between the acidic motif (identified
here) and a previously identified positively charged region, possibly located in the
APH, stabilise the formation of these oligomers and the TatA complexes are able to
form, Figure 7.1C. The apparently weak, but significant, TM domain interactions
could be a factor in the dynamic nature of the TatA, enabling the oligomers to
assemble and disassemble with relative ease.
A B C
Figure 7.1 Proposed model for TatA complex formation. A. The TatA monomer is inserted into the
membrane and association with the membrane stabilises the secondary structure of the APH. B. Weak
TM domain interactions drive the formation of higher order TatA oligomers. C. Charge interactions
between the acidic motif in the C-terminal domain and a positively charged region, possibly in the
APH, stabilise the formation of TatA oligomers.
7.4 Future directions
Despite the many studies of the Tat pathway there still remains much to be
determined about the mechanism of this interesting system. The research presented
here has again demonstrated the need for a high resolution structure of the
components of the Tat pathway and the complexes they form. High resolution
structures of the components of the Sec pathway have proved extremely important in
the characterisation of this system. So far attempts to obtain crystals of the
components if the Tat pathway have proved unsuccessful, possibly due to the
detergents required for purification. Work is currently underway to try and obtain
higher resolution structures of the Tat complexes using electron microscopy. It is
hoped these structures will provide information on how the components interact with
each other, which will enable accurate modelling of the Tat pathway.
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Another important future direction is the determination of the factors which drive
translocation. The electrochemical gradient has been identified as the major factor in
driving translocation (Bageshwar & Musser, 2007). By developing new tools to
analyse the Tat pathway in vitro it may be possible to determine if the TatA APH
inserts into the membrane as part of the translocation process. This would provide
essential information on the topology of TatA, which remains somewhat
controversial.
The discovery that components of the Tat pathway are involved in the degradation of
misassembled Tat substrates is a recent discovery and much more research is needed
to fully understand this process (Matos et al., 2008). Work is currently ongoing to try
and determine how the Tat pathway identifies, rejects and then directs these
misfolded proteins to be degraded. The identification of a role for TatD is an
important step towards understanding the proofreading capabilities of the Tat
pathway (Matos et al., 2009). It is hoped that by characterising the proofreading
process more information will be gained on other aspects of the Tat pathway.
In summary, the work presented here has led to an increased understanding of the Tat
pathway in Synechocystis and E. coli. Differences between the pathway in the two
bacteria have been highlighted, and it has been demonstrated that confocal
microscopy can be a useful tool in the analysis of the Synechocystis Tat pathway.
Detailed analysis of the three domains of E. coli TatA has identified interactions
which contribute to function and the formation of complexes, leading to the proposal
of a new model for the formation of TatA complexes. Much work remains to be done
in order to fully understand the mechanism of the Tat pathway; however this work
provides a platform for future research towards complete characterisation of this
important system.
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Number Gram-negative Bacteria Accession number
1 Escherichia coli (strain K12) P69428
2 Aquifex aeolicus O66477
3 Azotobacter chroococcum A1EHP9
4 Bdelliovibrio bacteriovorus Q6MK41
5 Campylobacter jejuni Q9PNB9
6 Caulobacter crescentus Q9A6T0
7 Enterobacter cloacae A6N9K1
8 Haemophilus influenzae P57046
9 Halorhodospira halophila A1WW03
10 Helicobacter pylori J99 Q9ZMB8
11 Legionella pneumophila Q5WSQ5
12 Pasteurella multicoda Q9CKD3
13 Pseudomonas aeruginosa Q9HUB5
14 Pseudomonas stutzeri P95557
15 Rhizobium loti Q98LC5
16 Rickettsie prowazekii Q9ZCJ1
17 Salmonella typhimurium P0A2H3
18 Vibrio cholerae P57051
19 Xyella fastidiosa Q9PFU3
20 Yersina pestia Q8ZAM2
Number Gram-positive bacteria Accession number
21 Alkaliphilus oremlandii A8MGV3
22 Bacillus anthracis Q81R17
23 Bacillus subtilis TatAc O31804
24 Bacillus subtilis TatAd O31467
25 Bacillus subtilis TatAy O05522
26 Corynebacterium diphtheriae Q6NH98
27 Corynebacterium glutamicum Q8NQE4
28 Corynebacterium jeikeium Q4JVQ1
29 Heliobacterium modesticaldum B0TFT7
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30 Listeria monocytogenes Q8YA04
31 Mycobacterium leprae P54079
32 Mycobacterium paratuberculosis Q73YX3
33 Mycobacterium tuberculosis P66889
34 Nocardia farcinica Q5YUY0
35 Rhodococcus erythropolis P72267
36 Rhodococcus sp. (strain RHA1) Q0SIG6
37 Staphylococcus aureus Q5DVX3
38 Streptococcus gordonii A8AXD8
39 Streptomyces avermitilis Q828H7
40 Streptomyces lividans Q7B115
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G-
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AD
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--
--
KE
KD
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SL
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TE
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DW
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LI
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VL
VF
G-
TK
RL
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LG
SD
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EA
IK
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DD
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DQ
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QP
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NQ
PH
TI
DA
QA
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--
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EP
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KD
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G-
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FV
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G-
AG
KL
PQ
VM
SD
LA
KG
LK
AF
KE
GM
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DG
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--
--
--
--
--
--
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ND
KT
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--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
-
--
--
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G-
-G
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G-
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SD
DD
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--
--
--
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KQ
DK
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AD
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AK
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KE
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--
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--
--
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--
--
--
--
--
--
--
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MF
SN
--
--
--
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IG
FP
G-
LI
LI
LV
AV
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G-
PK
KL
PE
IG
KA
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ET
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EF
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--
--
--
--
--
--
--
--
--
--
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KE
LT
D-
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-D
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--
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SG
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--
--
--
--
--
--
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--
--
--
--
--
--
--
--
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MF
SN
--
--
--
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IP
G-
LI
LI
FV
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G-
PS
KL
PE
IG
RA
AK
RT
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EF
KS
--
--
--
--
--
--
--
--
--
--
--
AT
KS
LV
SG
--
--
-D
EK
EE
KS
AE
LT
A-
--
--
--
--
--
-V
KQ
DK
NA
G-
--
--
--
--
--
--
--
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MP
--
--
--
--
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IG
PG
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LA
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AI
VA
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IF
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PK
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PE
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DT
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EF
KN
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--
--
--
--
--
--
--
--
--
AT
KG
LT
SD
--
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--
--
--
--
--
--
--
--
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KE
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--
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--
--
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--
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NR
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--
--
--
--
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--
--
--
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P-
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VP
E-
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FL
LF
G-
AT
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PN
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--
--
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AP
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QD
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--
--
--
--
--
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--
--
--
--
--
--
--
--
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--
--
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G-
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SN
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EE
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--
--
--
--
--
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AK
PP
VK
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DT
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P-
--
--
--
--
--
--
--
--
-S
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--
--
--
--
--
--
--
--
--
-
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--
--
--
--
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G-
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EF
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--
--
--
--
--
--
--
--
--
--
--
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--
--
--
--
--
--
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--
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-A
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--
--
--
--
--
--
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-
--
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--
--
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--
--
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--
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G-
-S
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PW
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--
--
--
--
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VD
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--
--
--
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--
--
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--
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--
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TP
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--
--
--
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AP
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QP
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P-
--
--
--
--
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AP
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PV
NQ
AE
QK
SA
--
--
--
--
--
--
--
--
-
--
--
--
-M
G-
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MS
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TP
AP
TA
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--
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P-
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The twin-arginine translocase (Tat) pathway transports folded proteins
across bacterial and thylakoid membranes. In Escherichia coli, a membrane-
bound TatA complex, which oligomerizes to form complexes of less than
100 to more than 500 kDa, is considered essential for translocation. We have
studied the contributions of various TatA domains to the assembly and
function of this heterogeneous TatA complex. The TOXCAT assay was used
to analyze the potential contribution of the TatA transmembrane (TM)
domain. We observed relatively weak interactions between TatA TM
domains, suggesting that the TM domain is not the sole driving force behind
oligomerization. A potential hydrogen-bonding role for a TM domain
glutamine was also investigated, and it was found that mutation blocks
transport at low expression levels, while assembly is unaffected at higher
expression levels. Analysis of truncated TatA proteins instead highlighted
an acidic motif directly following the TatA amphipathic helix. Mutating
these negatively charged residues to apolar uncharged residues completely
blocks activity, even at high levels of TatA, and appears to disrupt ordered
complex formation.
© 2009 Elsevier Ltd. All rights reserved.
Edited by J. Bowie
Keywords: protein transport; twin-arginine translocase; TatA; transmembrane
domain; TOXCAT
Introduction
In bacteria, two primary pathways are used for
the export of proteins across the cytoplasmic
membrane: the general secretory (Sec) pathway,
and the twin-arginine translocase (Tat) pathway.1,2
Unlike the Sec pathway, where proteins are
threaded through the Sec translocase in an unfolded
state, the Tat pathway is able to export folded
proteins. The pathway derives its name from the
twin-arginine motif in the N-terminal domain of the
signal peptide of Tat substrates.3,4
The minimal components of the Tat pathway in
Escherichia coli are TatA, TatB and TatC.5–7 TatA and
TatB are sequence-related proteins and are predicted
to have the same secondary structure: an N-terminal
α-helical transmembrane (TM) domain, followed by
an amphipathic α-helix (APH) and a largely
unstructured C-terminal region.8–10 Despite their
similarity, TatA and TatB have distinct roles in the
Tat pathway,10 and TatA is expressed at much
higher levels than TatB and TatC.
Two distinct types of complex have been char-
acterized in E. coli cytoplasmic membranes: a
TatABC complex and separate TatA complexes.
The TatABC complex has been purified and shown
to contain equal amounts of TatB and TatC and
variable amounts of TatA.11 The majority of TatA is
found in separate homo-oligomeric complexes that
range in size from less than 100 kDa to well over
500 kDa.8,9 These complexes have variable dia-
meters and have been proposed to form the
translocation pore through which proteins are
exported.8 It has been suggested that TatA size
heterogeneity may be linked to the need to transport
a variety of substrates, with the translocation pore
perhaps assembled from appropriately sized Tat
complexes. Counter to this idea, it has been shown
that TatA heterogeneity is unaffected in export-
defective TatC mutants.12
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Abbreviations used: Tat, twin-arginine translocase; TM,
transmembrane; Sec, secretory; APH, amphipathic
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It is highly unusual for single-span membrane
proteins to assemble into such a heterogeneous
range of complexes, and the mechanism of TatA
complex formation is still unknown. A recent study
has shown that, although TatB and TatC are
required for the correct formation of large TatA
complexes, smaller complexes containing an aver-
age of about four TatA molecules still form in the
absence of TatB and TatC.13 It has been hypothe-
sized that the TatA TM domain is an important
factor in TatA oligomerization.14–16 When TatA is
expressed without its TM domain it becomes a
monomeric, soluble protein and loses some of its
secondary structure.16 Furthermore, a recent
cysteine-scanning study highlighted a key gluta-
mine residue in the TM domain that was important
for Tat function.15 Polar residues in TM domains
have been implicated in the oligomerization of other
membrane proteins,17,18 although it has not been
determined whether substitution of the glutamine in
the TatATM domain affects the structure of the TatA
complex.15
It is also clear that regions other than the TM
domain play a role in functional assembly of TatA.
While the extreme TatA C-terminal domain can be
removed without loss of function,19 the APH is
essential for activity.20,21 Moreover, the TatA F39A
mutation (in the middle of the APH) was shown to
completely block Tat function21 and severely disrupt
TatA oligomerization.12
In this report we have set out to explore the roles
of the TM domain and other regions of the protein in
TatA assembly and function. We have used the
TOXCAT assay22 in conjunction with study of a
synthetic peptide to directly probe helix–helix
interactions between TatA TM domains, and we
demonstrate relatively weak interactions between
TM domains [compared to glycophorin A (GpA)].
Additionally, a new C-terminal truncation of TatA
has identified the minimal functional subunit of
TatA, which extends to a patch of negatively
charged residues immediately after the APH.
Through mutational analyses of this region, we
show this acidic motif is important for TatA complex
formation and function. These results have led us to
discuss a new model for TatA complex formation
that includes this acidic motif as well as the TM
domain.
Results
The primary sequence of the 89-residue TatA
polypeptide is shown in Fig. 1a. The putative
structure of TatA is shown in Fig. 1b together with
the various constructs used in this work. The TM
domain stretches from (approximately) residues 6–
20, followed by a predicted “hinge” region, an APH
and a more unstructured C-terminal domain. The
aim of this study was to analyze the role of these
various domains in TatA assembly and function and
to better understand the relationship between TatA
heterogeneity and function.
Homo-oligomerization of the TatA TM domain
In recent studies, it has been suggested that
oligomerization of TatA is mediated through TM
Fig. 1. TatA sequence and constructs used in this study. (a) The primary sequence of E. coli TatA. The glutamine in the
TM domain and an acidic motif identified in this study are highlighted, and three lysines in the APH that have been
shown to be important for function and complex formation are underlined.12 (b) TatA constructs used in this study, with
the TM domain and the APH labelled. Full-length TatA and C-terminal truncations by 20, 40, 45 and 50 amino acids were
tagged with His-6 (his) or Strep II™ (strep) tags (TatAh/s, TatA-20h, TatA-40h/s, TatA-45h/s, TatA-50h). Mutations were
introduced in the TM domain (Q8A, Q8C) and in the acidic motif after the APH (D45N, D46N, E47Q, NNQ, LLM). (c) The
TOXCAT chimera used in this study. The TatATM domain was inserted between the N-terminal dimerization-dependent
DNA binding domain of ToxR (■) and the monomeric periplasmic anchor MBP (●). The glutamine that was mutated to
both alanine and cysteine is highlighted.
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domain interactions,14–16 but the actual TatA assem-
bly process is still poorly understood. To test this
hypothesis in vitro, we analyzed a synthetic peptide
corresponding to the TatA TM domain (TatATM;
residues G2–K24). A lysine was added to the C-
terminus to aid solubility of this very hydrophobic
peptide, an approach that has been shown in the
past not to affect the oligomerization of strongly
interacting TM domains.23,24 SDS-PAGEwas used to
analyze the oligomeric state of the TatATM peptide at
different concentrations (Fig. 2a). At low concentra-
tions (10–50 μM), the peptide runs as a single band
of less than 4 kDa; however, at higher concentrations
(≥100 μM) a second band can be detected at about
6 kDa. The positions of the peptide bands do not
correspond exactly to the predicted monomer and
dimer masses (2.65 and 5.30 kDa, respectively). This
aberrant behavior has been seen in previous work
on membrane proteins and is thought to be caused
by conformational effects.25 Despite the difference in
size, the bands were assigned to monomer and
dimer, with the majority of the peptide present as a
monomer. The tendency of the TM domain peptide
to remain primarily as a monomer indicates that
although a small fraction of the TM domain does
oligomerize, these interactions are largely disrupted
by SDS.
To analyze the TM domain interactions in a
natural membrane environment, as opposed to
detergent micelles that can be highly denaturing,26
we used the TOXCAT assay22 (see Materials and
Methods). TOXCAT measures the ability of a given
TM domain, in isolation from the rest of the protein,
to self-associate in a membrane bilayer. Although
TOXCAT data cannot be used to determine the
precise oligomeric state, the data give a good
indication of the strength of TM helix–helix interac-
tions and, thus, of whether the TM domain is
significantly involved in homo-oligomerization. A
TOXCAT chimera containing the predicted TatATM
domain (Fig. 1c) was constructed and its topology in
the E. coli inner membrane was confirmed with the
malE complementation assay22 (Fig. 2b). Briefly, in
this assay, NT326 cells [which lack endogenous
maltose binding protein (MBP)] are grown on plates
where the sole carbon source is maltose. Growth in
this medium is supported only for cells expressing
TOXCAT chimera with the correct topology (i.e.,
MBP in the periplasm). Combined with the response
to oligomerization [chloramphenicol acetyl transfer-
ase (CAT) activity], which confirms the cytoplasmic
location of the ToxR domain, both the topology and
the correct membrane insertion are confirmed. The
resulting [CAT] activity of the chimera containing
the TatA TM domain is shown in Fig. 2c. The TatA
signal is normalized to a positive control, namely,
the TM domain of GpA, which is known to strongly
self-associate into dimers. Also shown are data from
a point mutant of GpA, G83I, which greatly reduces
the population of dimers27 and is used as a negative
control for the TOXCAT assay. Compared to the
strongly and weakly dimerizing controls (GpA and
G83I, respectively), the TatA TM yielded intermedi-
ate levels of CAT in the assay ([CAT] ∼38% of GpA),
suggesting that there is a significant level of
interaction between TatA TM domains, but that the
strength of this interaction is weaker than that
observed for GpA.
A recent cysteine-scanning study of the TM
domain and APH of TatA highlighted a glutamine
residue, Gln8, in the TM domain that was important
for function (Fig. 1a).15 Mutation of this residue to
Fig. 2. TatA TM domains demonstrate a small but significant ability to self-associate as measured using SDS-PAGE
gels and the TOXCAT assay. (a) SDS-PAGE analysis of the synthetic TatATM peptide was carried out over a range of
concentrations (stated below each lane). The majority of the peptide was present as monomer (m), with dimer (d) visible at
the highest concentrations. (b)malE-deficient E. coli cells (NT326) andNT326 cells expressing TOXCATchimera containing
the TM domain of GpA (positive control), a mutant of GpA (G83I, negative control), the TatATM domain (TatA) and the
TatATM domain with Gln8 mutated to alanine or cysteine (Q8A, Q8C), were grown on M9 agar containing 0.4% maltose
to test for the topology of the TOXCATchimera. (c) Levels of CATactivity in NT326 cells expressing the TatATM TOXCAT
chimera (TatA, Q8A, Q8C) were assayed (as detailed in Materials andMethods) along with GpA and G83I as positive and
negative controls, respectively. CAT activity was normalized to GpA. Error bars show the standard deviation of three
separate measurements. Anti-MBP immunoblots of each construct are shown below.
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cysteine or alanine severely affected the export of
TMAO (trimethylamine N-oxide) reductase (TorA)
to the periplasm. The presence of hydrophilic
residues in TM domains, and specifically Gln
residues, has been shown to drive TM helix–helix
association via electrostatic interactions and forma-
tion of interhelical hydrogen bonds.28,29 Therefore,
we studied the role of Gln8 in TatA TM domain
oligomerization by mutagenesis of this residue and
subsequent measurement with TOXCAT. Gln8 was
substituted with cysteine (Q8C) and alanine (Q8A),
and the resulting TOXCAT signals are shown in Fig.
2c. These mutations led to a noticeable decrease in
[CAT] activity compared to wild-type TatA TM
levels ([CAT]Q8A=24% and [CAT]Q8C=28%); how-
ever, the effect is only significant within the error for
the Q8A mutant.
Since these mutations did not dramatically affect
the strength of TatA TM interactions as measured
with the TOXCAT assay, we decided to analyze
these mutations in the full-length protein, using a
different expression system from the previous study
mentioned above.15 Mutants of TatAwere prepared
in the arabinose-inducible plasmid pBAD-ABC, and
the effects of each mutation were analyzed in terms
of both Tat export efficiency and TatA complex
formation. ΔABCDE cells containing pBAD-ABC or
mutated pBAD-ABC were grown in the presence or
in the absence of arabinose. The mutants were
analyzed at both low and high expression levels in
order to assess more rigorously any concentration-
dependent effects of mutation. Previous work11 has
shown that the pBAD-ABC plasmid provides a
near-wild-type level of Tat components when
induced with very low (5 μM) concentrations of
arabinose, and TatABC levels are slightly lower than
wild-type levels in the absence of arabinose. We
observe an approximately 25-fold increase over
wild-type levels when induced with arabinose at
50 μM concentrations: similar expression levels have
been reported in other studies of plasmid-borne Tat
proteins.30
We first tested the activity of the Gln8 mutations
using our expression system. Cells were separated
into periplasmic and cytoplasmic fractions and
assayed for the presence of TorA activity with the
use of a native gel assay (Fig. 3a). SDS-PAGE and
immunoblotting were also performed on membrane
fractions to monitor the expression of TatA and TatB
(Fig. 3b). In the control samples (Fig. 3a), TorA
activity is clearly apparent in the periplasm (P) of
wild-type MC4100 cells and no export is evident in
the tat deletion strain (ΔABCDE panel), where a
slowly migrating form of TorA (TorA⁎) is observed
in the cytoplasm (C).20,31 When arabinose was
omitted from the growth medium, the Tat compo-
nents were expressed at very low levels (Fig. 3b). At
these low expression levels, wild-type TatA
(ΔABCDE+ABC) is able to support export of
TorA, but no export is detectable with the mutated
forms (Q8A, Q8C). This result is in agreement with
previous reports15 studied in a different expression
system. Interestingly, when arabinose was used to
induce the expression of the Tat components, the
TatA Q8A and Q8C mutants were both able to
support export of TorA to the periplasm, as
indicated by white bands in the periplasmic lanes
of Fig. 3a. However, it is clear that these mutants are
not exporting at wild-type levels and therefore the
mutation is still having some effect even at higher
concentrations. This result suggests that Gln8 is
important, but not absolutely essential, for func-
tional activity. At higher levels of expression, the
increased concentration of TatA (∼25-fold increase
over wild type) can compensate for the deleterious
effects of the mutations, especially given that the Q8
mutants still oligomerize (albeit more weakly) when
analyzed using TOXCAT. A previous cysteine-
scanning study15 showed that the same mutations
Fig. 3. The Gln8 mutation affects TatA function at low
expression levels but does not affect complex formation.
Periplasmic (P) and cytoplasmic (C) samples were
prepared from wild-type E. coli cells (MC4100), from
ΔABCDE cells, and from ΔABCDE cells expressing wild-
type TatABC from plasmid pBAD-ABC (ΔABCDE+ABC),
or the same vector with TatA Gln8 mutated to alanine or
cysteine (Q8A, Q8C), grown in the absence or presence of
arabinose (uninduced, induced). (a) Native polyacryla-
mide gels of periplasmic and cytoplasmic samples were
stained for TorA activity. White bands indicate the
presence of TorA; TorA⁎ indicates a slower migrating
cytoplasmic form of TorA. (b) Immunoblots of membrane
samples using TatA and TatB antibodies. Arrows indicate
TatA and TatB. Asterisks denote unidentified TatA
adducts caused by the Gln8→Cys mutation. (c) Mem-
branes solubilized in digitonin were subjected to blue-
native gel analyses (as described in Materials and
Methods) and immunoblotted using TatA antibodies.
The mobility of molecular mass markers (in kilodaltons)
are indicated on the left.
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blocked export completely, but it is possible that the
mutants were expressed at very low concentrations
in that study.
By moderately overexpressing TatA, the higher
concentration of protein also allows us to study the
oligomeric state(s) of TatA mutants using blue-
native gels.9 Currently there is no method sensitive
enough to visualize TatA oligomers at wild-type
levels. High protein concentrations are necessary for
characterization of protein oligomeric state, and this
approach has been taken in several studies of
TatA.8,9,32 Although data must be interpreted with
care, valuable information on assembly of this and
many other protein complexes has been gained at
higher concentration.
Using blue-native PAGE (BN-PAGE), we ana-
lyzed overexpressed wild-type TatA as well as the
Q8A and Q8C mutants to determine how these
mutations affect complex formation. Membranes
isolated from ΔABCDE E. coli cells expressing the
wild-type and mutated pBAD-ABC plasmid were
run on blue-native gels and immunoblotted with
TatA antibodies to detect the range of TatA
complexes (Fig. 3c). These analyses were carried
out at protein concentrations similar to those used
for the induced TorA assay, where we saw reduced
export compared to those at wild-type levels.
However, both TatA mutants were able to form
oligomers identical to those formed by wild-type
TatA (spanning from 100 to 500 kDa). Taken
together, the above data suggest that Gln8 and the
TM domain are only moderately involved in
oligomer formation at these concentrations.
An acidic motif after the APH is important for
TatA function
TOXCAT, SDS-PAGE, TorA export and blue-native
analyses suggest that, while the TatA TM domain
demonstrates a small but significant degree of self-
association, there are most likely other regions in the
protein that also contribute to the functional assem-
bly of TatA. Previous work has shown that trunca-
tion of up to 40 amino acids from the C-terminus of
TatA (A-40) still resulted in fully functional protein;
however, truncation by 50 amino acids (A-50)
abolished function, suggesting that the stretch of
amino acids from residues 39 to 49 were crucial for
function.19 To further delineate important residues in
this region, a construct corresponding to TatA
truncated by 45 amino acids from the C-terminus
was prepared, containing either a His-6 or Strep II™
C-terminal tag (Fig. 1b). The tags were necessary for
detection in the absence of a suitable TatA antibody,
and previous work has shown that a C-terminal His-
6 tag on TatA does not affect its functional activity.33
Truncations of TatA by 20, 40 and 50 residueswith C-
terminal His-6 or Strep II™ tags (Fig. 1b) were also
prepared to allow comparison of our expression
system with the previous study in a different
expression system.19 The activities of the His-6-
and Strep II™-tagged truncation mutants were mea-
Fig. 4. C-terminal truncation of TatA identifies an acidic motif that is essential for function. Periplasmic (P) and
cytoplasmic (C) samples were prepared from wild-type E. coli cells (MC4100), ΔAE cells (ΔAE), and ΔAE expressing full-
length TatA, TatA truncated by 20, 40, 45 or 50 amino acids from the C-terminus with a C-terminal His-6 tag (Ah, A-20h,
A-40h, A-45h, A-50h), and full-length TatA, TatA truncated by 40 or 45 amino acids from the C-terminus with a Strep II™
tag (As, A-40s, A-45s) from the pBAD24 plasmid. A native polyacrylamide gel was stained for TorA activity. White bands
indicate the presence of TorA; TorA⁎ indicates a slower migrating cytoplasmic form of TorA.
Fig. 5. The TatA acidic motif is conserved in TatA homologs from other Gram-negative bacteria. Sequences of TatA
homologs from Gram-negative bacteria were identified and aligned using ClustalX34. The alignment shows the TM
domain, the APH and the region immediately following the APH. An acidic region after the predicted APH is boxed.
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sured with the TorA export assay (Fig. 4). In the
control samples, TorA activity is clearly apparent in
the periplasm of wild-type MC4100 cells and no
export is evident in cells lacking TatA and TatE (ΔAE
panel). Analysis of the tagged truncations show that
A-20 and A-40 mutants (A-20h, A-40h and A-40s
panels) support export of TorA, whereas the A-50
truncation mutant (A-50h panel) does not. These
results agree with the data reported by Lee et al.19 for
plasmid-borne, overexpressed TatA, confirming that
our tagged proteins were behaving in the same
manner as previously studied untagged versions. In
this study, an additional TatA mutant was prepared,
A-45, in which 45 amino acids were deleted from the
C-terminus. This mutation also abolished export via
the Tat pathway (Fig. 4, A-45h and A-45s panels),
identifying a stretch of five residues (Asp45–Lys49)
that is important for function.
Analysis of these five residues revealed three
consecutive acidic residues immediately following
the predicted APH (DDE sequence highlighted in
Fig. 1a). Alignment of TatA sequences from other
Gram-negative bacteria shows that this represents a
highly conserved acidic “motif” (Fig. 5). We use the
termmotif not to suggest the specific conservation of
the sequence DDE, but instead to indicate a region of
two or three acidic residues almost always present
after the APH of many TatA proteins. The structural
and functional relevance of these residues was
analyzed by mutagenesis of TatA. Each of the
three residues was mutated individually to a
structurally similar but uncharged residue (D45N,
D46N and E47Q), and a triple mutant was also
prepared (NNQ) (Fig. 1b). Because asparagine and
glutamine are able to hydrogen-bond and thus
participate in strong non-covalent interactions, an
additional triple mutant, which would be unable to
hydrogen-bond with other residues, was prepared
(LLM, Fig. 1b). The effect of each mutation on TatA
function was analyzed with the TorA export assay in
which TatA expression was induced with arabinose.
The single mutations in the DDE sequence have no
apparent effect on the functioning of the Tat path-
way (Fig. 6a), with most of the TorA activity found
in the periplasm in each case. However, the triple
NNQ mutation significantly inhibited the export of
TorA, with the majority of TorA found in the
cytoplasm. When arabinose was omitted from the
growth medium, resulting in almost wild-type
expression levels, no TorA activity was seen in the
periplasm (data not shown). The other triple
mutation (LLM mutant) has a more drastic effect,
completely blocking TorA export (Fig. 6a) even at
high protein concentrations.
Since the TorA assay is a rather qualitative assay,
the triple mutants were also examined using the
more quantitative TorA–GFP (green fluorescent
protein) export assay (Fig. 6b) to assess more
accurately the efficiency of export. This assay in-
volves expression of a chimeric construct composed
of the TorA signal peptide linked to GFP. Export
efficiencies can be assessed by immunoblotting.35
The data show that TorA–GFP is efficiently exported
in ΔABCDE cells expressing either TatABC (from
plasmid pEXT-ABC) or the same construct carrying
the TatA NNQ mutation. In each case, most of the
GFP is found as mature-sized protein in the
periplasm. However, the triple mutation LLM leads
to a complete block in export (Fig. 6b), as observed
Fig. 6. The acidic motif is critical for function, and
potentially for complex formation, but uncharged polar
residues can support translocation activity. The effects of
five different mutations of the acidic motif of TatA
(Asp45→Asn, D45N; Asp46→Asn, D46N; Glu47→Gln,
E47Q; Asp46→Asn, Asp46→Asn and Glu47→Gln, NNQ;
Asp45→Leu, Asp46→Leu and Glu47→Met, LLM) were
analyzed by a TorA activity assay, a TorA–GFP export
assay and blue-native gel analysis. (a) Native polyacryla-
mide gel stained for TorA activity. Periplasmic (P),
cytoplasmic (C) and membrane (M) samples were
prepared from wild-type E. coli cells (MC4100), from
ΔABCDE cells, and from ΔABCDE cells expressing
TatABC with mutated TatA (D45N; D46N; E47Q; NNQ;
LLM). White bands indicate the presence of TorA; TorA⁎
indicates a slower migrating cytoplasmic form of TorA. (b)
Immunoblots using a GFP antibody of C, M and P samples
fromΔABCDE cells expressing TorA–GFP from the pJDT1
plasmid (ΔABCDE), ΔABCDE cells expressing TorA–GFP
and wild-type TatABC from the pEXT-ABC plasmid
(pEXT-ABC), and ΔABCDE cells expressing TorA–GFP
and mutated TatABC from the pEXT-ABC plasmid (NNQ,
LLM). (c) Membranes from ΔABCDE cells expressing
wild-type or mutated TatA from the pBAD-ABC plasmid
solubilized in digitonin were subjected to blue-native gel
analyses and immunoblotted using TatA antibodies.
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above with TorA. The accumulation of mature-sized
GFP in the cytoplasm is due to proteolysis of TorA–
GFP when export is blocked.35,36 These data confirm
the importance of this motif of acidic amino acids
and show that polar residues such as Gln and Asn
can at least partially rescue function.
Oligomerization of TatA mutants carrying
substitutions in the acidic motif
In order to investigate the link between correct
TatA oligomer formation and function, blue-native
gel analyses were performed on each of the mutants
described above (Fig. 6c). The single mutants D45N,
D46N, and E47Q, all of which were functional in the
TorA assay, yield a banding pattern identical to that
of wild-type TatA, indicating that these mutations
have not affected the ability of TatA to assemble into
oligomers. The triple mutations, however, result in
substantial destabilization of the TatA complexes as
judged by this approach (Fig. 6c, panels NNQ and
LLM). Although there is some indication of oligo-
mer formation for these mutants, many fewer bands
are observed, and these bands are much broader
and appear at different molecular mass values. This
effect could be accounted for by the high theoretical
pI of the triple mutants (8.96) compared with the
ideal running conditions for BN-PAGE (pI≤8.6).37
Proteins with pIs of 9.3 or above typically display
broad bands in BN-PAGE, and their slow migration
down the gel reflects an inaccurately high molecular
mass.37 However, the NNQ and LLM mutants are
only just outside the range for BN-PAGE and,
although we do see broadening of the bands, we
also see many fewer bands. Taken with the
observation that we see no such effect when any
one of the acidic residues is removed independently,
these data suggest that there may be a link between
TatA structure and function, with most of the
mutants either active and correctly structured (the
single mutants), or inactive and disordered (LLM
triple mutant). However, this will need to be tested
further with complementary methods.
Discussion
TatA TM domains interact relatively weakly with
one another
TatA is proposed to form homo-oligomeric com-
plexes of variable diameters that act as the transloca-
tion pore. The mechanism by which assembly occurs
is not known, but the TM domain of TatA has been
strongly implicated in the formation of homo-
oligomers. Previous work has shown that TatA
expressedwithout its TMdomain purifies as a soluble
monomer,16 leading to the conclusion that the TM
domain was involved in oligomerization.14–16 This
conclusion was supported by a study that found that
a glutamine residue in the TatA TM domain (Q8)
was important for functional activity of the Tat
pathway.15 In this work, using a synthetic peptide
and the TOXCAT assay, respectively, we have
analyzed the TatA TM domain in vitro and in vivo in
order to assess its ability to self-associate. We have
also analyzed the role of Gln8 in this process, because
this Gln could potentially influence TM helix–helix
interactions through its ability to hydrogen-bond.
Perhaps surprisingly, our data indicate the TM
domains interact with each other relatively weakly.
Measurements in a natural bilayer using the TOX-
CAT assay, an assay that has been highly effective
for the study and quantification of inter-TM
association,18,22 suggests that TatA TM domains do
not have a strong intrinsic ability to oligomerize, but
instead demonstrate intermediate self-association. In
addition, we find that these TM domain interactions
are only mildly disrupted by the mutation of Gln8.
The data from TOXCAT measurements are further
supported by our results from blue-native gel
analyses, where mutation of Gln8 produced no effect
on the oligomerization of full-length TatA.
In light of the previous studies of TatA, where
formation of variable-sized complexes has been
observed, these results are less surprising. If one
expects promiscuous interactions for TatA (i.e.,
variable-sized complexes), one would not expect
an extremely strong interaction. These data also
suggest that the TM domain is, at most, only
partially responsible for the formation of TatA
complexes, and other regions of the protein almost
certainly play a role in the oligomerization observed
for wild-type TatA.
An acidic motif after the APH is important for
TatA function
Previous work has shown that the APH region is
important for both assembly and function of
TatA;20,21 the apparently disordered C-terminal
domain appears to be less important and can be
deleted without blocking activity.19 We have studied
a new C-terminal truncation of TatA in an attempt to
pinpoint specific areas within this region critical for
function and have discovered a key region—a motif
of consecutive acidic residues lying just outside the
APH. This acidic motif is highly conserved within
TatA subunits from Gram-negative bacteria, which
generally contain two to three acidic residues in this
region (see Fig. 5). Interestingly, the motif is much
less prevalent inGram-positive bacteria (not shown),
andwe speculate that thismay be correlatedwith the
recent observation that the TatA subunit from the
Bacillus subtilis does not oligomerize in the same
manner, instead forming a much smaller and more
homogeneous homo-oligomeric complex.38
Single mutations in the acidic motif (to uncharged
amino acids) did not apparently affect TatA function
or complex formation, and triple mutation to polar
but uncharged residues (NNQ) was still able to
support export of TorA and TorA–GFP to the
periplasm, although at a much reduced efficiency.
However, substitution by uncharged and hydro-
phobic residues (LLM) leads to a complete loss in
activity. These data indicate that negative charges
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are not an absolute requirement for translocation
activity, and we suggest that the motif may
optimally consist of extremely hydrophilic residues,
or perhaps those with an ability to hydrogen-bond.
How might the acidic motif be involved in TatA
function? Previous studies have highlighted the
importance of the three positively charged amino
acids in the APH of TatA: lysine 37, lysine 40 and
lysine 41.12,20 Mutating these three lysine residues to
glutamines, thus removing their charge, disrupted
both functional activity of the Tat pathway and
complex formation. Plotting these residues on a
helical wheel shows that they are located on the
same face of the APH (data not shown). Identifica-
tion of an important positively charged region in the
APH and a nearby negatively charged region leads
to the hypothesis that there is a charge (electrostatic)
interaction between these two regions, and the
disruption of this interaction affects complex forma-
tion and functional activity.
These results have led us to propose the following
method of TatA complex formation. In this model,
the TatA TM domain allows the protein to fold
correctly and stabilizes interactions between the
APH and the membrane. Weak interactions between
the TM domains also bring the proteins together in
the correct orientation, allowing the negative region
from one monomer to interact with positive residues
from another monomer, possibly located in the
APH. While further work is required to confirm the
mechanism of association, these charge interactions
could stabilize the formation of complexes and
allow TatA to oligomerize correctly and perform
its role in the export of proteins.
Materials and Methods
Bacterial strains and growth conditions
Bacterial strains used in this study are listed in Table 1.
For TorA activity assays, TorA–GFP export assays and
blue-native analyses, E. coli strain MC410039 was the
parental strain. ΔAE and ΔABCDE have been described
before,6,40 and arabinose-resistant derivatives were used
as described previously.33 E. coli was grown aerobically in
Luria broth (LB) at 37 °C and anaerobically in LB
supplemented with 0.5% glycerol, 0.4% TMAO and
1 μM sodium molybdate. Media supplements were used
at the following concentrations: ampicillin, 100 μg/ml;
kanamycin, 50 μg/ml; arabinose, 50 μM; and IPTG, 1 mM
unless otherwise stated. For TOXCATassays, E. coliNT326
cells41 were grown aerobically in LB supplemented with
ampicillin (200 μg/ml) as appropriate.
Plasmid construction
Plasmids used in this study are given in Table 1, and
TatA constructs made in the study are shown in Fig. 1b.
For the His-6- and Strep II™-tagged truncations, PCR was
used to amplify tatA truncated by the relevant number of
codons. Primers were designed to introduce a C-terminal
tag and NcoI/PstI sites during amplification. The NcoI/
PstI-digested PCR-amplified fragments were ligated into
the NcoI/PstI site of pBAD24.
For the TOXCAT assay, residues corresponding to the
TM domain of TatA (residues 4 to 23) were cloned into the
NheI/BamHI site of pccKAN to make plasmid pccTatA.
The TOXCAT chimera is shown in Fig. 1c.
Site-specific mutagenesis was used to mutate tatA in
pBAD-ABC, pEXT-ABC and pccTatA, using the Quik-
change® mutagenesis kit (Stratagene) according to the
manufacturer's instructions. All primers used in this study
are available on request.
TOXCAT assay
The TOXCAT assay was used to investigate the TM
domain of TatA in a natural membrane as described
previously.22 In the TOXCAT system, a chimeric protein is
used, which consists of the α-helical TM domain of interest
inserted between the N-terminal dimerization-dependent
DNA binding domain of ToxR, and the monomeric
periplasmic anchor MBP. The chimera is expressed in
malE-deficient E. coli NT326 cells along with a chloram-
phenicol acetyltransferase (CAT) reporter gene under the
control of the ToxR-responsive ctx promoter. If the TM
domains interact, the ToxR domain is able to dimerize and
activate the ctx promoter, leading to the expression of
Table 1. Plasmids and strains
Relevant properties Reference
E. coli strains
MC4100 F−ΔlacU169 araD139 rpsL150 relA1 ptsF rbs flbB5301 39
MC4100 ΔABCDE tat deletion strain 40
MC4100 ΔAE tatA and tatE deletion strain 6
NT326 F-(argF-lac)U169, rpsL150, relA1, rbsR, flbB5301, ptsF25,
thi-1, deoC1, ΔmalE444, recA, srlA+
41
Plasmids
pBAD24 Cloning vector araC, Ampr 42
pBAD-ABC pBAD24 derivative containing the E. coli tatABC operon
with a Strep II™ tag on the C-terminus of TatC; Ampr
11
pEXT-ABC pEXT22 derivative containing the E. coli tatABC operon; Kanr 35
pBAD-Ah pBAD24 derivative containing the E. coli tatA
gene with a C-terminal His-6 tag; Ampr
33
pccKAN Pkk232-8 (Stratagene) derivative containing the ctx::CAT
reporter construct and the gene encoding the
ToxR′-(kanamycin resistance cassette)-MBP chimera; Ampr and Kanr
22
pccGpA pccKAN derivative containing the GpA TM domain; Ampr 22
pccG83I pccGpA containing the G83I mutation (Gly83→Ile); Ampr 22
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CAT. The level of CAT expression in the cells expressing
the chimera is proportional to the strength of oligomeriza-
tion. The TM domain of GpA, which is known to strongly
dimerize, and its dimerization-defective mutant (G83I)
were used as positive and negative controls, respectively.
Expression levels of the chimera were checked by SDS-
PAGE and Western blotting using anti-MBP antibodies as
described below. Correct insertion and orientation of
chimera in the membrane were confirmed using sodium
hydroxide washes43, protease sensitivity in a spheroplast
assay,22 and the malE complementation assay22 where
cells were grown on M9 agar plates containing 0.4%
maltose. CAT assays were performed using the FAST
CAT® Green (deoxy) Chloramphenicol Acetyltransferase
assay kit (Invitrogen) according to the manufacturer's
instructions.
Peptide sequence and purification
A peptide corresponding to the TM domain of TatA
(TatATM) was synthesized by the Keck Facility at Yale
University using F-moc chemistry. The sequence of the
TatATM peptide was GGISIWQLLIIAVIVVLLFGTKKK,
containing residues G2–K24 from TatA as well as a non-
native lysine residue to aid solubility and end caps on the
C- and N-termini. The peptide was purified by reversed-
phase HPLC using a linear acetonitrile gradient including
0.1% trifluoroacetic acid on a Phenomenex C4 column. The
purity of pooled fractions was confirmed by mass
spectrometry before subsequent lyophilization.
SDS-PAGE and Western blotting
SDS-PAGE of the synthetic peptide was carried out
using NuPAGE 12% Bis–Tris gels (Invitrogen, Paisley,
UK). Peptide concentrations were estimated from the
absorbance at 280 nm using a molar extinction coefficient
(ɛ280) of 5500 mol
−1 cm−1 for TatATM. Peptide visualiza-
tion was achieved by staining with silver nitrate.
Proteins were separated by SDS-PAGE and immuno-
blotted using antibodies to TatA, TatB, GFP (Invitrogen),
MBP (Sigma) or His-6 tag (Invitrogen). TatA, TatB and
GFP were detected using horseradish-peroxidase-conju-
gated anti-rabbit IgG secondary antibody (Promega), and
His-6 tag and MBP were detected using horseradish-
peroxidase-conjugated anti-mouse IgG secondary anti-
body (Promega). The Strep II™ tag was detected directly
using a Streptactin–horseradish peroxidase conjugate
(Institut für Bioanalytik). An ECL detection kit (Amer-
sham Biosciences) was used to visualize the proteins.
TorA activity and TorA–GFP export assay
TorA activity assays were performed as previously
described.11,44 E. coli cells were grown anaerobically for
3.5 h with appropriate amounts of arabinose before being
separated into periplasmic, cytoplasmic and membrane
fractions as described in Ref. 31. Fractions were run on a
10% native gel that was assayed for TorA activity as
described previously. TorA–GFP export assays were
performed as previously described.35 E. coli cells contain-
ing pJDT1 and mutated pEXT-ABC were grown for 2 h in
the presence of 200 μM arabinose to induce the expression
of TorA–GFP. The cells were then washed and grown in
the presence of 1 mM IPTG for 3 h before being separated
into periplasmic, cytoplasmic and membrane fractions.
The presence of TorA–GFP was determined by SDS-PAGE
and immunoblotting with GFP antibodies as described
above.
Blue-native gel electrophoresis
ΔABCDE cells containing pBAD-ABC were grown
anaerobically for 3.5 h with 50 μM arabinose. Membranes
were prepared as described above and solubilized in
50 mM Bis–Tris, pH 7.0, 750 mM 6-aminocaproic acid and
2% (w/v) digitonin. Solubilized membranes were sepa-
rated on a 5–13% gradient polyacrylamide gel. Blue native
gel analysis was performed as described,9 based on the
method described by Schägger et al.37,45 Proteins were
detected by immunoblotting as described above.
Acknowledgements
We thank J. Crawford for peptide synthesis. This
work was supported by an Engineering and
Physical Sciences Research Council studentship to
G.W., by a Medical Research Council Grant to A.M.
D., and by Biotechnology and Biological Sciences
Research Council grants to C.R.
References
1. Muller, M. (2005). Twin-arginine-specific protein
export in Escherichia coli. Res. Microbiol. 156, 131–136.
2. Robinson, C. & Bolhuis, A. (2004). Tat-dependent
protein targeting in prokaryotes and chloroplasts.
Biochim. Biophys. Acta, 1694, 135–147.
3. Chaddock, A. M., Mant, A., Karnauchov, I., Brink, S.,
Herrmann, R. G., Klosgen, R. B. & Robinson, C. (1995).
A new type of signal peptide: central role of a twin-
arginine motif in transfer signals for the delta pH-
dependent thylakoidal protein translocase. EMBO J.
14, 2715–2722.
4. Stanley, N. R., Palmer, T. & Berks, B. C. (2000). The
twin arginine consensus motif of Tat signal peptides is
involved in Sec-independent protein targeting in
Escherichia coli. J. Biol. Chem. 275, 11591–11596.
5. Bogsch, E. G., Sargent, F., Stanley, N. R., Berks, B. C.,
Robinson, C. & Palmer, T. (1998). An essential
component of a novel bacterial protein export system
with homologues in plastids and mitochondria. J. Biol.
Chem. 273, 18003–18006.
6. Sargent, F., Bogsch, E. G., Stanley, N. R., Wexler, M.,
Robinson, C., Berks, B. C. & Palmer, T. (1998).
Overlapping functions of components of a bacterial
Sec-independent protein export pathway. EMBO J. 17,
3640–3650.
7. Weiner, J. H., Bilous, P. T., Shaw, G. M., Lubitz, S. P.,
Frost, L., Thomas, G. H. et al. (1998). A novel and
ubiquitous system for membrane targeting and secre-
tion of cofactor-containing proteins. Cell, 93, 93–101.
8. Gohlke, U., Pullan, L., McDevitt, C. A., Porcelli, I., de
Leeuw, E., Palmer, T. et al. (2005). The TatA component
of the twin-arginine protein transport system forms
channel complexes of variable diameter. Proc. Natl
Acad. Sci. USA, 102, 10482–10486.
9. Oates, J., Barrett, C. M., Barnett, J. P., Byrne, K. G.,
Bolhuis, A. & Robinson, C. (2005). The Escherichia coli
twin-arginine translocation apparatus incorporates a
130 Assembly and Function of TatA Complexes
distinct form of TatABC complex, spectrum of
modular TatA complexes and minor TatAB complex.
J. Mol. Biol. 346, 295–305.
10. Sargent, F., Stanley, N. R., Berks, B. C. & Palmer, T.
(1999). Sec-independent protein translocation in
Escherichia coli. A distinct and pivotal role for the
TatB protein. J. Biol. Chem. 274, 36073–36082.
11. Bolhuis, A., Mathers, J. E., Thomas, J. D., Barrett,
C.M. & Robinson, C. (2001). TatB and TatC form a
functional and structural unit of the twin-arginine
translocase from Escherichia coli. J. Biol. Chem. 276,
20213–20219.
12. Barrett, C. M., Mangels, D. & Robinson, C. (2005).
Mutations in subunits of the Escherichia coli twin-
arginine translocase block function via differing effects
on translocation activity or tat complex structure.
J. Mol. Biol. 347, 453–463.
13. Leake, M. C., Greene, N. P., Godun, R. M., Granjon, T.,
Buchanan, G., Chen, S. et al. (2008). Variable stoichio-
metry of the TatA component of the twin-arginine
protein transport system observed by in vivo single-
molecule imaging. Proc. Natl Acad. Sci. USA, 105,
15376–15381.
14. De Leeuw, E., Porcelli, I., Sargent, F., Palmer, T. &
Berks, B. C. (2001). Membrane interactions and self-
association of the TatA and TatB components of the
twin-arginine translocation pathway. FEBS Lett. 506,
143–148.
15. Greene, N. P., Porcelli, I., Buchanan, G., Hicks, M.
G., Schermann, S. M., Palmer, T. & Berks, B. C.
(2007). Cysteine scanning mutagenesis and disulfide
mapping studies of the TatA component of the
bacterial twin arginine translocase. J. Biol. Chem. 282,
23937–23945.
16. Porcelli, I., de Leeuw, E., Wallis, R., van den Brink-
van der Laan, E., de Kruijff, B., Wallace, B. A. et al.
(2002). Characterization and membrane assembly of
the TatA component of the Escherichia coli twin-
arginine protein transport system. Biochemistry, 41,
13690–13697.
17. Gratkowski, H., Lear, J. D. & DeGrado, W. F. (2001).
Polar side chains drive the association of model
transmembrane peptides. Proc. Natl Acad. Sci. USA,
98, 880–885.
18. Zhou, F. X., Merianos, H. J., Brunger, A. T. &
Engelman, D. M. (2001). Polar residues drive associa-
tion of polyleucine transmembrane helices. Proc. Natl
Acad. Sci. USA, 98, 2250–2255.
19. Lee, P. A., Buchanan, G., Stanley, N. R., Berks, B. C. &
Palmer, T. (2002). Truncation analysis of TatA and
TatB defines the minimal functional units required for
protein translocation. J. Bacteriol. 184, 5871–5879.
20. Barrett, C. M. & Robinson, C. (2005). Evidence for
interactions between domains of TatA and TatB from
mutagenesis of the TatABC subunits of the twin-
arginine translocase. FEBS J. 272, 2261–2275.
21. Hicks, M. G., Lee, P. A., Georgiou, G., Berks, B. C. &
Palmer, T. (2005). Positive selection for loss-of-func-
tion tat mutations identifies critical residues required
for TatA activity. J. Bacteriol. 187, 2920–2925.
22. Russ, W. P. & Engelman, D. M. (1999). TOXCAT: a
measure of transmembrane helix association in a
biological membrane. Proc. Natl Acad. Sci. USA, 96,
863–868.
23. Ding, F. X., Xie, H., Arshava, B., Becker, J. M. &
Naider, F. (2001). ATR–FTIR study of the structure and
orientation of transmembrane domains of the Sacchar-
omyces cerevisiae alpha-mating factor receptor in
phospholipids. Biochemistry, 40, 8945–8954.
24. Melnyk, R. A., Partridge, A. W., Yip, J., Wu, Y., Goto,
N. K. & Deber, C. M. (2003). Polar residue tagging of
transmembrane peptides. Biopolymers, 71, 675–685.
25. Therien, A. G., Grant, F. E. & Deber, C. M. (2001).
Interhelical hydrogen bonds in the CFTR membrane
domain. Nat. Struct. Biol. 8, 597–601.
26. Fisher, L. E., Engelman, D. M. & Sturgis, J. N.
(2003). Effect of detergents on the association of the
glycophorin A transmembrane helix. Biophys. J. 85,
3097–3105.
27. Doura, A. K., Kobus, F. J., Dubrovsky, L., Hibbard, E.
& Fleming, K. G. (2004). Sequence context modulates
the stability of a GxxxG-mediated transmembrane
helix–helix dimer. J. Mol. Biol. 341, 991–998.
28. Dixon, A. M., Stanley, B. J., Matthews, E. E., Dawson,
J. P. & Engelman, D. M. (2006). Invariant chain
transmembrane domain trimerization: a step in
MHC class II assembly. Biochemistry, 45, 5228–5234.
29. Freeman-Cook, L. L., Dixon, A. M., Frank, J. B.,
Xia, Y., Ely, L., Gerstein, M. et al. (2004). Selection
and characterization of small random transmem-
brane proteins that bind and activate the platelet-
derived growth factor beta receptor. J. Mol. Biol.
338, 907–920.
30. Buchanan, G., de Leeuw, E., Stanley, N. R., Wexler, M.,
Berks, B. C., Sargent, F. & Palmer, T. (2002). Functional
complexity of the twin-arginine translocase TatC
component revealed by site-directed mutagenesis.
Mol. Microbiol. 43, 1457–1470.
31. Barrett, C. M., Mathers, J. E. & Robinson, C. (2003).
Identification of key regions within the Escherichia coli
TatAB subunits. FEBS Lett. 537, 42–46.
32. Berthelmann, F., Mehner, D., Richter, S., Linden-
strauss, U., Lunsdorf, H., Hause, G. & Bruser, T.
(2008). Recombinant expression of tatABC and
tatAC results in the formation of interacting cyto-
plasmic TatA tubes in Escherichia coli. J. Biol. Chem.
283, 25281–25289.
33. Bolhuis, A., Bogsch, E. G. & Robinson, C. (2000).
Subunit interactions in the twin-arginine translocase
complex of Escherichia coli. FEBS Lett. 472, 88–92.
34. Larkin, M. A., Blackshields, G., Brown, N. P.,
Chenna, R., McGettigan, P. A., McWilliam, H. et al.
(2007). Clustal W and Clustal X version 2.0.
Bioinformatics, 23, 2947–2948.
35. Barrett, C. M., Ray, N., Thomas, J. D., Robinson, C. &
Bolhuis, A. (2003). Quantitative export of a reporter
protein, GFP, by the twin-arginine translocation
pathway in Escherichia coli. Biochem. Biophys. Res.
Commun. 304, 279–284.
36. Thomas, J. D., Daniel, R. A., Errington, J. & Robinson,
C. (2001). Export of active green fluorescent protein to
the periplasm by the twin-arginine translocase (Tat)
pathway in Escherichia coli. Mol. Microbiol. 39, 47–53.
37. Schagger, H., Cramer, W. A. & von Jagow, G. (1994).
Analysis of molecular masses and oligomeric states of
protein complexes by blue native electrophoresis and
isolation of membrane protein complexes by two-
dimensional native electrophoresis. Anal. Biochem.
217, 220–230.
38. Barnett, J. P., Eijlander, R. T., Kuipers, O. P. &
Robinson, C. (2008). A minimal Tat system from a
gram-positive organism: a bifunctional TatA subunit
participates in discrete TatAC and TatA complexes.
J. Biol. Chem. 283, 2534–2542.
39. Casadaban, M. J. & Cohen, S. N. (1979). Lactose genes
fused to exogenous promoters in one step using aMu-lac
bacteriophage: in vivo probe for transcriptional control
sequences. Proc. Natl Acad. Sci. USA, 76, 4530–4533.
131Assembly and Function of TatA Complexes
40. Wexler, M., Sargent, F., Jack, R. L., Stanley, N. R.,
Bogsch, E. G., Robinson, C. et al. (2000). TatD is a
cytoplasmic protein with DNase activity. No require-
ment for TatD family proteins in sec-independent
protein export.. J. Biol. Chem. 275, 16717–16722.
41. Treptow, N. A. & Shuman, H. A. (1985). Genetic
evidence for substrate and periplasmic-binding-pro-
tein recognition by the MalF and MalG proteins,
cytoplasmic membrane components of the Escherichia
colimaltose transport system. J. Bacteriol. 163, 654–660.
42. Guzman, L. M., Belin, D., Carson, M. J. & Beckwith, J.
(1995). Tight regulation, modulation, and high-level
expression by vectors containing the arabinose PBAD
promoter. J. Bacteriol. 177, 4121–4130.
43. Chen, H. & Kendall, D. A. (1995). Artificial transmem-
brane segments. J. Biol. Chem. 270, 14115–14122.
44. Silvestro, A., Pommier, J., Pascal, M. C. & Giordano,
G. (1989). The inducible trimethylamine N-oxide
reductase of Escherichia coli K12: its localization and
inducers. Biochim. Biophys. Acta, 999, 208–216.
45. Schagger, H. & von Jagow, G. (1991). Blue native
electrophoresis for isolation of membrane protein
complexes in enzymatically active form.Anal. Biochem.
199, 223–231.
132 Assembly and Function of TatA Complexes
